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Abstract 
Neuroblastoma is the most common extracranial solid tumor found in 
children. The long-term survival rate remains low for high-risk group patients in 
spite of the improvement in treatment strategies. Conjugated linolenic acid (CLN) is 
a group of positional and geometrical isomers of octadecatrienoic acid, C-18 
polyunsaturated fatty acid with three conjugated double bonds. Different isomers of 
CLN can be found in minor seed oils at high concentrations. CLN was reported to 
exhibit various biological activities including antioxidative, anti-carcinogenic, 
anti-obesity and hypolipidemic effects. However, the modulatory effects of CLN on 
human neuroblastoma cells and its action mechanisms remain poorly understood. In 
this M. Phil, project, the anti-tumor effects of CLN on the proliferation, apoptosis 
and differentiation of the human neuroblastoma cells were examined. 
Seven isomers of CLN (9Z, HE, 13ECLN;9E, HE, 13ECLN; 8E, lOE, 
12Z CLN; 8E, 1OE, 12E CLN; 9Z, 11E, 13Z CLN; 9E, HE, 13Z CLN and 8Z, 1OE, 
12Z CLN) were shown to exert an anti-proliferative effect on LA-N-1 neuroblastoma 
cells in a dose-dependent manner. Among the seven isomers tested, jacaric acid (8Z, 
lOE, 12Z-CLN) exhibited the most potent effect. The estimated IC50 was about 3.5 
|J,M after 72 hours of treatment. It was found that the three conjugated double bonds 
are important for the strong anti-proliferative effect of CLNs. The anti-proliferative 
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effect of jacaric acid was fairly specific to tumor cells, as it only showed little, if any, 
direct cytotoxicity to normal murine cells and human normal cells at the 
growth-inhibitory concentrations of jacaric acid for LA-N-1 cells. The effect of CLN 
was shown to be non-cell-line-specific. The combination of jacaric acid and daidzein 
or retinoic acid acted in synergy in inhibiting the proliferation of LA-N-1 cells. 
Jacaric acid also significantly suppressed the colony-forming ability of LA-N-1 cells 
in soft agar and their migratory ability in a dose-dependent manner. In addition, 
pre-treatment of the LA-N-1 cells with jacaric acid suppressed the in vivo 
tumorigenicity of the neuroblastoma cells in nude mice. 
Jacaric acid was found to suppress the number of cell division committed 
by LA-N-1 cells. Apoptosis was induced in jacaric acid-treated LA-N-1 cells as 
DNA fragmentation and chromatin condensation were observed. It was supported by 
an increase in the activity of caspase-3, externalization of phosphatidylserine, 
mitochondrial membrane depolarization and an increase in reactive oxygen species 
production in LA-N-1 cells treated with jacaric acid. Morphological study revealed 
that jacaric acid induced differentiation in LA-N-1 cells, as supported by neurite 
outgrowth in the treated cells and a slight increase in cell size and granularity. 
The growth-inhibitory effect of jacaric acid on LA-N-1 cells was reversed 
by a-tocopherol, suggesting the possible involvement of lipid peroxidation in the 
Abstract 
growth inhibition by jacaric acid on neuroblastoma cells. Pre-incubation of LA-N-1 
cells with caspase inhibitors reduced the growth-inhibitory effect of jacaric acid, 
confirming the participation of caspases in jacaric acid-induced growth-inhibition or 
apoptosis. Jacaric acid treatment of LA-N-1 cells lowered the mRNA expression 
levels of N-myc and Max while up-regulating the levels of N-myc antagonists Mad, 
Mga and Mnt. Moreover, the expression of N-myc protein was also suppressed. The 
changes of gene expression levels of the transcription factors by jacaric acid might 
result in the growth-inhibition or differentiation of the LA-N-1 cells. Finally, jacaric 
acid treatment was found to reduce the anti-apoptotic Bcl-2 expression while 
increasing the pro-apoptotic Bak mRNA expression levels in LA-N-1 cells. 
Collectively, our results show that jacaric acid might inhibit the 
proliferation of human neuroblastoma cells by inducing apoptosis, lipid peroxidation 
and/or neuronal differentiation of the cells. Since CLN can be obtained from 
natural products at high concentrations and is relatively non-toxic, it would be a good 
candidate for treatment of neuroblastoma in young patients. Further investigation is 
needed to understand the detailed molecular action mechanisms underlying the 
anti-tumor effects of CLN on neuroblastoma cells so that it could be developed as a 
therapeutic drug for human neuroblastoma. 
-Ill-
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-8，反式-10,順式-12共轭三稀酸（蘭花酸）的抑制細胞增殖作用最為顯著’ 
其抑制細胞增殖達 5 0 % 之濃度於七十二小時估計為 3 . 5 ^ i M � 我們發現共 
輕三稀酸中的三個共輕雙鍵對其顯著抑制增殖作用的重要性。蘭花酸只對 
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氨酸蛋白S每 - 3 )參與蘭花酸引致的生長抑制或細胞调亡。即時定量聚合晦連 
鎖反應的結果顯示，蘭花酸下調N - m y c和M a x轉錄因子的m R N A表達水 
平，同時上調似^7^/, M g a 和轉錄因子的 m R N A 表達。除此之外，透過 
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西方蛋白質印跡實驗， N - m y c 蛋白表達亦有所降低，蘭花酸對 L A - N - 1 細 
胞引起的生長抑制和分化可能與以上轉錄因子的表達水平改變相關。最 
後，蘭花酸降低抗細胞调亡的 B c l - 2表達同時亦升高促進細胞〉周亡的 B a k 
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Chapter 1 ： General Introduction 
1.1 Neuroblastoma 
1.1.1 An overview of neuroblastoma 
Neuroblastoma is the most common extracranial solid tumor in childhood 
(aged 0 - 1 4 years). It is a tumor of the sympathetic nervous system firstly reported 
by Wright in 1910. It is derived from the sympathetic neural precursor cells in the 
neural crest. Neuroblastoma is known to be very heterogeneous in biological and 
genetic features (Brodeur, 2003). Spontaneous regression of the tumor was observed 
in a subset of patients while disseminated and aggressive disease was found in 
another group of children (Castleberry et al., 1997; Cohn et al., 2009). The 
differential clinical behavior of neuroblastoma was found to be associated with 
cellular heterogeneity and extent of cell differentiation (Shimada et al., 2001). The 
cause of neuroblastoma remains poorly understood. Familial cases were reported and 
they only account for less than 5% of all neuroblastomas (Claviez et al,, 2004; Heck 
et al., 2009). About half of the neuroblastoma originates from the adrenal medulla. 
The remaining arises from paraspinal sympathetic ganglia in the chest or abdomen, 
or in the pelvic ganglia (Brodeur, 2003). Neuroblastoma accounts for 6.9% of ail 
childhood cancers in the U.S. (American Cancer Society, 2009) and 6% of those in 
East Asia (Garcia et al., 2007). The overall 5-year survival rate of neuroblastoma is 
70% (American Cancer Society, 2009). An increase in urinary adrenaline was first 
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detected in neuroblastoma patients by Mason et al. (1957) and the first 
internationally accepted staging system for neuroblastoma was proposed by Evans et 
al, (1971). Patients are assessed according to their age, tumor histology, location of 
the tumor and genetic features for allocation into different risk groups. The treatment 
strategies would be prescribed based on the risk group assigned. 
Although neuroblastoma is almost exclusive for children aged below 15 years, 
the treatment strategies share a lot in common with those for adult cancers. 
According to the risk assessment of the neuroblastoma patients, low-risk children 
would be prescribed surgery alone to remove the tumor completely (La Quaglia, 
2005). Nevertheless, high-risk patients would be given multimodal treatment with a 
combination of intensive multi-agent induction chemotherapy, surgery, myeloblative 
consolidation therapy by high-dose chemotherapy followed by autologous bone 
marrow transplantation and control of minimal residual disease with differentiating 
agents (Matthay and Cheung, 2005). Surgery may result in complications including 
massive hemorrhage, respiratory failure and major vascular injury (La Quaglia, 2005) 
depending on the site of tumor to be removed. Radiation may also lead to many side 
effects such as nausea, impaired growth, organ dysfunction and induction of 
secondary malignancies (Wolden and Haas-Kogan, 2005). These may have a 
significant effect on the growth and development for the young patients. Despite the 
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aggressive treatment, the long-term survival rate was less than 40% for the high-risk 
group (Pearson et al., 2008; Zage et al., 2008). Relapse tumor with drug resistance 
was found in about 50% of the high-risk patients in spite of the intensive multimodal 
treatment (Matthay et al., 1999; Weinstein et al., 2003). Novel strategies with lower 
cytotoxic effect and more targeted approach would be necessary to overcome drug 
resistance. 
1.1.2 Classification of neuroblastoma 
Neuroblastoma belongs to a group of cancer called peripheral neuroblastic 
tumors (Tornoczky et al., 2007). According to the International Neuroblastoma 
Pathology Classification (Figure 1.1), neuroblastoma is defined as a peripheral 
neuroblastic tumor which is poor in Schwannian stroma development (Peuchmaur et 
al” 2003). The disease was classified into favourable or unfavourable histology in 
regard to the degree of cell differentiation (namely undifferentiated, poorly 
differentiated and differentiating), age of the patients and the mitosis-karyorrhexis 
index of the neuroblastoma cells. Another more commonly used staging system is 
called International Neuroblastoma Staging System (INSS) (Table 1.1). The system 
takes several factors into account in classifying the stage of the neuroblastoma, 
including the age of the patient, surgical resectability, whether the tumor is 
disseminated and the location of metastatic tumor, etc. This system was easily 
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applied in multicentre setting with relatively low rate of error in staging (Caste 1 et al., 
1999). Later on, the staging system was further modified with the advances in 
understanding the neuroblastoma genetics. Based on the INSS, the neuroblastoma 
patients were allocated into different risk groups with respect to additional clinical 
and biological features (Table 1.2). The information on risk groups can be used 
during the choice of treatment. A recent publication by Monclair et al. (2009) 
reported the limitations of INSS of requiring assessment of lymph node involvement 
and surgical excision before classifying the disease. A new staging method called 
International Neuroblastoma Risk Groups Staging System (INRGSS) was established 
for pre-treatment classification and risk assessment. The short-version staging 
definitions are listed in Table 1.3. Monclair et al. (2009) anticipated that INRGSS 
would not replace INSS but be used in parallel. The major differences between INSS 
and INRGSS are the extension of age group of stage 4S in INSS to 18 months in 
stage MS of INRGSS, based on preoperative imaging and image-defined risk factors, 
and exclusion of lymph node and midline status. In the hope of easier comparison 
among results of different clinical trials in different countries with the use of 
INRGSS, better idea would be provided for the choice of optimal treatment for 
neuroblastoma patients. 
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Figure 1.1 International Neuroblastoma Pathology Classification 
FH: Favourable histology; UH: Unfavourable histology; MKI: mitosis-karyorrhexis 
index; MKC: mitosis-karyorrhexis cells; ** MKC 4%, 200 of 5000 cells 
(Adopted from Peuchmaur et al., 2003) 
Table 1.1 International Neuroblastoma Staging System 
Stage Definition 
1 Localized tumor with complete gross excision, with or without microscopic residual 
disease; representative ipsilateral lymph nodes negative for tumor microscopically (nodes 
attached to and removed with the primary tumor may be positive) 
2 A Localized tumor with incomplete gross excision; representative ipsilateral non-adherent 
lymph nodes negative for tumor microscopically 
2 B Localized tumor with or without complete gross excision, with ipsilateral non-adherent 
lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative 
microscopically 
3 Unresectable unilateral tumor infiltrating across the midline, with or without regional 
lymph node involvement; or localized unilateral tumor with contralateral regional lymph 
node involvement; or midline tumor with bilateral extension by infiltration (unresectable) 
or by lymph node involvement 
4 Any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, 
skin and/or other organs (except as defined for stage 4S) 
4 S Localized primary tumor (as defined for stage 1, 2A or 2B), with dissemination limited to 
skin, liver and/or bone marrow (limited to infants <1 year of age) 
(Modified from Castel et al.’ 1999) -6-
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Table 1.2 Neuroblastoma risk groups based on clinical and biological features 
stage* Low risk Intermediate risk High risk 
1 AJI None None 
2A .2B Age <1 year, or None Aqe 1 -21 years and MVCA/AMP + UH 
age 1 - 2 1 yeans and MYCN 
non-AMR or 
age 1 - 2 1 years and MYCN 
AMP十广 FH 
3 None Age < 1 year and MYCN non-AMF； Age 0 - 2 1 years and MYCNm?, 
or or 
age 1 -21 years and MYCN non-AMP age 1 -21 years aivJ MYCN ivdivAMP + UH 
+ FH 
4 None Age <1 year and MYCN non-AMP Age < 1 year and MYCN Af^-IR 
or 
age 1 -21 years 
4S MVCA/non-AMP; FH; Dl >1 MYCN i ion-AMP; UH; Dl=1 MYCN AMP 
AMP: amplified; DI: DNA index (ploidy); FH: favourable histology; non-AMP: not 
amplified; UH: unfavourable histology 
(Adopted from Brodeur, 2003) 
Table 1.3 International Neuroblastoma Risk Groups Staging System 
Stage Definition 
LI Localized tumor not involving vital structures as defined by the list of 
image-defined risk factors and confined to one body compartment 
L2 Locoregional tumor with presence of one or more image defined risk factors 
M Distant metastatic disease (except stage MS) 
MS Metastatic disease in children younger than 18 months with metastases confined 
to skin, liver, and/or bone marrow 
(Modified from Monclair et al, 2008) 
1.1.3 Epidemiology of neuroblastoma 
Neuroblastoma is extremely rare in adults, therefore most of the 
epidemiological studies are focused on children under 15 years old (Heck et al., 
2009). Each year, approximately 650 new cases of neuroblastoma are diagnosed in 
the U.S. (Goodman et al., 1999). The annual incidence in white children is 10 per 
million and 8 per million in black children in the U.S. (Howman-Giles et al., 2007). 
Comparatively, the annual incidence in Chinese children (4.5 per million) is much 
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lower (Stiller and Parkin, 1992). About 50% of the patients are diagnosed having 
neuroblastoma before 2 years of age and 90% before age of 5 years in the U.S. 
(Howman-Giles et al., 2007). The incidence rate was found to be dependent on age 
strongly, with 29 per million during the second year of life compared to 64 per 
million in infancy (below 1 year of age). It is relatively more common in boys (9.4 
per million) than in girls (8.9 per million) (Goodman et al., 1999). The overall 5-year 
survival rate for neuroblastoma patients aged from 0 to 14 years has improved from 
52.4% in 1975 — 1977 to 74.2% in 1999-2005 (Horner et al, 2009), probably due to 
the advancement in treatment protocols. Patients younger than 18 months old, even 
with metastatic disease, usually have better prognosis than those older than 18 
months old (George et al” 2005; Evans and D'Angio et al., 2005; London et al., 
2005). Over 80% of the children diagnosed with neuroblastoma during infancy were 
alive after 5 years after diagnosis while only 45% of the children diagnosed with 
neuroblastoma after one year old were still alive (Gurney et al., 1999). The 5-year 
survival rate was slightly higher in female (67%) than male (62%) in 1985-94. In 
addition, the rate was slightly higher in white children (64%) than in black children 
(61%) during the same period (Goodman et al., 1999). Neuroblastoma led to death at 
an annual rate of about 6 per million in 1993-95 in the U.S. (Gloeckler Ries, 1999). 
Despite of the intensive multimodal treatment strategy, the prognosis of the subset of 
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children with high-risk neuroblastoma remains poor (Gray and Kohler, 2009). 
Risk factors that were reported to be related to neuroblastoma can be divided 
into a number of categories, including genetic predisposition and familial risk, 
parental demographics, use of tobacco, alcohol and recreational drugs, maternal 
medication use, chronic illness and interventions in pregnancy, infections and 
immunity, gestational age, birth weight, nutrition and growth in early childhood 
(Heck et al” 2009). Increased risk was reported for parental occupation likely to be 
exposed to electromagnetic field, such as telephone operators and power plant 
operators (Olshan et al, 1999). Elevated odd ratios were found in parents with 
exposure to insecticides and petroleum during work (Kerr et al., 2000). Schuz et al. 
(2001) reported positive correlations for maternal use of alcohol, oral contraceptives 
or other sex hormones during pregnancy with neuroblastoma in the offspring. 
Maternal intake of diuretics and antihypertensives during pregnancy was found to 
correlate with increased risk of neuroblastoma (Schuz et al., 2007) whereas vitamin 
intake was associated with reduced risk (Michalek et al., 1996; Olshan et al., 2002). 
For birth characteristics, Hamrick et al. (2001) found correlations between premature 
delivery and very low birth weight with risk of neuroblastoma. The epidemiological 
studies of neuroblastoma did not give consistent results in different research groups 
since some of the surveys strongly depended on the accurate recall and reports from 
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parents. With the limitation of the rarity of neuroblastoma, large-scale studies with 
careful choice of control groups are required to overcome the current challenges. 
1.1.4 Clinical manifestation of neuroblastoma 
The signs and symptoms presented in the neuroblastoma patients depend on 
both the location of the primary tumor and the extent of the disease (Berthold and 
Simon, 2005). The most common presentation is the distension of abdomen due to 
infiltration of cancer cells into the liver and results in liver enlargement 
(Howman-Giles et ai, 2007). The massive hepatomegaly would cause respiratory 
distress and obstruction of kidney or bowel function (Berthold and Simon, 2005). 
Many patients experience weight loss, fever, diarrhea, bone pain and bruising around 
the eyes. Subcutaneous blueberry nodules can be found due to metastasis. 
Hypertension is observed in some of the cases caused by pressure exerted on the 
renal artery by the tumor. Some rarer manifestations include opsomyoclonus-ataxia 
syndrome characterized by rapid and irregular eye movements, and/or ataxia and 
myoclonus of limbs, trunk and eyelids (Berthold and Simon, 2005). 
1.1.5 Diagnosis of neuroblastoma 
To establish a diagnosis of neuroblastoma, either of the following should be 
achieved: (i) Examination of tumor tissue by light microscopy to give an unequivocal 
pathologic diagnosis; (ii) Unequivocal tumor cells are found in bone marrow aspirate 
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or trephine biopsy with an increased level of catecholamine metabolites in urine or 
serum (Berthold and Simon, 2005). Catecholamine metabolites are one of the most 
sensitive and specific markers for neuroblastoma. Determination of the levels of 
catecholamine metabolites such as vanillylmandelic acid, homovanillic acid and 
dopamine in serum and urine is not only useful in diagnosis but can also be applied 
to disease response evaluation (Hero et al., 2001). High levels of a number of 
biochemical markers such as neuron-specific enolase, ferritin and lactate 
dehydrogenase are associated with poor prognosis (Zeltzer et al., 1983; Hann et al” 
1981; Lau 2002). In addition to biochemical markers, genetic markers are also 
assessed in diagnosis of neuroblastoma. The major markers are N-myc amplification, 
DNA content (ploidy changes), deletions of chromosome Ip and l lq and gain of 
chromosome 17q (Schwab, 2005; Howman-Giles et al” 2007). 
There are a number of imaging modalities that can be used in diagnosis, 
examination for resectability and response to therapy in neuroblastoma. For example, 
ultrasonography, computerized axial tomography (CT), magnetic resonance imaging 
(MRl), metaiodobenzylguanidine ( I-MIBG) scintigraphy and positron emission 
tomography (PET) scan (Abramson and Shulkin, 2005). MIBG is an analog of 
catecholamine precursors and it is actively transported into catecholamine storage 
vesicles of catecholamine-secreting cells. It is commonly used in diagnosis of both 
-11-
Chapter 1: General Introduction 
primary and metastatic neuroblastoma as it accumulates in 90% to 95% of the cases 
in the primary site as well as metastatic sites such as bone, bone marrow, lymph 
nodes and soft tissues (Howman-Giles et al., 2007). On the other hand, PET scan 
using ‘ ^ F-fluorodeoxyglucose (FDG) is particularly valuable in examining 
neuroblastomas which do not concentrate MIBG (Abramson and Shulkin, 2005). As 
majority of the neuroblastomas are metabolically active, tumors cells with increase 
glycocytic rate and glucose uptake would accumulate FDG (Howman-Giles et al., 
2007). Prenatal diagnosis of fetal or congenital neuroblastoma can be done during 
routine prenatal ultrasonography (Abramson and Shulkin, 2005). MRI is chosen for 
initial examination of neuroblastoma over CT since it does not involve ionizing 
radiation. It can also be used to detect bone marrow disease. After all the above 
examinations, the information obtained would be used for risk group stratification 
and treatment design. 
1.1.6 Conventional therapy of neuroblastoma 
As mentioned, neuroblastoma patients are classified into different risk groups, 
namely low, intermediate and high. Treatment and disease management is tailored 
based on the risk group. Low-risk neuroblastoma is usually curable with surgery 
alone or with minimal chemotherapy. It is strongly associated with spontaneous 
regression (Kushner and Cohn, 2005). A subset of infants with small adrenal tumors 
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can be monitored safely without any treatment. Surgery is not recommended for 
some patients if the operation would result in acute risks like major organ loss or 
damage to important nerves while the tumor is likely to be stable or regress 
spontaneously. 
For children with intermediate-risk neuroblastoma, the main goal of the 
treatment is to minimize acute and long-term toxicity while maintaining high cure 
rate. In general, modest doses of chemotherapy are prescribed. Removal of residual 
tumor after surgery or radiotherapy may not be necessary since the potential for low-
er intermediate-risk neuroblastoma to progress aggressively is limited (Matthay et al., 
1989; Nickerson et al., 2000). 
The therapy for patients with high-risk neuroblastoma consists of four stages: 
intense multiagent induction chemotherapy, surgery at primary site, high-dose 
marrow ablative therapy and control of minimal residual disease. The induction 
therapy usually consists of cycles using varying combinations of alkylating agents, 
platinum compounds, anthracyclines and epipodophyllotoxins (Wagner and Danks, 
2009). The induction therapy aims to reduce the tumor burden and facilitate later 
surgery. After the completion of the induction therapy, surgical resection of the 
primary tumor would be performed. Through surgery, it is hoped that the tumor cells 
which are resistant to or inaccessible by chemotherapy due to insufficient 
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vascularization can be eliminated (Matthay and Cheung, 2005). It is followed by 
consolidation with myeloablative therapy using high-dose chemotherapeutic drugs 
including carboplatin, etoposide and melphalan. Consolidation is supported by 
autologous hematopoietic stem cell transplantation. Finally, the residual disease is 
managed by focal radiation after recovery from acute effect of myeloablation 
(Wagner and Danks, 2009). Unfortunately, tumor relapse occurs in about 50% of 
high-risk patients with drug resistance (Matthay et al, 1999; Weinstein et al, 2003). 
In addition, the overall cure rate for these patients is less than 40% (Matthay and 
Cheung, 2005; Pearson et al,’ 2008). Novel treatments with lower toxicity are highly 
desirable. 
1.1.7 Novel treatments of neuroblastoma 
There are numerous ongoing clinical trials for relapsed high-risk 
neuroblastoma. Unlike conventional therapy which broadly affects rapidly 
proliferating cells, many of them are focusing on specific targets (Wagner and Danks, 
2009). The most commonly used novel agent other than conventional cytotoxic drugs 
in neuroblastoma treatment is 13-d5-retinoic acid (RA). Matthay et al. (1999) first 
demonstrated the use of 13-c/5-RA increased the 3-year event-free survival rate in a 
clinical trial. RA binds to nuclear retinoid receptors which regulate the expression of 
a number of genes and results in growth inhibition and differentiation induction in 
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neuroblastoma cells. However, Finklestein et al. (1992) found that little activity was 
exerted by IS-cw-RA on advanced metastatic neuroblastoma. 
Immunotherapy is an attractive alternative for neuroblastoma treatment (Gray 
and Kohler, 2009). A number of tumour associated antigens such as tyrosine 
hydroxylase (Lode et al., 2000) and anaplastic lymphoma kinase (Osajima-Hakomori 
et al., 2005) have been studied. To date, the most promising target is monoclonal 
antibodies against a glycosphingolipid disialoganglioside (GD2). GD2 is stably 
expressed at a high density ( 5 - 1 0 million copies per cell) on the cell membranes of 
most of human neuroblastoma cells (Wu et al., 1986; Kramer et al., 2001; Modak 
and Cheung, 2007). A chimeric mouse-human antibody against GD2 called chl4.18, 
designed to lower the generation of human anti-mouse antibodies, showed improved 
anti-tumor activity compared to murine antibodies by inducing antibody-dependent 
cellular cytotoxicity and complement-dependent cytotoxicity (Ozkaynak et al., 2000). 
Simon et al. (2004) reported an increase in overall survival in patients treated with 
chl4.18 (68.5%) after completion of initial treatment compared to those did not 
receive additional therapy (46.8%) and those received a 12-month low-dose 
maintenance chemotherapy (56.6%). 
Novel agents including a soy isoflavone, daidzein and a pentacyclic 
triterpenoid from licorice, glycyrrhizin were examined previously in our group for 
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their anti-tumor effects on neuroblastoma cells. Lo (2007) demonstrated that daidzein 
induced apoptosis and differentiation in murine neuroblastoma cells in vitro. It also 
reduced the in vivo tumorigenicity of human neuroblastoma cells in nude mice. Lee 
(2003) showed that glycyrrhizin and its metabolite 18p-glycyrrhetinic acid exerted 
anti-proliferative and differentiation-inducing effects on neuroblastoma cells in vitro. 
These compounds can be found naturally in soy beans and medicinal herbs. They 
require further investigations and clinical trials before developing into therapeutic 
agents in neuroblastoma treatment. 
1.2 Conjugated linolenic acid 
1.2.1 An overview of polyunsaturated fatty acids and conjugated fatty acids 
Polyunsaturated fatty acids (PUFA) are fatty acids with double bonds in their 
carbon chains (—C=C—C—C=C—). They are named according to the position of the 
first double bond counting from the terminal methyl carbon {n or co) (Colomer et ai, 
2007). n-3 and n-6 fatty acids are two groups of well-known essential PUFAs which 
have been studied intensively on their biological effects. Linoleic acid (18:2^-6), 
y-linolenic acid (GLA, 18:3«-6) and arachidonic acid (20:4«-6) are examples of n-6 
fatty acids. The number before the colon represents the number of carbon in the 
hydrocarbon chain and the number behind the colon indicates the number of double 
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bonds, a-linolenic acid (ALA, 18:3«-3), eicosapentaenoic acid (EPA, 20:5^7-3) and 
docosahexaenoic acid (DHA, 22:6«-3) are examples of fatty acids. Both n-3 and 
n-6 fatty acids have vital functions in our body. Kelley (2001) reported that n-6 fatty 
acids have pro-inflammatory effects whereas n-3 fatty acids are anti-inflammatory by 
competing in the production of inflammatory lipid mediators. It was found that n-3 
fatty acids exhibit inhibitory effect on tumor growth in general while n-6 fatty acids 
have a tumor promoting effect (Escrich et al., 2007; Tsubura et al” 2009). 
Very-long-chain n-3 fatty acids from fish and fish-oil supplements such as EPA and 
DHA were found to reduce cardiac mortality and stroke (Wang et al., 2006). 
Another group of fatty acids which attracted much interest in recent years is the 
conjugated fatty acids. Conjugated fatty acids contain conjugated double bonds 
which are only separated by a single carbon-carbon bond (—C=C—C=C—) (Figure 
1.2). The members of this group of fatty acids include conjugated linoleic acid 
(CLA), conjugated linolenic acid (CLN), conjugated EPA (cEPA) and conjugated 
DHA (cDHA). Conjugated EPA, which is naturally found in seaweed (Lopez and 
Gerwick, 1987) and cDHA, which can be prepared by alkaline isomerization of DHA 
(Igarashi and Miyazawa, 2000) were found to be more potent in growth-inhibitory 
effect on colon cancer cells (Igarashi and Miyazawa, 2000; Danbara et al., 2004) and 
breast cancer cells (Tsujita-Kyutoku, et al., 2004) than their non-conjugated 
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counterparts. 
CLA, which can be found in ruminant products such as milk and meat of 
ruminant animals, was studied in numerous research groups for its health beneficial 
effects. CLA was reported to exert anti-atherogenic (Lee et al., 1994; MacDonald, 
2000; Toomey et al” 2006)， anti-diabetic (Houseknecht et ai, 1998), 
immunomodulatory (Yang and Cook, 2003)，chemopreventive (Lee et al., 2005), and 
most interestingly anti-cancer effect (Bhattacharya et al,, 2006). Despite of the many 
beneficial effects, the occurrence of CLA in food is usually less than 1% (Noguchi et 
al., 2003). On the other hand, the content of CLN, another conjugated fatty acid 
which contains three conjugated double bonds, can be found at high content naturally 
in many minor seed oils. The properties and studies about CLN would be discussed 
in details in the following sections. 
H H H I I I c . c . c . 
/ � � Z � Z c c c I I I 
H H H 
Figure 1.2 Conjugated double bonds 
1.2.2 Chemical structure and physical properties of CLNs 
CLN (or conjugated trienoic acid) refers to a group of positional and 
geometrical isomers of octadecatrienoic acid (18:3) in which the three double bonds 
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are conjugated. The first two isomers isolated were a-eleostearic acid and punicic 
acid (Hopkins and Chisholm, 1962). Seven isomers were isolated and characterized 
so far. They are 8Z, lOE, 12Z CLN; 8E, lOE, 12Z CLN; 8E, lOE, 12E CLN; 9Z, HE, 
13Z CLN; 9Z, HE, 13E CLN; 9E, HE, 13E CLN and 9E, HE, 13Z CLN. Their 
chemical structures are shown in Figure 1.3 - 1.9. 
H � � / W V = V W \ A / h ' 
Fig. 1.3 Structure of cis-%, trans-W, cis-12 conjugated linolenic acid (CLN) isomer 
Fig. 1.4 Structure of trans-8, trans-lO, cis-12 CLN isomer 
HOOC 
Fig. 1.5 Structure of trans-S, trans-10, trans-M CLN isomer 
h � � \ A ^ / = \ A = / V \ 
Fig. 1.6 Structure of cis-9’ trans-\\, cis-\3 CLN isomer 
Fig. 1.7 Structure of cis-9, trans-\\, trans-\3 conjugated CLN isomer 
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HOOC 
Fig. 1.8 Structure of trans-9, trans-\\, trans-\3 CLN isomer 
HOOC ^ ^ ^ � CH, V V V W V ^ \ A / 
Fig. 1.9 Structure of trans-9, trans-11, cis-13 CLN isomer 
CLN isomers are less stable when compared to their non-conjugated 
counterparts (Tsuzuki et al., 2004a). Yang et al. (2009) have performed a detailed 
Study on the oxidative stability of CLNs. When CLNs are heated in the air at 50°C, 
more than 90% would be lost within 22 hours as determined by gas-liquid 
chromatography analyses and headspace oxygen analyses. They are highly 
susceptible to oxidation, with an oxidative stability lower than CLA. The oxidation 
can be slowed down by addition of an antioxidant such as a-tocopherol (Tsuzuki et 
al., 2004c), green tea catechins and butylated hydroxytoluene (Yang et al., 2009). 
Jacaric acid (8Z, lOE, 12Z CLN) and punicic acid (9Z, HE, 13Z CLN) have 
very similar melting points (43.5 - 44°C) and UV spectrum 265, 275, 287 |im) 
(Chisholm and Hopkins, 1962). The UV absorption maxima of CLN isomers are 
listed in Table 1.4. Chisholm and Hopkins (1962) also summarized the melting points 
of CLN isomers determined previously by different research groups (Table 1.5). 
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Table 1.4 Absorption maxima for the CLN isomers (in cyclohexane) 
Configuration Absorption maximum (^m) A 8，10, 12 A 9, 11, 13 
cis-trans-cis 265, 275, 287 (jacaric acid) 265, 275, 287 (punicic acid) 
cis-cis-trans unknown 271 
cis-trans-trans unknown 261，272’ 282 (a-eleostearic acid) 
trans-trans-cis 262, 272，283 (a-calendic acid) 262，272，283 (catalpic acid) 
trans-trans-trans 259, 269，280 (P-calendic acid) 260，269, 281 (p-eleostearic acid) 
Modified from Chisholm and Hopkins, 1962, 
Table 1.5 Melting points of the CLN isomers 
Melting point (°C) 
Configuration A 8，10，12 A 9, 11’ 13 
cis-trans-cis 43.5 - 44 (jacaric acid) 43.5 - 44 (punicic acid) 
cis-cis-trans unknown 3 5 - 3 8 
cis-trans-trans unknown 48 (a-eleostearic acid) 
trans-trans-cis 40 - 40.5 (a-calendic acid) 31.5-31 (catalpic acid) 
trans-trans-trans 77 - 78 (p-calendic acid) 72 (P-eleostearic acid) 
Modified from Chisholm and Hopkins, 1962. 
1.2.3 Natural occurrence of CLNs 
CLNs are found in the seed oils of some terrestrial plants at high level (30 -
80% of total fatty acids) (Koba et al, 2007a). For example, bitter gourd seed oil 
contains 51.1% (w/w) of conjugated trienoic acid (Dhar and Bhattacharyya, 1998). 
Jacaric acid (8Z, lOE, 12Z CLN) is found in jacaranda seeds at a level of 30 - 40% 
while similar content of calendic acid (8E, lOE, 12Z CLN) is found in pot marigold 
(Koba et al., 2007a). Table 1.6 summarizes the natural occurrence of the known CLN 
isomers and their configurations. 
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Table 1.6 Configurations and natural sources of CLN isomers 
Configuration Trivial name Typical source(s) 
C/5-8, trans-10，cis-12 Jacaric acid Jacaranda mimoifolia 
Trans-S, trans-10, cis-\2 a-Calendic acid Calendula officianalis (pot marigold) 
Trans-S, trans-10, trans-\2 p-Calendic acid Calendula officianalis (pot marigold) 
Cis-9, trans-] 1，cis-13 Punicic acid Punicia grannatum (pomegranate) 
Trichosanthes anguina (snake gourd) 
Monordica balsamina 
Cis-9, trans-11，trans-13 a-Eleostearic acid Aleurites fordit (tung) 
Monordica charantia (bitter gourd) 
Prunus mahaleb 
Trans-9, tram-11, trans-13 p-Eleostearic acid Aleurites fordit (tung) 
Trans-9, trans-11，cis-13 Catalpic acid Catalpa ovata 
Modified from Narayan et al., 2006 
1.2.4 Synthesis ofCLNs 
CLN isomers can be chemically synthesized by alkaline isomerization of ALA 
and GLA. However, the product usually consists of a mixture of CLN isomers and 
CLA. The mixture can be separated by high-performance liquid chromatography 
(HPLC) such as Ag+ impregnated HPLC (Cao et al.’ 2006). 
CLNs that are naturally found in seed oils can be isolated with «-hexane at 
room temperature (Suzuki et al., 2001). The formation of CLN in the plant seed was 
found to be catalyzed by a number of enzymes. Cahoon et al. (1999) reported the 
conversion of linoleate moieties, which were bound to phosphatidylcholine, to 
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a-eleostearic acid by an enzyme called A'^-oleic acid desaturase (also named 
conjugase) in the seed of Momordica charantia. The cw-12 double bond of linoleic 
acid is converted into the two trans-\\- and trans-\3 double bonds in a-eleostearic 
acid. Nevertheless, the situation was found to be different in the biosynthesis of 
calendic acid. The cis-9 double bond in linoleic acid was modified into trans-S- and 
trans-\0-doub\Q bonds by a variant of the conjugase found in Calendula officianalis 
(Cahoon et al., 2001). Other enzymes that are involved in the synthesis of different 
CLN isomers are diverged forms of desaturases including hydroxylases, 
epoxygenases and acetylenases (Dyer et al, 2002; Narayan et al； 2006). Figure 1.10 
shows an example how a-eleostearic acid can be synthesized from its precursors. 
Oleic acid (9c) 
vw\rWw 謹 
A12 Desaturase 
Linoleic acid (9c,12c) Oj 2HP 
NAD(P)H • H* NAO(P)* 
AArVWw_ C C ：： ! ^ 丄 一 人 C 
A15 Desaturase 
a-LinolenIc acid (9c,12c,15c) ^^'"^'"""^COOH — /"^^..-^--^COOH 
:-Unol«nic add •Elcocteartc acM 
Figure 1.10 Possible mechanisms involved in formation of a-eleostearic acid. 
(Modified from Narayan et al., 2006; Koba et al., 2007a) 
It is also possible to produce CLNs by recombinant protein technology since the 
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cDNA sequence of the conjugase that converts linoleic acid to CLN has been found. 
Koba et al. (2007b) isolated punicic acid from a plant transfected with a vector 
containing the conjugase gene. This technique can be used industrially to produce 
CLN in a large scale. 
1.2.5 Metabolism and pharmacokinetics of CLNs 
Noguchi et al. (2003) reported that no CLN isomer was detected in the liver 
total lipid and phosphatidylcholine of rats fed with CLN in the diet. On the contrary, 
CLA was found in the liver lipids while no CLA was included in the CLN diet. A 
parallel experiment was performed on mice. CLN isomer was not detected in the 
liver lipid of mice fed with diet containing bitter gourd oil while CLA was found. 
The group also examined the bioconversion of CLN to CLA in cell culture system. 
They found that the level of incorporated CLN in the cells decreased with an increase 
in the CLA level, indicating the bioconversion of CLN to CLA in the cells. 
Another study conducted by Tsuzuki et al. (2004b) demonstrated a significant 
increase in CLA content in the plasma, liver and kidney of rats after orally 
administering tung oil which contains high content of a-eleostearic acid after as short 
as 3 hours. They proposed that a-eleostearic acid was metabolized to CLA by the 
reaction called A13-saturation in the rat liver and small intestine mucosa. Similarly, 
punicic acid was also found to be converted into CLA in the rat intestine (Tsuzuki et 
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ai, 2006). It is proposed that the enzyme responsible for the conversion is probably a 
type of oxidoreductase which is NADPH dependent and able to saturate double 
bonds. 
Conjugated a-linolenic acid (18:3 cis-9, trans-11, cis-15 or 18:3 cis-9, trans-
c/5-15) was found to be preferentially incorporated into neutral lipids. Plourde et al. 
(2006) showed that the two isomers were metabolized into conjugated 22:6 n-3 and 
20:5 n-3 via the elongation/desaturation pathway, which was a bit different from the 
previous reports. 
1.2.6 Major biological and pharmacological activities of CLNs 
1.2.6.1 Hypolipidemic and anti-obese effects 
The modulatory effect of CLN on body fat was studied by a few research 
groups. Dhar and Bhattacharyya (1998) reported that karela oil containing 
a-eleostearic acid increased the cholesterol and triglyceride concentrations in the 
serum of rats, whereas it tended to lower the liver triglyceride. Noguchi et al. (2001) 
demonstrated that bitter gourd oil in the diet significantly lowered the free 
cholesterol levels in rats with a trend of HDL cholesterol increase. In addition, CLN 
prepared by alkaline isomerization of a-linolenic acid significantly increased the 
concentrations of triglyceride in serum and liver of rats (Koba e/ al., 2002). The 
weight of the perirenal adipose tissue of the rats was also markedly lowered. Similar 
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trend was observed for the epididymal adipose tissues. Moreover, the serum 
concentration of cholesterol was significantly lower in the rats fed with CLN than in 
those fed with a-linolenic acid. The hepatic p-oxidation activity was considerably 
higher in the CLN-fed animals. Koba et al. (2002) proposed that the increase in 
triglyceride in liver might be resulted from the overwhelming fatty acid influx which 
exceeded the fatty acid-oxidizing ability of the liver despite the increase in 
p-oxidation activity. On the other hand, reduction in adipose tissue weight might be 
associated with lipolysis in the tissues or reduced triglyceride deposition from 
circulation. Arao et al. (2004a) also found that punicic acid (9Z, HE, 13Z CLN) 
significantly relieved the hepatic triglyceride accumulation in obese, hyperlipidemic 
rats, probably involving the suppression of A-9 desaturation by steroyl-CoA 
desaturase. Another report by Arao et al. (2004b) proposed the hypolipidemic effect 
of punicic acid was due to the lowered triglyceride synthesis and hence lower 
secretion of apolipoprotein BlOO which is an essential component in 
very-low-density lipoprotein. Nevertheless, Yang et al. (2005) reported that CLN was 
not hypocholesterolemic in hamsters. A systematic investigation is required to further 
elucidate the observed effects of CLNs on the body fat composition. 
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1.2.6.2 Anti-cancer effects 
1.2.6.2.1 Anti-proliferation 
Igarashi and Miyazawa (2000) were one of the first few groups to find the 
cytotoxic effect of CLNs on cancer cells. They tested both tung oil and CLN 
prepared by alkaline isomerization of a-linolenic acid. CLN mixture prepared by 
high concentration of KOH contained more conjugated triene (22.5%) and was found 
to be more cytotoxic to the cancer cell lines including colon cancer DLD-1, 
hepatoma HepG2, lung cancer A549 and stomach tubular adenocarcinoma MKN-7. 
Tung seed oil which contains 68% a-eleostearic acid (9Z, HE, 13E CLN) was even 
more potent in the cytotoxicity on the cancer cells compared to the CLN mixture 
chemically prepared. 
Suzuki et al. (2001) tried to compare the cytotoxicity of naturally occurring 
CLNs from seed oils on human monocytic leukemia U-937 cells, mouse normal 
fibroblast cell A31 and the transformed counterpart SV-T2 cells. They demonstrated 
that the seed oils were relatively more cytotoxic in the transformed murine cells than 
their normal counterpart. In addition, Suzuki et al. (2001) proposed the stronger 
cytotoxic effect of 9,11,13-CLN on both murine and human cancer cells compared to 
8,10,12-CLN was due to their differences in oxidative stability. Nevertheless, only 
one 8,10,12-CLN isomer (a-calendic acid in pot marigold seed oil) was tested in the 
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Study compared to three 9,11,13-CLN isomers. 
1.2,6.2.2 Chemoprevention 
Kohno et al. (2004a; 2004b) conducted two parallel investigations on the 
anti-carcinogenic effect of pomegranate seed oil and bitter gourd seed oil on 
chemically induced colonic aberrant crypt foci. Azoxymethane was injected 
subcutaneously to the rats once a week for 2 weeks. Both seed oils were found to 
suppress the carcinogenesis induced chemically. Suzuki et al. (2006) also repeated 
the same experiment with another seed oil from catalpa which is rich in 9E, 1 IE, 13Z 
CLN and obtained similar results. The inhibitory effect was proposed to be 
associated with the increased CLA content in the colon and liver and/or increase in 
the expression of a nuclear receptor called peroxisome pro 1 iferator-activated receptor 
(PPAR)y in the colon. PPARy controls differentiation of adipocytes, systemic glucose 
levels and lipid homeostasis (Willson et al., 2000). The diminished tumor incidence 
may be resulted from the activation of PPARy which was shown to induce growth 
arrest and cell differentiation in colon cancer cells (Sarraf et al., 1998). PPARy would 
be an attractive target in studying the potential therapeutic effects of CLN on other 
cancers. 
1.2.6.2.3 Apoptosis-inducing effect 
Tsuzuki et al. (2004a) first reported the apoptosis-inducing effect of 
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CLN-containing seed oil on colon cancer cells as evidence by DNA fragmentation 
and activation of caspases-3, -8 and -9. They also showed that tung oil which 
contains high percentage of a-eleostearic acid (9Z, HE, 13E CLN) was more potent 
in the apoptosis-inducing effect on the colon cancer cells than CLA. In addition, 
increases in lipid hydroperoxide and TBARS in cells treated with a-eleostearic acid 
indicated the involvement of lipid peroxidation in the growth inhibition. Addition of 
an antioxidant a-tocopherol could suppress the apoptosis induced by a-eleostearic 
acid, furthering confirming the role of lipid peroxidation in the induced apoptosis. 
A more detailed study on the molecular mechanism by which CLN-containing 
seed oil induces apoptosis was conducted by Yasui et al. (2005). a-eleostearic acid 
extracted from bitter gourd seed was found to induce apoptosis in the colon cancer 
Caco-2 cells, as evidenced by the occurrence of DNA fragmentation. An 
anti-apoptotic protein Bcl-2 was shown to be down-regulated in the cells treated with 
bitter gourd extracted fatty acid. The mRNA expression levels of p53 and growth 
arrest and DNA damage-inducible gene 45 (GADD45) were increased by bitter 
gourd oil in a dose- and time-dependent manner. GADD45 and p53 both play an 
important role in growth inhibition and apoptosis induction (Han et al.’ 2003). 
GADD45 was reported to be a downstream gene of p53. The results indicated that the 
bitter gourd seed oil-induced apoptosis may be p53-dependent and via the GADD45 
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pathway. 
In 2006, Yasui et al. (2006a) published another piece of work on the effect of 
aW-trans-CLN isomers (9E, HE, 13E CLN and 8E, lOE, 12E CLN) on human colon 
cancer cells. They demonstrated that a higher level of DNA fragmentation was 
induced in Caco-2 cells by all-^ra;75-isomers compared to the isomers with mixture 
of cis- and trans-doub\Q bonds. Furthermore, the down-regulation of the gene Bcl-2 
which encodes an anti-apoptotic protein and the up-regulation of the gene Bax which 
encodes a pro-apoptotic protein by p-eleostearic acid were greater than those by 
a-eleostearic acid. Further investigations are required to delineate the detailed 
mechanism underlying the apoptosis-inducing activities of CLN on cancer. 
Previous work by our group (Yip, 2007) showed that one of the CLN isomers, 
jacaric acid (8Z, lOE, 12Z CLN), was most potent in inhibiting the growth of human 
promyelocytic leukemia cells in vitro and in vivo. The growth-inhibitory effect was 
found to be attributed to the induction of cell cycle arrest and apoptosis by CLN in 
the cells. The pro-apoptotic proteins were up-regulated by this CLN isomer while the 
anti-apoptotic proteins were down-regulated. This imbalance in the Bcl-2 family 
member triggered mitochondrial membrane permeability, leading to mitochondrial 
release of apoptogenic factors and activation of caspases. 
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1.3 Aims and scope of the study 
CLN is a group of fatty acids which has been reported to exhibit many health 
beneficial effects. The anti-tumor effect of CLN on different tumor cell lines and 
animal models was studied previously by different research groups. However, there 
is little information about the anti-tumor effect of CLN on human neuroblastoma to 
date. Since the long-term survival of high-risk neuroblastoma patients remains poor, 
it would be of great interest and importance to investigate whether CLN is a suitable 
candidate to be developed into a therapeutic agent for neuroblastoma treatment. 
In the present study, seven commercially available CLN isomers listed in 
Section 1.2.2 were compared for their potency in the growth-inhibitory effect on 
human neuroblastoma LA-N-1 cells by MTT reduction assay. In addition, in order to 
confirm the importance of the conjugated double bonds in mediating the 
anti-proliferative effect of CLN, the IC50 values were compared to those of CLA and 
other fatty acids without conjugated double bonds. After determining which CLN 
isomer is the most potent among the seven, it was tested on two other human 
neuroblastoma cell lines SH-SY5Y and SK-N-DZ to ensure its anti-proliferative 
effect is not tumor-cell line specific. The most sensitive cell line was chosen for 
further mechanistic studies. The most potent isomer was then tested for its cytotoxic 
effect on murine normal cells and human normal cells. To find out whether the CLN 
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isomer exert its growth-inhibitory activity on human neuroblastoma cells by direct 
cytotoxicity or via its cytostatic effect, trypan blue exclusion test was performed on 
the CLN-treated neuroblastoma cells. The kinetics and reversibility of the 
growth-inhibitory effect of CLN on the neuroblastoma cells were studied. It would 
be intriguing to examine whether CLN has any effect on the malignant properties of 
neuroblastoma. Therefore, the effect of the CLN isomer on the colony forming ability, 
invasiveness and in vivo tumorigenicity of human neuroblastoma cells were 
investigated. 
The possible mechanisms for the anti-proliferative effect of CLN on the 
neuroblastoma cells include induction of cell cycle arrest, apoptosis and neuronal 
differentiation. Therefore, the cell cycle profile of the CLN-treated neuroblastoma 
cells was analysed by flow cytometry after PI staining. The number of cell division 
committed by the neuroblastoma cells could be followed by CFSE staining with flow 
cytometric analysis. For detection of apoptosis, the biochemical and morphological 
events could be monitored by gel electrophoresis of extracted DNA from the cells to 
detect DNA fragmentation, Hoechst staining to observe chromatin condensation, 
Annexin V/PI dual staining to detect phosphatidylserine externalization, JC-1 
staining to detect mitochondrial membrane depolarization, fluorometric measurement 
of caspase-3 activity and H 2 D C F D A staining to detect the change in reactive oxygen 
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species production. Morphological changes of the CLN-treated neuroblastoma cells 
were observed by microscopic examination and flow cytometry. 
To further understand the underlying mechanisms of the anti-proliferative 
effect of CLN on human neuroblastoma cells, the possible involvements of lipid 
peroxidation, caspase activities, Max/N-myc/Max transcription factor family and 
apoptosis-related genes were investigated. 
-33-
Chapter Two 
Materials and Methods 
Chapter 2: Materials and Methods 
Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Animals 
Inbred BALB/c female mice and inbred BALB/c nude mice (Albino: $ 
nu/+ X hairless: (5^nu/nu) of 6 to 8 weeks old were bred at the Laboratory Animal 
under a specific sterile 
and rodent diet (Chow 
Services Center of The Chinese University of Hong Kong 
condition. They were given ad libitum access to tap water 
5001, Rodent Laboratory). 
2.1.2 Cell lines 
Cell lines used in this study were listed below: 
1) LA-N-1 
LA-N-1 (RCB0483) is a human neuroblastoma cell line derived from the 
metastatic neuroblastoma cells in the bone marrow of a 2-year-old boy (Seeger et al, 
1977). The cell line was purchased from RIKEN BioResource Center Cell Bank, 
Japan. 
2) SH-SY5Y 
SH-SY5Y (ATCC CRL-2266) is a human neuroblastoma cell line subcloned 
three times from the parental SK-N-SH cell line (SK-N-SH SH-SY — SH-SY5 
SH-SY5Y) which was established from a human metastatic neuroblastoma in bone 
marrow tissue (Biedler et al, 1973). The cell line was purchased from American 
Type Culture Collection (ATCC), USA. 
-35-
Chapter 2: Materials and Methods 
3) SK-N-DZ 
SK-N-DZ (ATCC CRL-2149) is a human neuroblastoma cell line derived 
from a poorly differentiated embryonal neuroblastoma of stage IV in a one-year-old 
girl with bone marrow metastasis in 1978 (Sugimoto et al., 1984). The cell line was 
purchased from ATCC. 
4) HEK-293 
HEK-293 (ATCC CRL1573) is a human embryonic kidney cell line. It was 
derived by transformation of primary culture of human embryonic kidney cells with 
sheared fragments of adenovirus type 5 DNA (Graham et aL, 1977). The cell line 
was kindly provided by Prof. W.P. Fong, Department of Biochemistry, The Chinese 
University of Hong Kong, Hong Kong, China. 
5) NIH-3T3 
NIH-3T3 (ATCC CRL1658) is a continuous mouse fibroblast cell line 
consisted of highly contact-inhibited cells which were developed by Jainchill et al. in 
1969. The cell line was bought from the ATCC. 
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2.1.3 Cell culture media, buffers and other reagents 
2.1.3.1 Cell culture reagents 
i) RPMI 1640 medium 
The liquid form of RPMI 1640 medium (GIBCO BRL Life Technologies 
Inc.), containing L-glutamine was used for subculturing of LA-N-1 cells. The 
medium was stored in dark at 4° C until use. 
ii) Dulbecco's Modified Eagle's Medium (DMEM) . 
The powdered form of DMEM medium (GIBCO BRL Life Technologies 
Inc.), containing 4500 mg/L D-glucose, 4 mM L-glutamine, 110 mg/L sodium 
pyruvate and 4 mg/L pyridoxine hydrochloride was used for subculturing of SK-N-
DZ and HEK-293 cells. The powder was dissolved in deionized water and was 
buffered with sodium bicarbonate (NaHCOs) (Sigma-Aldrich Co.). 
iii) DMEM/F12 medium 
The liquid form of DMEM/F12 medium (GIBCO BRL Life Technologies 
Inc.), containing 15 mM N-2-hydroxy-ethyl-piperazine-N'-2-ethane-sulfonic acid 
(HEPES) and L-glutamine was used for subculturing of SH-SY5Y cells. The 
medium was stored at 4° C in dark until use. 
iv) Serum supplements 
Fetal bovine serum (FBS) was bought from GIBCO BRL Life Technologies 
Inc. It was stored as 50 ml and 20 ml aliquots. To prepare heat-inactivated fetal 
bovine serum (HI-FBS), the aliquots were heated at 56° C for 30 minutes. Both 
aliquots were frozen at -20° C for storage. 
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v) Antibiotic solutions 
Two kinds of antibiotic solutions were added to medium in alternate periods. 
One of them is PSN Antibiotic mixture (lOOX) which consists of 5 mg/ml penicillin, 
5 mg/ml streptomycin and 10 mg/ml neomycin. Another one is Antibiotic-
Antimycotic (PSF, lOOX) which consists of 10,000 units/ml penicillin G (sodium 
salt), 10,000 |Lig/ml streptomycin sulphate and 25 |ig/ml amphotericin B as Fungizone 
in 0.85% saline. The stock solutions were bought from GIBCO BRL Life 
Technologies and they were kept at -20° C in 5 ml aliquots for storage. The lOOX 
solutions were added to medium to give 1% antibiotics to reduce the possibility of 
cell culture contamination. 
vi) MEM non-essential amino acids 
MEM non-essential amino acids (NEAA) lOOX solution purchased from 
GIBCO BRL Life Technologies was added to DMEM/F12 medium for subculturing 
of SH-SY5Y cells. The stock solution was kept in dark at 4° C until use. 
vii) Sodium pyruvate solution 
MEM sodium pyruvate 100 mM (lOOX solution) purchased from GIBCO 
BRL Life Technologies was added to DMEM/F12 medium for subculturing of SH-
SY5Y cells. The stock solution was kept in dark at 4° C until use. 
viii) Complete culture media 
"Plain medium" was prepared by adding 1% antibiotic solution to RPMl 
1640, DMEM or DMEM/F12 medium. Complete culture media were prepared by 
supplementing 10 - 15% (v/v) FBS for subculturing of cells, while complete media 
with HI-FBS were used for in vitro bioassays. Complete medium for sub-culturing 
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SH-SY5Y cells was supplemented with 15% FBS, 1 mM sodium pyruvate and 1% 
NEAA. 
ix) Trypsin-EDTA solution 
Trypsin-EDTA solution was bought from GIBCO BRL Life Technologies Inc. 
The solution consists of 0.25 g/L trypsin and 0.38 g/L EDTA-tetrasodium in Hanks' 
balanced salt solution (HBSS) exclusive of calcium and magnesium ions. It was kept 
at -20° C in 20 ml aliquots. 
X) Phosphate-buffered saline (PBS) 
Phosphate-buffered saline was prepared by dissolving 8 g NaCl (137 mM), 
0.2 g KCl (2.7 mM), 0.24 g K H 2 P O 4 (1.5 mM) and 1.15 g NazHPCU (4.3 mM) in one 
litre deionized water. The chemicals were purchased from Sigma-Aldrich Co. The 
pH of the solution was adjusted to 7.4 by adding 1 M HCl or NaOH. The buffer was 
then sterilized by autoclaving at 121° C for 20 minutes. PBS was kept at 4°C until 
use. 
xi) Ammonium chloride potassium (ACK) buffer 
ACK buffer was prepared by dissolving 8.3 g N H 4 C I (150 mM), 1 g K H C O 3 
(10 mM) and 1.8 ml 5% EDTA (0.001 mM) in one litre deionized water and the pH 
of the buffer was adjusted to 7.2 - 7.4 by adding 1 M HCl or NaOH. It was then 
sterilized by filtration and was stored at 4°C until use. N H 4 C I and K H C O 3 were 
bought from Sigma-Aldrich Co. and EDTA was bought from USB Corporation. 
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xii) B P Matrigel™ Basement Membrane Matrix 
The Matrigel™ Basement Membrane Matrix purchased from BD Biosciences 
is a solubilized basement membrane preparation isolated from Engelbreth-Holm-
Swarm (EHS) mouse sarcoma, a tumor rich in extracellular matrix proteins. The 
main ingredient in the MatrigeF"^ is laminin, followed by collagen IV, heparan 
sulphate proteoglycan and entactin. The matrix was used in cell invasion and 
migration studies, as well as xenograft transplantation of human tumor in immune-
suppressed nude mice to increase the success rate. The solution was stored as 300 )il 
aliquots at -20° C and was thawed at room temperature before use. 
xiii) Gelatin (0.1%. w/v) 
Gelatin solution (0.1%, w/v) was used to coat the wells in 24-well microplate 
for LA-N-1 cells in Hoechst 33342 staining assay. The solution was prepared by 
dissolving 1 g of gelatin in 100 ml deionized water and autoclaved at 121° C for 20 
minutes for sterilization. 
2.1.3.2 Chemicals, reagents and dyes 
i) MethV 1thiazoletetrazoHum (MTT) 
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) 
powder was bought from USB Corporation and was dissolved in sterile PBS as 4 
mg/ml stock solution. Thirty microlitres of stock solution was added to each well in 
96-well flat-bottomed microplate. The stock solution was stored in dark at 4° C and 
the container was wrapped by aluminium foil. 
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ii) Thioglycollate (TG) broth 
Thioglycollate (TG) (3%, w/v) broth was prepared by dissolving 3 g of 
thioglycollate powder (Difco Laboratories) in 100 ml deionized water. The solution 
was heated for complete dissolution and autoclaved at 121° C for 20 minutes for 
sterilization. It was stored in dark at room temperature for at least a month before 
use. 
iii) rMethvl-^H1 Thymidine (r^H1-TdR) 
The stock solution with radioactive concentration of 1 mCi/ml and specific 
activity of 2 Ci/mmol was bought from Amersham Life Science Ltd. It was kept at 
4° C as 500 aliquots. The working solution of 25 |j.Ci/ml was prepared by diluting 
the stock solution with complete RPMI medium right before use. In tritiated 
thymidine incorporation assay, 20 [l\ working solution was added to each well of the 
96-well flat-bottomed microplate. 
iv) Liquid scintillation cocktail 
The OptiPhase "Hisafe"2 liquid scintillation cocktail was bought from 
Perkin-Elmer Co. The cocktail was based on biodegradable solvents with dioctyl 
sulfosuccinate, sodium salts and poly(ethyleneglycol)mono(4-nonylphenyl)-ether. It 
can be used readily and stored in dark at room temperature. 
V) Dye solutions 
a) Hemacolor staining solutions 
Hemacolor® Rapid Staining of Blood Smear Set (Merck Chemicals) includes 
three solutions for cell fixing and staining. Solution 1 contains methanol which is for 
fixation. Solution 2 is a reagent in red colour and Solution 3 is a reagent in blue 
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colour. The solutions were used to fix and stain cells grown on 13 mm coverslips for 
cell morphological study. The solutions were stored in dark, light-protected and 
tightly closed glass bottles at room temperature. 
b) Trypan blue solution 
Trypan blue solution was bought from Sigma-Aldrich Co. It consists of 0.4% 
(w/v) trypan blue dissolved in solution of 0.81% (w/v) sodium chloride and 0.06% 
(w/v) dibasic potassium phosphate. The solution was kept at room temperature. 
vi) Fatty acids 
a) Conjugated linolenic acids (CLNs) 
Conjugated linolenic acids used in this study were purchased from Larodan 
Fine Chemicals AB. Their estimated purity was listed in Table 2.1. The stock 
solutions were prepared by dissolving the powder in sterile, culture-tested ethanol 
(Sigma-Aldrich Co.). The working solutions (0.02 M) were prepared by diluting the 
stock 10 fold with ethanol. The stock solutions were kept at -80° C while the working 
solutions were stored at -20° C in dark and used within two months. 
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Table 2.1 Conjugated linolenic acids (CLNs) used in this study 
CLN Estimated purity (%) 
Stock concentration 
(M) 
9(Z), 11 (E), 13(E)-Octadecatrienoic Acid 
(Alpha-Eleostearic Acid) >97.0 0.2 
9(E), 1 l(E),13(E)-Octadecatrienoic Acid 
(Beta-Eleostearic Acid) >97.0 0.2 
8(E), 10(E), 12(Z)-Octadecatrienoic Acid 
(Alpha-Calendic Acid) >97.0 0.2 
8(E), 10(E), 12(E)-Octadecatrienoic Acid 
(Beta-Calendic Acid) > 97.0 0.2 
9(Z), 11 (E), 13(Z)-Octadecatrienoic Acid 
(Punicic Acid) >97.0 0.2 
8(Z), 10(E), 12(Z)-Octadecatrienoic Acid 
(Jacaric Acid) >97.0 0.2 
9(E), 11 (E), 13(Z)-Octadecatrienoic Acid 
(Catalpic Acid) >97.0 0.2 
b) Conjugated linoleic acids (CLAs) 
Conjugated linoleic acids used in this study were purchased from Matreya, 
Inc. Their estimated purity was listed in Table 2.2. The stock solutions were prepared 
by dissolving the powder in sterile, cell culture-tested ethanol (Sigma-Aldrich Co.). 
All stock solutions were kept at -20° C and used within two months. 
Table 2.2 Conjugated linoleic acids (CLAs) used in this study 
CLA Estimated purity (%) 
Stock concentration 
(M) 
9(E), 11 (E)-Octadecadienoic acid >98.0 0.2 
9(Z),1 l(E)-Octadecadienoic acid >98.0 0.2 
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c) Linolenic acids 
Linolenic acids used in this study were purchased from Larodan Fine 
Chemicals AB. Their estimated purity was listed in Table 2.3. The stock solutions 
were prepared by dissolving the powder in sterile, cell culture-tested ethanol (Sigma-
Aldrich Co.). All stock solutions were kept at -20° C and used within two months. 
Table 2.3 Linolenic acids used in this study 
Common Name Chemical Name Estimated purity (%) 
Stock 
concentration (M) 
a-linolenic Acid 9(Z), 12(Z), 15(Z)-octadecatrienoic Acid > 9 9 0.2 
y-linolenic Acid 6(Z)，9(Z)，12(Z)-octadecatrienoic Acid >99 0.2 
d) Stearic acid (octadecanoic acid) 
Stearic acid (Sigma-Aldrich Co.) has an estimated purity higher than or equal 
to 98.5%. The stock solution (25 mM) was prepared by dissolving the powder in 
sterile, culture-tested ethanol and it was kept at 4° C. It was a kind gift from Prof. K.P. 
Fung, Department of Biochemistry, The Chinese University of Hong Kong, Hong 
Kong, China. 
vii) g-Tocopherol (Vitamin E) 
a-Tocopherol (Sigma-Aldrich Co.) has an estimated purity higher than or 
equal to 96%. It is an antioxidant which is shown to protect cells from oxidative 
stress. The stock was stored at 4° C. Working solution (0.45 M) was freshly prepared 
before use by diluting the stock (with density of 0.95g/ml) in ethanol. 
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viii) Daidzein 
Daidzein (4',7-Dihydroxyisoflavone) has an estimated purity higher than 99%. 
It was purchased from LC Laboratories. The stock solution (0.2 M) was prepared by 
dissolving the powder in sterile, cell culture-tested dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich Co.). It was kept at -20° C in dark and used within two months. 
ix) Retinoic acid 
Retinoic acid (Sigma-Aldrich Co.) has an estimated purity higher than or 
equal to 98%. The stock solution (0.2 M) was prepared by dissolving the powder in 
sterile, cell culture-tested DMSO (Sigma-Aldrich Co.). It was kept at -20° C in dark. 
X) Caspase-3 inhibitor IV 
The inhibitor Ac-DMQD-CHO is a specific caspase-3 inhibitor. The stock 
solution (20 mM) was prepared by dissolving the white solid in DMSO. It was kept 
at-20° C in dark. 
xi) Caspase inhibitor III 
The inhibitor benzyloxycarbonyl-Asp(OMe)fluoromethylketone (Boc-D-
FMK) is a broad-spectrum cell-permeable and irreversible caspase inhibitor. The 
stock solution (20 mM) was prepared by dissolving the white solid in DMSO. It was 
kept at -20° C in dark. 
2.1.3.3 Agar for colony forming assay 
Agar powder purchased from Sigma-Aldrich Co. was dissolved in deionized 
water by gentle boiling in water bath to form 1.6% (w/v) and 3% (w/v) solution. The 
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solidified solutions were stored at 4° C and were heated in water bath to melted form 
before use. 
2.1.4 Reagents for DNA extraction 
i) IGEPAL CA-630 lysis buffer 
The buffer was prepared with 20 mM EDTA and 3% non-ionic detergent 
IGEPAL CA-630 ((Octylphenoxy) polyethoxyethanol) in 50 mM Tris 
[hydroxymethyl] amino methane (Tris)-HCl of pH 7.5. It was stored at room 
temperature. 
ii) Sodium dodecyl sulphate SDS (5%, w/v) 
The SDS solution (5%, w/v) was prepared by dissolving 5 g of SDS powder 
(USB Corporation) in 100 ml deionized water. It was stored at room temperature. 
iii) TinEnj buffer 
The buffer contains 10 mM Tris-HCl (pH 7.5) and 0.1 mM EDTA in 
deionized water. It was kept at room temperature. 
iv) RNase A 
RNase A, extracted from bovine pancreas, was purchased from USB 
Corporation. The stock solution was prepared by dissolving RNase A powder in 
TioEo.i buffer at a concentration of 10 |xg/)xl. The stock solution was boiled for 15 
minutes for denaturation of any contaminated DNase and then kept as 500 |il aliquots 
a t - 2 0 � C . 
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V) Proteinase K 
Proteinase K is a highly active subtilisin kind of protease which was isolated 
from Tritirachium album Limber. The stock solution (20 |ag/}il) was prepared by 
dissolving the proteinase powder (USB Corporation) in autoclaved deionized water 
and stored at -20° C as 500 fil aliquots. 
vi) Sodium acetate solution fNaOAc) (3 M, pH 5.2) 
The 3 M stock solution was prepared by dissolving 24.61 g NaOAc powder 
(Sigma-Aldrich Co.) in 100 ml deionized water and the pH was adjusted to 5.2 with 
glacial acetic acid. The solution was sterilized by autoclaving at 121° C for 20 
minutes and was stored at room temperature. 
2.1.5 Reagents for gel electrophoresis of nucleic acids 
i) 5X Tris-borate-EDTA (TBE) buffer 
The 5X buffer stock was prepared by dissolving 54 g Tris, 27.5 g boric acid 
and 20 ml 0.5 M EDTA in one litre deionized water. The pH of the buffer was 
adjusted to 8.0. The stock solution was diluted to 10 fold with deionized water for 
preparation of working buffer (0.5X). Both the stock and the working buffer 
solutions were kept at 4° C. 
ii) 5X gel loading solution 
The gel loading solution consists of 0.05% (w/v) bromophenol blue, which 
acts as a tracking dye; 40% (w/v) sucrose, which increases the density of the sample 
and facilitates loading; 0.1 M EDTA, which inhibits the catalytic activity of enzymes 
that require divalent cations and 0.5% (w/v) SDS, which facilitates DNA-protein 
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complexes dissociation. The loading solution was used for non-denaturing agarose 
gel electrophoresis of nucleic acids. One volume of the solution was mixed with four 
volumes of DNA sample before loading into the wells of agarose gel. The solution 
was stored at room temperature. 
iii) 100 bp DNA ladder 
100 bp DNA ladder (1 |Lig/|al) was bought from Invitrogen Life Technologies. 
The working solution (0.1 |ag/|al) was prepared by diluting the stock to 10 fold using 
TioEo.i buffer. The stock solution was stored at -20° C while the working solution 
was kept at 4° C. 
iv) Agarose gel 
Agarose-LE powder was bought from USB Corporation. Agarose gels (1% 
and 2%, w/v) were prepared by dissolving 10 g (for 1% gel) and 20 g (for 2% gel) of 
agarose in one litre 0.5X TBE buffer. Then the solutions were heated at 7 0 � C with 
continuous stirring until all the powder dissolved and the solutions became clear. 
They were stored at room temperature in a closed container. The solidified agarose 
gel was heated in the microwave oven to melted form before use. 
V) Ethidium bromide (EtBr) 
The powdered form of EtBr (Sigma-Aldrich Co.) was dissolved in deionized 
water to prepare the stock solution (10 mg/ml). Working solution (1 )ig/ml) was 
prepared by diluting the stock to 10,000 fold using deionized water. Both the stock 
and working solutions were stored in dark at room temperature. 
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2.1.6 Reagents and buffers for flow cytometry 
i) Propidium iodide (PI) DNA staining solution 
The PI DNA staining solution was prepared by adding 20 |il PI (40 p-g/ml) 
(from Sigma-Aldrich Co.) and 1 |LI1 RNase A (8 fxg/ml) (from USB Corporation) into 
979 (il PBS right before use. The PI stock and PBS were stored at 4° C whereas 
RNase A stock solution was kept at -20° C. The container of PI stock was wrapped 
by aluminium foil. 
ii) Carboxvfluorescein diacetate succinimidyl ester (CFSE) 
CFSE is a fixable-cell-permeant, fluorescein-based tracer for long-term cell 
labeling. It was purchased from Molecular Probes Inc. and the stock solution (5 mM) 
was prepared by dissolving the compound in DMSO. The stock solution was stored 
at -20° C in dark. The staining solution was prepared by diluting the stock solution 
with PBS to a concentration of 20 }j.M. 
iii) Annexin V-Green Fluorescent Protein (GFP) fusion protein 
Annexin V-GFP fusion protein used in this study was purchased from Prof. 
S.K. Kong's research group, Department of Biochemistry, The Chinese University of 
Hong Kong, China. The stock solution was stored at -20° C in dark. 
iv) Annexin V binding buffer 
Annexin V binding buffer was prepared by mixing 10 mM HEPES at pH 7.4, 
150 mM NaCl, 5 mM KCl, 1 mM MgCb and 2 mM CaCb. The chemicals were 
purchased from USB Corporation and the buffer was kept at 4° C. 
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V) JC-1 staining solution 
5,5',6,6'-tetrachloro-l,r,3,3'-tetraethylbenzimidzoylcarbocyanine iodide 
(JC-1) was purchased from Molecular Probes Inc. JC-1 is a cationic carbocyanine 
dye that accumulates in mitochondria. The stock solution was prepared by dissolving 
the compound in dehydrated DMSO at a concentration of 5 mg/ml. It was stored at -
20° C in dark and diluted to 10 fiM in PBS before use. To facilitate solvation, the 
staining solution was sonicated for 3 minutes right before use. 
vi) 2\7'-Dichlorodihvdrofluorescein diacetate (H^DCFDA) 
H2DCFDA, purchased from Calbiochem, is a cell-permeable fluorogenic 
probe for detection of reactive oxygen species (ROS) and nitric oxide (.NO). It can 
be used to determine the degree of overall oxidative stress in cells. The stock solution 
(10 mM) was prepared by dissolving 4.873 mg in 1 ml DMSO and kept at -20° C in 
dark. The working solution was prepared freshly before use by diluting the stock 
solution to 100 jxM in PBS. 
vii) Ethanol (70%. v M 
Absolute ethanol (analytical grade) was bought from Merck Biosciences. By 
diluting 70 ml absolute ethanol with 30 ml deionized water, ethanol (70%, v/v) for 
cell fixation in cell cycle analysis was prepared. It was stored at 4° C. 
2.1.7 Reagents and buffers for measuring caspase activity 
i) Cell lysis buffer 
The buffer consists of 1% (v/v) IGEPAL CA-630 (Sigma-Aldrich Co.), 150 
mM NaCl, 50 mM Tris-HCl, 1 mM EDTA and one tablet of Complete Protease 
-50-
Chapter 2: Materials and Methods 
Inhibitor Cocktail (Roche Diagnostics) in 50 ml deionized water. The pH of the 
buffer was adjusted to 7.5. The buffer was stored at 4° C. 
ii) Dithiothreitol (DTD 
DTT (GIBCO BRL Life Technologies Inc.) was dissolved in deionized water 
to make up 1 M stock solution. It was added to the reaction buffer (2X) to a final 
concentration of 10 mM to stabilize the enzymes with free sulfhydryl groups in order 
to elicit the full enzymatic activity. The stock solution was stored at -20° C. 
iii) Bovine serum albumin (BSA) 
Bovine serum albumin, purchased from Sigma-Aldrich Co., was dissolved in 
deionized water to make up stock solutions of 2 mg/ml and 10 mg/ml. Stock solution 
of 2 mg/ml was used in construction of protein standard curve during quantification 
of protein samples. Stock solution of 10 mg/ml was added to 2X reaction buffer to a 
final concentration of 100 )ig/ml. Stock solutions of both concentrations were stored 
at-20°C. 
iv) Reaction buffer (2X) 
The 2X reaction buffer consists of 20 mM HEPES-KOH (pH 7), 80 mM p-
glycerophosphate, 100 mM NaCl, 4 mM MgCb, 10 mM EGTA, 0.2% CHAPS. The 
buffer was stored at 4°C. DTT (10 mM) and BSA (100 |ig/ml) were added to the 
buffer right before use. 
V) Bradford reagent 
The Bradford reagent (Sigma-Aldrich Co.) was a 2X solution. During 
determination of protein concentration, one volume of the Bradford reagent was 
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mixed with one volume of diluted protein samples. The Bradford reagent was stored 
at 4° C and the container is light-exclusive. 
vi) Caspase-3 inhibitor. Ac-DEVD-CHO 
Acetyl-Asp-Glu-Val-Asp-aldehyde (Ac-DEVD-CHO) was purchased from 
Alexis Biochemicals. It is a specific reversible caspase-3 inhibitor. The stock 
solution (10 mM) was prepared by dissolving 1 mg lyophilized peptide powder in 0.2 
ml DMSO. The working solution (1 mM) was prepared by diluting the stock solution 
with RPMI medium. Both the stock and working solutions were kept in dark at 
-20° C. 
vii) Caspase-3 substrate, Ac-DEVD-AMC 
N-acetyl-Asp-Glu-Val-Asp-7-Amido-4-methylcoumarin (Ac-DEVD-AMC) 
was purchased from Sigma-Aldrich Co. It is a fluorogenic substrate for caspase-3. 
The stock solution was prepared by dissolving the powder in DMSO at a 
concentration of 2 mM. It was kept at 20° C in dark. 
viii) 7-Amino-4-methvl coumarin (AMC) 
AMC (Sigma-Aldrich Co.) was used as a standard calibrator during 
quantification of caspase-3 activity. The stock solution was prepared by dissolving 
powder in DMSO at a concentration of 50 mM. It was further diluted to 100 |iM in 
lysis buffer. Both solutions were stored at 4° C in dark until use. 
-52-
Chapter 2: Materials and Methods 
2.1.8 Reagent for Hoechst staining 
Hoechst 33342 
Hoechst 33342 nucleic acid stain (Molecular Probes Inc.) is a cell-permeable 
nuclear counterstain which emits blue fluorescence when bound to double-stranded 
DNA. The stock solution (10 mg/ml) was stored at 4° C and protected from light. The 
working solution was prepared freshly by diluting the stock solution by 1000-fold 
with PBS before use. 
2.1.9 Reagents and buffers for total RNA extraction 
i) TRIZOL® Reagent 
The reagent is a mono-phasic solution of phenol and guanidine isothiocyanate. 
It is a ready-to-use reagent purchased from Invitrogen Life Technologies Inc. It was 
used to isolate RNA by disrupting cells and dissolving cell components. The reagent 
was stored at 4° C in dark. 
ii) DEPC-treated deionized water 
Diethyl pyrocarbonate (DEPC) was purchased from Sigma-Aldrich Co. The 
liquid was added to deionized water to make up 0.1% (v/v) solution. The solution 
was shaken and mixed thoroughly and then stood overnight. It was autoclaved at 
121° C for 20 minutes to destroy the remaining DEPC. The 0.1% solution can 
inactivate RNase, thus protecting RNA against degradation. 
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iii) Chloroform 
Chloroform (BDH Laboratory Supplies) with purity of 99.0 - 99.4% was used 
with TRJZOL® Reagent to extract RNA. The stock was stored at room temperature 
while the aliquot was stored at 4° C. 
iv) Isopropanol 
Isopropanol (BDH Laboratory Supplies) with purity of 99.7% was used to 
precipitate RNA. The stock was stored at room temperature while the aliquot was 
stored at 4° C. 
V) Ethanol (75%. w/v) 
Absolute ethanol (analytical grade) was bought from Merck Biosciences. By 
diluting 75 ml absolute ethanol with 25 ml DEPC-treated deionized water, ethanol 
(75%, v/v) for washing RNA was prepared. The solution was stored at 4° C. 
2.1.10 Reagents and buffers for DNA digestion 
i) DNase I (Amplification Grade) 
Deoxyribonuclease I (Invitrogen Life Technologies) was used to digest DNA 
during RNA purification. The enzyme was purified from bovine pancreas and has a 
specific activity of > 10,000 U/mg. It was stored in buffer containing 20 mM sodium 
acetate (pH 6.5), 5 mM CaCb, 0.1 mM PMSF and 50% (v/v) glycerol. The 
concentration of the solution is 1 U/|LI1 and it is ready-to-use. It was stored at - 2 0 ° C . 
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ii) DNase I reaction buffer riOX) 
The lOX buffer (Invitrogen Life Technologies) contains 200 mM Tris-HCl 
(pH 8.4), 20 mM MgCb and 500 mM KCl. It was stored at - 20�C. 
iii) EDTA (25 mM) 
EDTA (25 mM, pH 8.0) was purchased from Invitrogen Life Technologies. It 
was added to the reaction mixture after DNA digestion to inactivate the DNase I. The 
EDTA solution was stored at -20° C. 
2.1.11 Reagents and buffers for reverse transcription 
i) RNaseOUT™ recombinant ribonuclease inhibitor 
RNaseOUT™ (Invitrogen Incorporation) is a potent non-competitive 
inhibitor of pancreatic-type ribonucleases such as RNase A. It is an acidic protein 
with a molecular mass of around 52 kDa. It can inhibit the activities of RNase A, 
RNase B and RNase C. It was purified using affinity chromatography from E. coli 
expressing a cloned porcine gene. Its purity is greater than 90% and its specific 
activity is larger than 80,000 units/mg. One unit is defined as the amount which will 
inhibit 5 ng of RNase A by 50%. Its concentration is 40 units/|al and it was stored in 
a buffer consisting of 20 mM Tris-HCl (pH 8.0), 50 mM KCl, 0.5 mM EDTA, 8 mM 
DTT and 50% (v/v) glycerol. It was stored at -20° C and required 1 mM DTT to 
maintain activity. 
ii) M-MLV reverse transcriptase 
Moloney murine leukemia virus reverse transcriptase (M-MLV RT) was 
purchased from Invitrogen Incorporation. It is a recombinant DNA polymerase that 
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synthesizes a complementary DNA strand from single-stranded RNA or DNA in the 
presence of a primer. It was purified from E. coli expressing the pol gene of M-MLV 
on a plasmid. It has a concentration of 200 units/|il and it was stored in a buffer 
consisting of 20 mM Tris-HCl (pH 7.5)，100 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 
0.01% (v/v) NP-40 and 50% (v/v) glycerol. One unit of M-MLV RT is the amount of 
enzyme required to incorporate one nmole of deoxyribonucleotide into acid-
precipitable material in 10 minutes at 37° C using poly(A)*oligo(dT)25 as template-
primer. The enzyme was stored at -20° C. 
iii) First-strand buffer (5X) 
The buffer (5X) was purchased from Invitrogen Incorporation. It contains 250 
mM Tris-HCl (pH 8.3 at room temperature), 375 mM KCl and 15 mM MgCb. It was 
stored at -20° C. 
iv) Deoxyribonucleoside triphosphate (dNTP) 
Deoxyribonucleoside triphosphate set (PCR grade, sodium salt) was 
purchased from Roche Applied Science. It contains 4 individual vials of dATP, 
dCTP, dGTP and dTTP, each as a 100 mM solution of sodium salt. To prepare a 100 
|xl working dNTP mix, 10 )j,l of each deoxyribonucleoside stock was mixed with 60 
|xl of DEPC-treated deionized water. Both the stock set and the working mix were 
stored at -20° C. 
v) 01igo(dT)i9.is primer 
01igo(dT)i2-i8 primer was purchased from Invitrogen Life Technologies. It 
hybridizes to the poly(A) tail of mRNA. The primer was supplied at a concentration 
of 0.5 )xg/|4.1 in DEPC-treated water. The working solution of primer was prepared by 
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diluting the stock to 0.1 g^/)Lil with TioEo.i buffer. Both the stock and working 
solutions were stored at -20° C. 
vi) DTT (0.1 m 
Dithiothreitol (O.IM) was purchased from Invitrogen Incorporation. It was 
stored at -20° C. 
viilTj^E 丄 buffer 
The buffer contains 10 mM Tris-HCl (pH 7.5) and 1 mM EDTA in DEPC-
treated deionized water. All the chemicals were purchased from USB Corporation 
and the buffer was stored at room temperature. 
2.1.12 Reagents for real-time polymerase chain reaction (PGR) 
i) Primer pairs 
The specific oligonucleotide primer pairs used in real-time PCR were 
designed based on the published cloned cDNA sequences and were intended to prime 
on the sense and antisense sequences of the corresponding cDNA. The annealing 
temperature of the primers ranged from 56° C to 61° C. The designed primers were 
synthesized by Invitrogen Life Technologies and the lyophilized primer pairs were 
then reconstituted in DEPC-treated deionized water to a working concentration of 2.5 
)iM. They were stored at -20° C as 500 [i\ aliquots. The sequences of the primers and 
the predicted size of PCR products were shown in Table 2.4. 
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Table 2.4 Primers used in real-time PCR and the predicted size of PCR products 
cDNA 
amplified Strand Sequence (5，to 3，） 
Predicted size of 
the amplified PCR 
product(bp) 
Mad Sense GGC AGG TGA CAC AAA GGA T 218 
Antisense GCA TTC AAA AGG GAC CTC A 
Mnt Sense TGC GAG ACT CTG ATG G 166 
Antisense GAC AGC AAT AGC AGC A 
ii) Power SYBR® Green PCR Master Mix 
The master mix was purchased from Applied Biosystems and was stored at 
4°C. 
iii) Tag Man® Universal PCR Master Mix 
The master mix was purchased from Applied Biosystems and was stored at 
4°C. 
iv) TaqMan® Gene Expression Assays 
TaqMan® Gene Expression Assays (Applied Biosystems) for Bak 
(Hs00832876), Bcl-2 (Hs00608023), GAPDH (Hs99999905), Mad (Hs00231137), 
Max (Hs00231142), Mga (Hs00289686), Mnt (Hs00232758) and N-myc 
(Hs00232074) were stored at -20° C. Each pre-formulated assay (20X mix) contains 
two unlabelled PCR primers (900 nM each final concentration) and one FAM™ dye-
labelled TaqMan® MGB probe (250 nM final concentration). 
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2.1.13 Reagents and buffers for Western blotting 
i) Cell lysis buffer 
The buffer consists of 1% (v/v) IGEPAL CA-630 (Sigma-Aldrich Co.), 150 
mM NaCl, 50 mM Tris-HCl, 1 mM EDTA and one tablet of Complete Protease 
Inhibitor Cocktail (Roche Diagnostics) in 50 ml deionized water. The pH of the 
buffer was adjusted to 7.5. The buffer was stored at 4° C. 
ii) Bradford reagent 
The Bradford reagent (Sigma-Aldrich Co.) was a 2X solution. During 
determination of protein concentration, one volume of the Bradford reagent was 
mixed with one volume of diluted protein samples. The Bradford reagent was stored 
at 4° C and the container is light-exclusive. 
iii) Bovine serum albumin (BSA) 
Bovine serum albumin (Sigma-Aldrich Co.) was dissolved in deionized water 
to make up a stock solution of 2 mg/ml. The stock solution was used in construction 
of protein standard curve by diluting with deionized water to concentrations of 2 - 10 
|_ig/ml. The powder was stored at 4° C while the stock solution was stored at -20° C. 
iv) Lower buffer for separating gel 
The lower buffer was prepared by dissolving 18.15 g Tris (USD Corporation) 
in 100 ml deionized water to make up 1.5 M solution and the pH was adjusted to 8.8. 
The buffer was stored at 4° C. 
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V) Upper buffer for stacking gel 
The upper buffer was prepared by dissolving 6 g Tris (USD Corporation) in 
100 ml deionized water to make up 0.5 M solution and the pH was adjusted to 6.8. 
The buffer was stored at 4° C. 
vi) Sodium dodecvl sulphate (SDS) solution 
The SDS solution (10%, w/v) was prepared by dissolving 10 g of SDS 
powder (USB Corporation) in 100 ml deionized water. It was stored at room 
temperature. 
vii) Acrvlamide/ bis solution (30%, w/v) 
N，N’-methylene-bis-acrylamide electrophoresis purity reagent (37.5:1) was 
purchased from Bio-Rad Laboratories. The 500 ml ready-to-use solution contains 
146.1 g acrylamide and 3.9 g N,N'-methylene-bis-acrylamide at a total monomer to 
crosslinker ratio of 37.5:1. It was stored 4° C in a light-exclusive container. 
viii) N,N,N，,N’-Tetra-methvlethvlenediamine (TEMED) 
TEMED was purchased from Bio-Rad Laboratories and was stored at 4° C. It 
was added to catalyze the polymerization of acrylamide in SDS-polyacrylamide gel. 
The container was light-exclusive. 
ix) Ammonium persulfate (APS) 
Ammonium persulfate was purchased from Bio-Rad Laboratories. The 
working solution (10%, w/v) was prepared by dissolving 0.1 g APS powder in 1 ml 
deionized water. The solution was stored at -20° C. 
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X) Sample loading buffer (4X) 
The loading buffer was prepared by mixing 2 ml glycerol, 2 ml upper buffer, 
2 ml 10% (w/v) SDS, 0.4 ml 0.05% (w/v) bromophenol blue, 0.2 ml 2-
mercaptoethanol and 1.4 ml deionized water. The buffer was stored at 4°C and 
protected from light. 
xi) Novex® Sharp Protein Standard 
The protein standard was purchased from Invitrogen Corporation. It consists 
of 12 pre-stained protein bands in the range of 3.5 - 260 kDa. It was prepared in 65 
mM Tris (pH 6.5)，30% glycerol, 2% SDS and 2.5 mM EDTA. It is in a ready-to-use 
form and stored at -20° C. 
xii) SDS running buffer O OX) 
The lOX buffer was prepared by dissolving 30.3 g Tris base (pH 8.6), 144 g 
glycine and 10 g SDS to one litre deionized water. The IX running buffer was 
freshly prepared by diluting the lOX stock solution to 10-fold with deionzied water. 
All the chemicals were purchased from USB Corporation and the solutions were 
stored at 4° C. 
xiii) Transfer buffer OOX) 
The lOX buffer was prepared by dissolving 30.3 g Tris base (pH 8.6) and 144 
g glycine in one litre deionized water. The IX working transfer buffer was prepared 
by diluting 40 ml lOX buffer with 360 ml deionized water and mixed with 100 ml 
methanol (Fisher Scientific). The buffer solutions were stored at 4° C. 
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xiv) Polyvinylidene fluoride (PVDF) membrane 
The PVDF membrane with a pore size of 0.45 was purchased from 
Millipore Corporation. It was stored at room temperature and cut into size of 8.5 cm 
X 5.5 cm before use. 
XV) Filter paper 
Whatman 3MM chromatography paper with thickness of 0.34 mm was cut 
into size of 8.5 cm x 5.5 cm for the use as transfer filter paper. 
xvi) TBS-Tween washing buffer dOX) 
The buffer contains 100 mM Tris (pH 7.5), 1 M NaCl and 1% (v/v) Tween 20 
(Sigma-Aldrich Co.) in deionized water. The working IX buffer was freshly 
prepared by diluting the lOX buffer to 10-fold with deionized water. The solutions 
were stored at 4° C. 
XVii) Non-fat milk solution (5%, w/v blocking solution) 
The blocking solution was prepared freshly by dissolving 0.25 g Nestle non 
fat milk powder in 5 ml washing buffer for each membrane to make up a 5% solution. 
xviii) Primary antibodies 
a) Mouse anti-p-actin monoclonal antibodv 
The antibody was derived from the AC-74 hybridoma produced by the fusion 
of mouse myeloma cells and splenocytes from an immunized mouse. It was 
purchased from Sigma-Aldrich Co. It recognizes an epitope at the N-terminal of p-
isoform of actin in tissues from many species including human, bovine, mouse, rat, 
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chicken, fruit fly, etc. The antibody is in a form of ascites fluid with 0.1% sodium 
azide added as a preservative. It was stored at -20° C. 
b) Rabbit anti-N-myc polyclonal antibody 
The antibody is an affinity purified rabbit polyclonal antibody against a 
peptide mapping within the C-terminus of N-myc of human origin. It was purchased 
from Santa Cruz Biotechnology. It can be used to detect N-myc (67 kDa) of mouse, 
rat and human origin. Each vial contains 200 jig IgG in 1 ml PBS with less than 0.1% 
sodium azide and 0.2% gelatin. The antibody was stored at 4° C. 
xix) Secondary antibodies 
ECL™ Anti-mouse IgG, horseradish peroxidase linked whole antibody from 
sheep and ECL™ Anti-rabbit IgG, horseradish peroxidase linked whole antibody 
from donkey were purchased from Amersham Biosciences. They were supplied in 
phosphate-buffered saline of pH 7.35, containing 1% (w/v) BSA and anti-microbial 
agent. They were stored at 4° C. 
XX) Western blotting luminol reagents 
The reagents (Santa Cruz Biotechnology) consist of solutions A and B. The 
solutions were mixed in a ratio of 1:1 right before use. The solutions were stored at 
4° C in light-exclusive containers. 
xxi) X-ray films 
The medical X-ray films were purchased from Fujifilm Corporation. They 
were stored at 4° C in dark. 
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2.2 Methods 
2.2.1 Culture of cell lines 
The human neuroblastoma cell line LA-N-1 was seeded in complete RPMI 
1640 medium containing 1% antibiotics and supplemented with 10% FBS as 
continuous adherent cultures. The human neuroblastoma cell line SH-SY5Y was 
cultured in DMEM/ F12 medium supplemented with 1% antibiotics, 15% FBS, 1 
mM sodium pyruvate and MEM NEAA. Another human neuroblastoma cell line SK-
N-DZ and the human embryonic kidney cell line HEK-293- were maintained in 
DMEM supplemented with 1% antibiotics and 10% FBS. All the cell lines were 
cultured in 75 or 150 cm^ tissue culture flask and incubated at 37° C in a humidified 
incubator supplying 5% CO2. The cell lines were subcultured every 2 - 4 days 
depending on the doubling time of the cell line. Cells in exponential growth phase 
were used for different assays. The cell lines can be stored for long period by 
cryopreservation in liquid nitrogen. The medium for cryopreservation consists of 
50% FBS, 40% RPMI and 10% DMSO. 
For subculture of LA-N-1 cells, the cells were detached by gentle pipetting. 
For subculture of the adherent cell lines HEK-293, SH-SY5Y and SK-N-DZ, the 
medium was discarded and the adherent cells were washed with warm PBS once. 
The cells were then incubated with 1 ml (for 75 cm^ culture flask) or 2 ml (for 150 
cm2 culture flask) warm trypsin-EDTA solution at 37° C for 2 minutes. Complete 
RPMI medium was added to the mixture to stop the process of trypsinization. The 
cell suspension was then centrifuged and a suitable amount of cells was seeded into a 
new tissue culture flask with fresh complete medium. 
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2.2.2 Preparation of NIH-3T3 conditioned medium 
NIH-3T3 cells (2 x 10^) were seeded in a 100 mm culture dish overnight. The 
medium was then replaced with 10 ml serum-free RPMI 1640 medium. After further 
incubation of 48 hours, the conditioned medium was collected and the cells were 
removed by centrifugation. The conditioned medium was then filtered through a 
syringe filter with 0.2 |im pore size. The filtered conditioned medium was stored at 
4°C. 
2.2.3 Determination of cell viability 
1) MTT reduction assay 
The cell lines (1 x 10^ cells/ml) were seeded into 96-well flat-bottomed 
microplates and incubated with different concentrations of CLNs in the wells for 24, 
48 or 72 hours at 37° C in a humidified incubator with 5% CO2 supply. Cells treated 
with diluted ethanol acted a solvent control. After incubation, 30 |il of MTT solution 
(4 mg/ml) was added to the wells and incubated for further 2 to 4 hours. The plate 
was taken to centrifugation at 300 x g for 10 minutes and the medium was replaced 
with 50 |il DMSO to dissolve the purple formazan. The absorbance of the samples 
was measured at 540 nm by a microplate reader (Bio-Rad Laboratories). The results 
were expressed as average percentage cell viability 土 standard error (S.E.) of 
quadruplicate cultures. The percentage of cell viability was calculated as follows: 
0/0 viability = [OD540 of test sample/ OD540 of control] x 100% 
2) Trypan blue exclusion assay 
Trypan blue exclusion assay was used to determine the number of viable cells 
in the cultures. It is based on the integrity of plasma membrane and the ability of the 
viable cells to exclude the trypan blue dye. The cells were treated with different 
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concentrations of jacaric acid for 24，48 or 72 hours at 37° C in a humidified 
incubator with 5% CO2 supply. After incubation, the cells were detached and the 
suspension underwent centrifugation. The pellet was resuspended in fresh medium. 
Ten microlitres of cell suspension was mixed with 10 |il of trypan blue solution, and 
10 of the mixture was drawn and filled the chamber of hematocytometer by 
capillary action. Viable cells exclude the dye and remain visible cell bodies while 
dead cells without intact membrane were stained blue. The number of both viable 
and dead cells was counted under a light microscope and the percentage of cell 
viability was calculated by the following equation: 
0/0 viability = (number of viable cells/ total number of cells counted) x 100% 
2.2.4 Determination of cell proliferation by tritiated thymidine 
([^H]-TdR) incorporation assay 
LA-N-1 cells (1 X 10^  cells/ml) were seeded into the wells of 96-well flat-
bottomed microplates and cultured overnight. The cells were then incubated with 
different concentrations of CLNs in the wells at 37° C for 72 hours in a humidified 
incubator with 5% CO2 supply. Then the cells were pulsed with 0.5 fiCi [^H]-TdR in 
20 complete medium for 6 hours at 37° C in the incubator. After incubation, the 
microplates were transferred to a -20° C freezer for overnight. The microplates were 
thawed in a 37° C incubator in the next day and the cells were harvested onto a glass 
microfiber filter plate by a cell harvester (Packard FilterMate™). The filter plate was 
air-dried and then sealed with adhesive Backseal on the bottom. Liquid scintillation 
cocktail (30 |il) was added into each well on the plate. The radioactivity, which was 
expressed in counts per minute (cpm), was measured using a microplate scintillation 
and luminescence counter (TopCount® NXT™). The results were expressed as the 
-66-
Chapter 2: Materials and Methods 
average percentage inhibition of [^H]-TdR incorporation 土 S.E. of quadruplicate 
cultures, comparing to the untreated cells which acted as a control. The percentage 
inhibition of [^H]-TdR incorporation was calculated using the following equation: 
% inhibition = [(cpm of control - cpm of test sample)/ cpm of control] x 100% 
2.2.5 Cytotoxicity test of CLNs on murine peritoneal macrophages 
One millilitre 3% thioglycollate broth was injected intraperitoneally (i.p.) into 
each BALB/c mouse aged between 6 to 8 weeks. The mice were then sacrificed after 
3 days by cervical dislocation. The mice were placed on a clean surface with ventral 
side facing up and the skin of the abdomen was cleaned with 70% ethanol. The skin 
was then cut and pulled apart so that the abdominal wall was exposed. Plain RPMI 
medium (3 ml) and equal volume of air was injected into the abdominal cavity using 
a 5 ml syringe fitted with a 20-gauge needle and the peritoneal cavity was washed 3 
times to collect the peritoneal exudate cells (PEC). The PEC were washed with cold 
plain RPMI medium and resuspended in complete RPMI medium at a density of 
10^/ml for further use. 
Murine PEC at a cell density of 5 x 10^ cells/ml in complete RPMI medium 
were introduced into the wells of 96-well flat-bottomed microplate and incubated at 
37° C for 3 hours to allow attachment of the cells to the well. The wells were then 
washed with warm plain RPMI medium to remove the non-adherent cells. Different 
concentrations of CLNs were added to the peritoneal macrophages and the cells were 
incubated for 24 hours at 37° C. The viability of macrophages was determined by 
MTT reduction assay (Section 2.2.3). 
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2.2.6 Cytotoxicity test of CLNs on murine bone marrow cells 
BALB/c mice aged between 6 to 8 weeks were sacrificed by cervical 
dislocation. The skin of the mouse was wetted and sterilized with 70% ethanol. The 
femurs were removed with aseptic techniques and put into a Petri dish containing 
cold complete medium. The ends of the bones were cut and the bone marrow cells 
were flushed out with a 2 ml syringe fitted with a 25 G needle containing complete 
RPMI medium in the Petri dish. The cell suspension was transferred to a conical 
culture tube and centrifuged at 300 x g for 5 minutes. The cells were resuspended in 
ACK buffer for 5 minutes to lyse the red blood cells by osmotic pressure to obtain 
bone marrow cells. The cell suspension was washed with RPMI medium and then 
introduced into the wells of 96-well flat-bottomed microplate. Different 
concentrations of CLNs were added to the bone marrow cells and the cells were 
incubated for 24 hours at 37° C. The viability of the bone marrow cells was 
determined by MTT reduction assay (Section 2.2.3). 
2.2.7 Cytotoxicity test of CLNs on murine splenocytes 
BALB/c mice aged between 6 to 8 weeks were sacrificed by cervical 
dislocation. The skin of the mouse was wetted and sterilized with 70% ethanol, A 
small dorsoventral incision was made through the skin of the left flank and the skin 
was pulled apart. After making a small incision through the peritoneum, the spleen 
was exposed and removed. The fatty or connective tissues attached to the spleen 
were removed and the spleen was put in a Petri dish containing 5 ml of complete 
RPMI 1640 medium. The spleen was cut into small fragments with scissors and the 
fragments were gently pressed through a sterile wire sieve in complete medium using 
the piston from a 5 ml plastic disposable syringe. The cells were collected by 
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centrifugation and resuspended in complete RPMI 1640 medium. The cells were 
seeded into wells of 96-well flat-bottomed microplate and incubated with different 
concentrations of CLNs for 24 to 48 hours at 37° C in a humidified incubator with 
5% CO2 supply. The viability of splenocytes was determined by MTT reduction 
assay (Section 2.2.3). 
2.2.8 Cytotoxicity test of CLNs on human peripheral blood 
mononuclear cells (PBMC) 
A pack of human peripheral blood donated by healthy individual was 
provided by the Hong Kong Red Cross Blood Transfusion Service through the Prince 
of Wales Hospital, Shatin, Hong Kong. The blood was subjected to centrifugation on 
Ficoll-paque gradient to eliminate dead cells and red blood cells. The PBMC 
obtained were washed twice with plain RPMI 1640 medium and resuspended in 
complete medium. The cells were seeded into wells of 96-well flat-bottomed 
microplate and incubated with different concentrations of CLNs for 48 hours at 37° C 
in a humidified incubator with 5% CO2 supply. The viability of PBMC was 
determined by MTT reduction assay (Section 2.2.3). 
2.2.9 CFSE staining analysed by flow cytometry 
LA-N-1 cells (5 x 10^) were stained with 20 |iM CFSE at room temperature 
for 7 - 8 minutes with occasional mixing on day 0. Unbound CFSE was quenched by 
adding 1 ml FBS to the cell suspension. The stained cells were then serum starved 
for 24 hours until day 1. Analysis of the fluorescent intensity of 1 x 10^ cells was 
performed by flow cytometry to determine the initial reading. The remaining cells 
were supplemented with 10% serum and treated with either solvent control (0.02% 
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ethanol) or different concentrations of jacaric acid ( 2 - 4 fxM) for 4 days (i.e. until 
day 5). The cells were harvested and the fluorescent intensity of the cells was 
measured by the FACSCanto flow cytometer (BD Biosciences) with excitation at 
488 nm and emission at 525 nm. 
2.2.10 Determination of colony forming ability 
An agar base layer consisted of 1 ml agar (1.5%) in complete medium was 
overlaid in 35-mm 6-well plate. The 1.5% agar in complete medium mixture was 
prepared by adding 450 i^l melted 3% agar to 450 i^l RPMl 1640 medium (2X) with 
2% antibiotics and 100 [i\ FBS. The upper layer containing 2.5 x lO"^  LA-N-1 cells in 
1 ml agar (0.8%) in complete medium was overlaid on top of the base layer in the 
35-mm wells. The upper layer was prepared by adding 450 |il melted 1.6% agar to 
LA-N-1 cells suspended in 450 RPMI 1640 medium (2X) with 2% antibiotics, 
jacaric acid or solvent control, and 100 |xl FBS. Each treatment was performed in 
triplicate cultures. The plates were incubated at 37° C in a humidified incubator with 
5% CO2 supply. Colonies were visible after 14 to 21 days and were counted under a 
light microscope with 100-fold magnification. 
2.2.11 Determination of cell invasiveness 
The in vitro cell invasiveness of untreated or jacaric acid-treated LA-N-1 
cells was measured using Transwell plates (Costar, USA) with polycarbonate 
membrane having pore size of 8 |im. The upper compartment of each Transwell was 
coated with 30 |LI1 Matrigel while the lower compartment was filled with NIH-3T3 
conditioned medium. LA-N-1 cells (1 x 10^) treated with solvent control (0.02% 
ethanol) or jacaric acid ( 2 - 4 jiM) for 48 hours and resuspended in 100 |j.l complete 
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medium was applied on the Matrigel layer in the upper compartment. Each treatment 
was performed in triplicate cultures. After 24 hours of incubation at 37° C in a 
humidified incubator with 5% CO2 supply, the cells on the upper side of the 
membrane were removed by a cotton swab. Cells on the lower side of the membrane 
were fixed and stained with Hemacolor® staining solutions. The number of cells on 
the lower surface of the membrane was counted under a light microscope with 320-
fold magnification in 5 random fields. 
2.2.12 In vivo tumorigenicity assay 
Human neuroblastoma LA-N-1 cells (5 x 10^) were incubated with solvent 
control (0.02% ethanol) or different concentrations of jacaric acid for 16 hours at 
37° C in a humidified incubator with 5% CO2 supply. The cells were then harvested 
and washed with PBS once. The cells were then resuspended in plain RPMI 1640 
medium at a concentration of 5 x 10^/ml. Cell suspension (100 ^1) was mixed with 
100 \x\ BD M a t r i g e l ™ and then inoculated subcutaneously on the back of female 
inbred BALB/c nude mice with a 1 ml syringe fitted with a 25-gauge needle. The 
tumor volume was measured every other day using a vernier caliper. The volume 
was calculated using the formula [volume = length x width x height x 兀/6]. The body 
weight of the mice and the tumor weight were measured at the end of the experiment 
after sacrificing the mice by cervical dislocation. 
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2.2.13 Analysis of cell cycle profile/ DNA content by flow cytometry 
LA-N-1 cells (1 X 10^) were synchronized overnight and incubated with 
different concentrations of jacaric acid for 24 and 48 hours. The cells were collected 
and washed with PBS by spinning at 720 x g for 3 minutes. They were then fixed 
with 1 ml 70% ethanol at 4° C for 30 minutes. After fixing, the ethanol was removed 
by centrifuging at 720 x g for 10 minutes and then washed with PBS once. The cell 
pellets were resuspended in 1 ml freshly prepared propidium iodide (PI) staining 
solution consisting of 20 \i\ PI (40 |ig/ml) and 1 i^l RNase A (8 (ig/ml). The 
suspension was incubated in dark at 37° C for 30 minutes upon gentle shaking. The 
stained cells were analyzed for fluorescent intensity by the FACSCanto™ flow 
cytometer (BD Biosciences) with ModFit LT 3.0 programme (Verity Software 
House). 
2.2.14 Measurements of apoptosis 
i) Detection of DNA fragmentation by agarose gel electrophoresis 
LA-N-1 cells (3 x 10^) were treated with various concentrations of jacaric 
acid for 16, 48 or 64 hours at 37° C. After incubation, the cells were collected and 
washed with PBS once by centrifugation at 580 x g for 3 minutes. The cell density 
and viability were determined by cell counting with trypan blue. At least 2 x 1 0 ^ 
cells were spun down at 720 x g for 5 minutes and treated with 200 |il lysis buffer 
(3% IGEPAL cA630, 20 mM EDTA and 50 mM Tris pH 7.5) at 37° C for 10 minutes. 
After incubation, the samples were centrifuged at 6,000 x g for 5 minutes and the 
DNA fragments were obtained in the supernatant. The supernatants were transferred 
to new tubes and 50 |li1 5% sodium dodecyl sulphate (SDS) was added to each tube. 
The samples were stored at 4° C until use. 
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The samples were incubated with 10 |il RNase A (10 fxg/jil) at 56° C for 1.5 
hours to digest cellular RNA. After that, 20 fil proteinase K (20 jxg/^l) was added and 
incubated for further 1.5 hours at 56° C to remove RNase and other proteins. The 
DNA was precipitated with 30 |LI1 3 M NaOAc and 750 |il of ice-cold 100% ethanol. 
The mixture was centrifuged at 20,000 x g for 30 minutes at 4°C. The DNA pellet 
was washed with 70% ice-cold ethanol and then 100% ethanol. The supernatant was 
discarded and the pellet was air-dried. The dried pellet was resuspended in 20 i^l 
TioEo.i buffer at 37° C until the pellet was completely dissolved. The DNA samples 
were warmed at 65° C for 5 minutes before separated by agarose gel electrophoresis 
to denature any secondary structures. Each sample (20 )LI1) was mixed with 5 |il of 5X 
gel loading solution while 8 [i\ of 100 bp DNA ladder was mixed with 2 fxl of 5X gel 
loading solution. The samples were loaded into the wells of 2% agarose gel and 
underwent electrophoresis at a constant voltage (90 V). The current was stopped 
when the tracking dye reached the opposite end of the gel. The gel was stained with 
EtBr for 5 minutes and destained with distilled water for 10 minutes. The DNA 
bands were detected by UV illumination using Gel Doc 2000 UV transilluminator 
(Bio-Rad Laboratories). 
ii) Annexin V-GFP/PI dual staining as measured by flow cytometry 
LA-N-1 cells and SH-SY5Y cells (1 x 10^) were treated with various 
concentrations of CLNs for different periods of time at 37° C in culture dishes. The 
control and treated cells were detached by gentle pipetting and collected. The cells 
were washed with PBS by centrifugation at 720 x g for 3 minutes. The pellets were 
resuspended in 0.5 ml Annexin V binding buffer. The cells were kept on ice 
throughout the course. Reaction binding buffer (0.5 ml) containing 5 |xl Annexin V-
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GFP fusion protein and 2 |xl PI (1 mg/ml) was added to the resuspended cells. The 
reaction mixture was incubated in dark for 15 minutes at room temperature. The 
samples were then analyzed for PerCP-Cy5.5 (emission wavelength: 695 nm) versus 
FITC fluorescence (emission wavelength: 525nm) using the FACSCanto™ flow 
cytometer (BD Biosciences). The percentages of cell population in the four quadrants 
were calculated by the WinMDI software (version 2.9). 
iii) Detection of mitochondrial membrane potential changes (JC-1 staining) 
LA-N-1 and SH-SY5Y cells (1 x 10^) were treated either with solvent control 
(0.03% ethanol) or different concentrations ( 2 - 6 |xM) of jacaric acid for 24 hours at 
37°C in culture dishes. After incubation, the cells were washed once with warm PBS 
and trypsinized for 3 to 5 minutes until the cells detached. Complete medium was 
added to stop the trypsinization and the cells were collected by centrifugation. The 
cell pellet was resuspended in 1 ml JC-1 staining solution (10 |xM JC-1 in PBS) and 
incubated in dark at 37° C for 15 minutes upon gentle shaking. The samples were 
then analyzed for PE (emission wavelength: 575 nm) versus FITC fluorescence 
(emission wavelength: 525 nm) using the FACSCanto™ flow cytometer (BD 
Biosciences). The percentage of cell population with mitochondrial membrane 
depolarized was calculated by the WinMDI software (version 2.9). 
iv) Detection of intracellular reactive oxygen species (ROS) generation 
LA-N-1 and SH-SY5Y cells (1 x 10^) were treated either with solvent control 
(0.03 % ethanol) or different concentrations (0 - 6 |iM) of jacaric acid for 18 to 24 
hours at 37° C in culture dishes. The control and treated cells were detached by gentle 
pipetting and collected. The cells were washed with PBS by centrifugation at 720 x g 
for 3 minutes. The cell pellets were resuspended in freshly diluted H2DCFDA 
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solution (100 |iM in PBS) and incubated in dark at 37° C for 30 minutes upon gentle 
shaking. The fluorescent intensity of the stained cells was measured by the 
FACSCanto™ flow cytometer (BD Biosciences) with excitation at 488 nm and 
emission at 525 nm. The data from flow cytometric analysis were analyzed by the 
WinMDI software (version 2.9). For quantitative analysis, the cells were treated in 
96-well microplate. After staining with H2DCFDA, the fluorescent intensity was 
measured by the Polarion automated microplate fluorescent reader (Tecan) at with 
excitation at 488 nm and emission at 535 nm. 
V) Measurement of caspase-3 activity 
LA-N-1 cells (5 x 10^) were seeded in culture flask and cultured overnight. 
The cells were then either treated with solvent control (0.03% ethanol) or different 
concentrations of jacaric acid (2 - 6 |J.M) for 48 hours at 37°C. The cells were 
harvested and then lysed with lysis buffer (50 jj.1 / 10^ cells) on ice for 10 minutes. 
After incubation, the lysate was vortexed vigorously and then centrifuged at 20,000 x 
g for 5 minutes at 4�C. The supernatant containing caspases was taken to determine 
the protein concentration by Bradford protein assay. Briefly, BSA standard solutions 
( 2 - 1 0 ^ig/ml) were set up by diluting BSA stock solution (2 mg/ml) with deionized 
water. Protein samples (1 |il) were diluted in 500 |LI1 deionized water and mixed with 
500 \x\ Bradford reagent (Sigma-Aldrich Co.). The absorbance at 595 nm was 
measured by BioPhotometer (Eppendorf) and the protein concentrations were 
calculated using the BSA standard curve. 
The protein samples were diluted to a concentration of 1 p-g/^l and 50 of 
diluted samples were mixed with 50 p-l of reaction buffer (2X). Control was set up by 
adding specific caspase-3 inhibitor Ac-DEVD-CHO (1 |al) to the 100 |j.l reaction 
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mixture in order to ensure the specificity of the signal detected. The reaction 
mixtures with inhibitor were incubated at 37°C upon gentle shaking while the ones 
without inhibitor were kept on ice for 30 minutes. Specific caspase-3 substrate Ac-
DEVD-AMC (0.5 fil) was added to all reaction mixtures and incubated at 37°C upon 
gentle shaking for 1 hour in dark. After incubation, the reaction mixtures were 
transferred to a microplate and the fluorescent intensity was measured at excitation 
360 nm and emission at 465 nm by Polarion fluorescent plate reader (Tecan). The 
specific caspase-3 activity was calculated against an AMC standard curve. The AMC 
standard curve was plotted by serial dilution of AMC stock solution to 
concentrations of 5 |jM, 2.5 i^M, 1.25 |J.M and 0.625 |a.M with lysis buffer. 
vi) Hoechst 33342 staining 
The wells of a 24-well microplate were first coated with 0.1% (w/v) gelatin. LA-
N-1 cells (2.5 X 10"^ ) were seeded to the wells and cultured overnight. The cells were 
incubated either with solvent control (0.02 % ethanol) or different concentrations of 
jacaric acid ( 0 - 4 (j-M) at 37°C for 48 hours. After incubation, the cells were fixed 
with 70% ethanol for 20 minutes, followed by washing with PBS. The cells were 
then stained with Hoechst 33342 staining solution (10 |ig/ml) for 20 minutes in dark. 
The cells were observed under a fluorescent microscope (Nikon TE2000) for 
ultrastructural changes. 
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2.2.15 Measurements of differentiation 
i) Cell morphological study 
LA-N-1 cells (2 x lO* cells/well) or SH-SY5Y cells (2.5 x 10^ cells/well) 
were seeded on 13 mm sterile thermanox plastic cell culture coverslip (Nunc™) in a 
24-well plate overnight. The cells were incubated either with solvent control (0.01% 
ethanol) or different concentrations of jacaric acid ( 0 - 2 |LIM) for 72 to 96 hours at 
37�C in a humidified incubator with 5% CO2 supply. The cells were then fixed with 
methanol and stained with Hemacolor® staining solutions. After destaining with PBS, 
the coverslips were washed with deionized water once and then mounted onto glass 
slides. The cell morphology was observed under the Axioskop II light microscope 
(Carl Zeiss, Inc.). 
ii) Analysis of morphological changes by flow cytometry 
Flow cytometry can measure multiple cellular parameters such as cell size 
and internal complexity based on light scattering properties of the cells. Side scatter 
refers to light scattered by particles to an angle of 90° from the illuminating beam 
and is related to the granularity of the cells. Forward scatter refers to light scattered 
by cells in the liquid stream in the range of 1° to 10° off the axis of the illuminating 
light and is related to the size of the cells. LA-N-1 cells or SH-SY5Y cells (1 x 10^ 
cells) treated with different concentrations of jacaric acid for 72 to 96 hours were 
collected and washed with PBS. The pellet was resuspended in PBS. The samples 
were transferred to test tubes for FSC versus SSC analysis by the FACSCanto™ flow 
cytometer (BD Biosciences). 
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2.2.16 Gene expression study 
There were five steps to study the gene expression: 
i) Total cellular RNA extraction 
LA-N-1 cells (3 x 10^) were seeded in culture flask and cultured overnight. 
The cells were then either treated with solvent control (0.03% ethanol) or different 
concentrations of jacaric acid ( 2 - 6 p-M) at 37°C for 48 hours. After treatment, the 
cells were detached by gentle pipetting and collected by centrifugation. The cell 
pellet was resuspended in 0.6 ml TRIZOL Reagent and incubated at room 
temperature for 5 minutes. Chloroform (0.12 ml) was added to the cell suspension in 
TRIZOL® and the mixture was vortexed vigorously for 15 seconds until a pink 
emulsion was obtained. The emulsion was incubated for 3 minutes at room 
temperature and centrifuged at 12,000 x g for 15 minutes at 4�C. After centrifugation, 
the upper aqueous layer with RNA was transferred to a new microtube and 0.3 ml 
isopropanol was added to the tube to precipitate RNA. The samples were incubated 
at room temperature for 10 minutes or at -20�C overnight to increase yield. The 
samples were centrifuged at 12,000 x g at 4 � C for 10 minutes to obtain the RNA 
pellet. The pellet was washed with 0.6 ml 75% ethanol once and then the supernatant 
was removed after centrifugation at 7,400 x g for 5 minutes. The RNA pellet was air-
dried for around 5 minutes and it was dissolved in 30 |_il DEPC-treated deionized 
water. To facilitate dissolution, the samples were vortexed vigorously for 30 seconds. 
The samples were stored at -20°C or used immediately. 
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ii) DNA digestion 
DNase I (0.5 |j.1) and lOX DNase I reaction buffer (0.5 fil) were added to each 
RNA sample (10 )il). The reaction mixture was incubated at 38�C for 15 minutes to 
allow DNase I to digest DNA in the samples. Afterwards, 1 \i\ EDTA was added to 
each sample and the DNase I was inactivated by heating the reaction mixture at 60°C 
for 10 minutes. The samples were then stored at -20°C or used immediately. 
iii) Determination of RNA extraction yield and purity 
To determine the RNA concentration, the absorbance at 260 nm (A260) was 
measured. For purity, the ratio of A260/A280 was determined. The RNA samples (3 
were diluted 100-fold by adding 297 |j.l deionized water and the absorbance at 260 
nm and 280 nm was measured in a UV cuvette (Eppendorf). Samples with A260/A280 
ranged within 1.5 to 2.0 were considered as pure. The concentration of RNA samples 
was calculated by the equation [yield = A260 x 4]. 
To check the integrity of the RNA samples, the samples were diluted to 0.5 
|ig/|xl. Diluted RNA samples (5 p-L) were mixed with 1 [l\ 6X loading dye and were 
electrophoresed on 1% agarose gel. The gel was stained with ethidium bromide and 
then visualized by UV illumination using Gel Doc 2000 UV transilluminator (Bio-
Rad Laboratories). The presence of 28S and 18S rRNA bands should be found on the 
gel. 
iv) Reverse transcription 
The RNA samples were reversely transcribed to complementary DNA (cDNA) 
prior to amplification of target gene by real-time PCR. RNA sample (1 fag) was 
mixed with 40 units of RNaseOUT™ recombinant ribonuclease inhibitor, 200 units 
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of M-MLV reverse transcriptase, 10 mM DTT, 0.5 mM of each of the four dNTPs, 
0.1 |j,g oligo(dT)I2-I8 primer and IX M-MLV first strand buffer in 20 volume. A 
negative control was set up by replacing RNA sample with DEPC-treated deionized 
water to ensure the reagents were not contaminated. The reaction mixtures were 
incubated at 37°C for 1 hour in Veriti™ 96-well Thermal Cycler (Applied 
Biosystems). To inactivate the reverse transcriptase and denature the RNA template, 
the reaction mixtures were then incubated at 99°C for 5 minutes. At the end, the 
samples were cooled down to 4°C and stored at -20�C until use. 
v) Real-time PCR 
a) Real-time PCR using SYBR® Green 
Real-time PCR was carried out in a 20 \x\ reaction mixture containing cDNA 
(equivalent to 0.05 [ig total RNA), 2X Power SYBR® Green PCR Master Mix (10 
|Lil), 0.125 |LIM of both sense and antisense oligonucleotide pr imers and DEPC-treated 
deionized water using 7500 Real-Time PCR System (Applied Biosystems). The 
thermal cycling profile includes an initial denaturation step at 95°C for 10 minutes, 
followed by 40 thermal cycles of denaturation at 95°C for 15 seconds, annealing and 
elongation at 60°C for 1 minute. The threshold cycle (CT), which indicates the 
number of PCR cycles at which an increase in reporter fluorescence above a baseline 
signal, was detected by 7500 Fast System SDS Software version 1.3.1.21. The 
relative gene expression level compared to the endogenous gene GAPDH was 
analyzed by the comparative Ct (AACt) method previously described in User bulletin 
No. 2，ABI Prism 7700 Sequence Detection System (1997). 
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b) Real-time PCR using TaqMan® Gene Expression Assays 
Real-time PCR was carried out in a 20 |LI1 reaction mixture containing cDNA 
(equivalent to 0.05 |ag total RNA), 2X TaqMan® Universal PCR Master Mix (10 \i\), 
20X TaqMan® Gene Expression Assay (1 ^il) and DEPC-treated deionized water 
using 7500 Real-Time PCR System (Applied Biosystems). The thermal cycling 
profile includes an initial denaturation step at 95°C for 10 minutes, followed by 40 
thermal cycles of denaturation at 95�C for 15 seconds, annealing and extension at 
60�C for 1 minute. The threshold cycle (CT), which indicates the number of PCR 
cycles at which an increase in reporter fluorescence above a baseline signal, was 
detected by 7500 Fast System SDS Software version 1.3.1.21. The relative gene 
expression level compared to the endogenous gene GAPDH was analyzed by the 
comparative Ct (AACt) method previously described in User bulletin No. 2, ABI 
Prism 7700 Sequence Detection System (1997). 
2.2.17 Protein expression study 
There are five steps in the study of protein expression: 
i) Cell treatment and extraction of protein 
LA-N-1 cells (3 x 10^) were cultured overnight and then incubated either with 
solvent control (0.03% ethanol) or different concentrations of jacaric acid ( 2 - 6 ^iM) 
for 48 hours at 37°C. After treatment, the cells were detached by gentle pipetting and 
collected by centrifugation. The cell pellet was lysed with lysis buffer (50 [i\ / 10^ 
cells) on ice for 10 minutes. After incubation, the lysate was vortexed vigorously and 
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then centrifuged at 20,000 x g for 5 minutes at 4�C. The supernatant containing 
proteins was transferred to a new microtube and stored at -20�C until use. 
ii) Determination of protein concentration 
The concentration of protein obtained was determined by Bradford protein 
assay. Briefly, BSA standard solutions ( 2 - 1 0 |ag/ml) were set up by diluting BSA 
stock solution (2 mg/ml) with deionized water. Protein samples (1 |il) were diluted in 
500 deionized water and mixed with 500 |LI1 Bradford reagent (Sigma-Aldrich Co.). 
The absorbance at 595 nm was measured by BioPhotometer (Eppendorf). The 
photometer was set blank with 500 |al deionized water mixed with 500 \i\ Bradford 
reagent in a semi-micro cuvette made of polystyrene (Sarstedt). The protein 
concentration of the samples was calculated using the BSA standard curve. The 
samples were diluted with lysis buffer to a concentration of 1 |ig/|il protein. 
iii) SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed to resolve the proteins by their molecular weights. 
The polyacrylamide gel consisted of two parts: separating gel and stacking gel. The 
percentage of acrylamide added to the separating gel varied with the size of the 
protein of interest. For proteins with larger molecular weight, a gel of lower 
percentage acrylamide was employed, and vice versa. The composition of the 
separating gel and the stacking gel is shown in Table 2.5. 
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Table 2.5 Composition of the separating gel and stacking gel used in SDS-PAGE 
Stacking Gel (3 ml) Separating Gel (5 ml) 
Gel percentage 5% 7.5% 10% 
Deionized Water 1.65 ml 2.4 ml 2 ml 
Lower Buffer … 1.25 ml 1.25 ml 
Upper Buffer 0.75 ml … 
Acrylamide Stock 0.5 ml 1.25 ml 1.665 ml 
lOo/oSDS 30 III 25 111 25 i^l 
10% APS 40 1^1 75 [i\ 75… 
TEMED 3^1 2[i\ 2… 
Protein samples (18 |al) were mixed with 6 fa.1 sample loading buffer (4X) 
and the mixture was then boiled for 5 minutes. The samples and the protein standard 
(6 |Lil) were then loaded to the wells of the SDS-polyacrylamide gel. A constant 
voltage of 100 V was applied and the gel was run for about 2 hours until the dye 
front reached the bottom end of the gel. 
iv) Semi-dry transfer of protein to PVDF membrane 
A piece of PVDF membrane (dimensions: 8.5 cm X 5.5 cm) was activated by 
soaking in 100% methanol for 5 seconds. Six pieces of filter paper of same size with 
the membrane were immersed in IX transfer buffer for 5 minutes and three of them 
were placed onto the Trans-blot SD semi-dry transfer cell (Bio-Rad Laboratories). 
Then the activated membrane was placed on top. The separating gel from SDS-
PAGE was washed with deionized water and then placed onto the membrane. Finally 
the other three pieces of soaked filter paper were placed on top. Air bubbles between 
the layers were removed by rolling a test tube on the filter paper. A constant voltage 
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of 16 V was applied for 45 minutes to transfer the protein on the separating gel to the 
PVDF membrane. The membrane with protein attached was blocked with 5% non-fat 
milk solution for 30 minutes. 
V) Enhanced chemiluminescence (ECL) detection 
The membrane was probed with primary antibody against the target protein 
by adding the antibody into the milk solution at a ratio of 1:1000. The membrane was 
incubated with the primary antibody overnight at 4°C on rotation and then washed 
with TBS-Tween washing buffer for 5 minutes thrice. The membrane was then 
probed with corresponding horseradish peroxidase-linked secondary antibody on 
rotation for 1 hour at a dilution of 1:1000 in washing buffer. After one hour 
incubation, the membrane was washed with washing buffer for 5 minutes thrice. The 
two luminol reagents (0.5 ml each) were mixed and then added onto the membrane. 
The membrane was incubated with the luminol mixture for 1 minute and excess 
mixture was removed. The membrane was wrapped with plastic sheet and put into a 
film cassette. A piece of X-ray film was placed onto the membrane in the cassette in 
a dark room and exposed for different periods of time (10 seconds to 5 minutes). The 
film was then developed and fixed using an X-ray film processor (Kodak). Specific 
band(s) could be visualized and the intensity was analyzed by ImageJ software. The 
relative intensity of the bands was compared with the solvent control after 
normalizing with the housekeeping protein p-actin. 
2.2.18 Statistical analysis 
Each experiment was performed at least two to three times with consistent 
results and only one of the representative experiments was presented in this thesis. 
The data were expressed as arithmetic mean 土 standard error and were processed 
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The Student's t-test was used for statistical analysis and p 
was considered to be statistically significantly different. 
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Anti-proliferative Effect of CLN 
Isomers on Human 
Neuroblastoma Cells 
Chapter 3: Anti-proliferative Effect 
3.1 Introduction 
The term conjugated linolenic acids (CLNs) represents a group of positional 
and geometric isomers of octadecatrienoic acid (18:3) with three conjugated double 
bonds in the carbon chain. Conjugated double bonds refer to double bonds that are 
separated from each other by a single carbon-carbon bond only. Unlike conjugated 
linoleic acid (CLA) in milk fat, cheese and ruminant meat, CLNs can be found at a 
high content (30 - 70% by weight of lipid) in many seed oils such as bitter gourd 
seed oil, pomegranate seed oil and pot marigold seed oil (Narayan et al., 2006). The 
first two CLNs isolated in 1956 were a-eleostearic acid (9Z, HE, 13E CLN) and 
punicic acid (9Z, HE, 13Z CLN) (Hopkins and Chisholm, 1962). Since then, many 
research groups tried to purify and characterize various isomers of CLNs from 
different seed oils. To date, at least seven CLN isomers have been found in nature. 
In recent years, investigation has been done intensively on the anti-tumor effect 
of CLNs on colon cancer (Kohno et al, 2002; Yasui et al., 2005; Yasui et al., 2006b; 
Tsuzuki and Kawakami, 2008). The growth-inhibitory effect of CLNs on different 
human tumor cell lines including hepatoma, lung carcinoma and breast 
adenocarcinoma were also reported (Igarashi and Miyazawa, 2000; Tsuzuki, et al., 
2004a). CLN has attracted a great deal of interest since it was found to be much more 
potent in its anti-proliferative effect when compared to CLA (Igarashi and Miyazawa, 
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2000; Suzuki et al., 2001; Tsuzuki et al., 2004a). A pilot study in our group has 
demonstrated the anti-proliferative effect of CLA on the murine neuroblastoma cell 
line Neura-2a BU-1 (Ho, 2007). However, the growth-inhibitory effect of CLN on 
human neuroblastoma cells has yet to be elucidated. 
In this chapter, the anti-proliferative effect of different CLN isomers on several 
human neuroblastoma cell lines was examined and their potency was compared. The 
seven CLN isomers used in this study are commercially available with relatively 
high purity (> 97.0%) and they include different positional (8,10,12-18:3 and 
9,11,13-18:3) and geometric (t,t,t-CLN, c，t’t-CLN, t,t,c-CLN and c，t,c-CLN) isomers. 
Three human neuroblastoma cell lines, LA-N-1, SH-SY5Y and SK-N-DZ were used 
to show the anti-proliferative effect of CLNs was not tumor cell line specific. The 
most potent isomer, jacaric acid (8Z, lOE, 12Z CLN), was used for investigating the 
kinetics and reversibility of its growth-inhibitory effect on neuroblastoma cells. The 
direct cytotoxic effects of jacaric acid on the most sensitive human neuroblastoma 
cell line LA-N-1, as well as the normal murine and human cells, were tested. The 
effects of jacaric acid on the cell cycle profile, the migratory ability and the colony 
forming ability of LA-N-1 cells were also examined. In addition to all the in vitro 
experiments mentioned above, the effect of jacaric acid on the in vivo tumorigenicity 
of LA-N-1 cells was also studied in the xenogeneic athymic nude mice. 
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3.2 Results 
3.2.1 Anti-proliferative effect of CLN isomers on various human neuroblastoma 
cell lines in vitro 
The growth-inhibitory effect of seven CLN isomers on three neuroblastoma 
cell lines was examined by MTT reduction assay. MTT assay is a relatively safe 
method to measure cell proliferation since it is a non-radioactive assay. After 72 
hours of incubation with different concentrations of CLN isomers, MTT solution (30 
1^ 1) was added to each well in the 96-welI plate and the plate was further incubated 
for 4 hours. Time was allowed for the conversion of yellow water-soluble form of 
MTT into purple insoluble formazan by mitochondrial dehydrogenases in viable cells. 
In addition, the anti-proliferative effect of CLA as well as non-conjugated fatty acids, 
including stearic acid, a- and y-linolenic acids, on LA-N-1 cells was tested. 
As shown Figure 3.1 and Figure 3.2, all the seven CLN isomers were found to 
exhibit an inhibitory effect on the proliferation of LA-N-1 and SH-SY5Y cells in a 
dose-dependent manner. Similar effect of two CLN isomers (a-eleostearic acid and 
jacaric acid) was observed in another human neuroblastoma cell line SK-N-DZ 
(Figure 3.3). The solvent control (up to 0.1%, v/v ethanol) did not show any 
significant growth-inhibitory effect on LA-N-1 cells (Figure 3.1). The 
non-conjugated counterparts of CLN, a- and y-linolenic acids, also did not exhibit 
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any growth-inhibitory activity up to a concentration of 40 jxM (Figure 3.4). Similarly, 
stearic acid with same length of carbon chain with CLN but without any double 
bonds did not show any anti-proliferative effect at a concentration up to 25 fxM. For 
CLA which has one less conjugated double bond compared to CLN, its potency was 
much lower than that of CLN (Figure 3.5). The estimated IC50 values at 72-hour 
incubation for the seven CLN isomers, CLA, stearic acid, and a- and y-linolenic 
acids on the three human neuroblastoma cell lines were summarized in Table 3.1. 
Jacaric acid was found to be the most potent isomer among the seven in its 
anti-proliferative effect on all the three cell lines, with IC50 values equal to or lower 
than 5 |j,M. As shown in Figure 3.6, jacaric acid exhibited strong inhibitory effect on 
the growth of the three human neuroblastoma cell lines. Among the three cell lines, 
LA-N-1 was the most sensitive one and it was chosen for further investigations. 
Moreover, this cell line is a well characterized human neuroblastoma cell line which 
can form tumor in athymic nude mice (Seeger et al., 1977). It is known to be very 
invasive and can be used as a model for tumor metastasis in vivo (Engler et al., 2001). 
Therefore, the LA-N-1 cell line was used as a major model in my subsequent studies 
on the anti-tumor effects of CLN. 
To confirm the anti-proliferative effect of jacaric acid on LA-N-1 cells, another 
assay called tritiated thymidine incorporation assay was used to measure the amount 
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of thymidine uptake during DNA replication and cell division. The assay can 
specifically determine cell proliferation whereas the MTT reduction assay can 
measure both cell proliferation and cell cytotoxicity. It involved incubation of 
radioactive thymidine with jacaric acid-treated cells for 6 hours in 96-well plate and 
then harvest of cells onto glass fibre filter after a freeze-and-thaw process. The 
radioactivity (counts per minute) measured was proportional to the rate of 
proliferation of cells and thus, the inhibitory effect on the growth of LA-N-1 cells 
can be quantified. The estimated IC50 values at 72-hour incubation determined was 
found to be 4.5 fxM, which is similar to that determined using MTT reduction assay 
(Figure 3.7). 
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Figure 3.1 Growth-inhibitory effects of different positional and geometric 
isomers o f CLNs on the human neuroblastoma L A - N - 1 cells. LA -N-1 cells (1 x 
10^ cells/ml) were cultured overnight in 96-wel l microplate and incubated wi th 
different concentrations o f (A) «-eleostearic acid (9Z, H E , 13E CLN) , y^-eleostearic 
acid (9E, H E , 13E CLN) , jacaric acid (8Z, lOE, 12Z CLN) , punicic acid (9Z, H E , 
13Z C L N ) (0 - 20 fxM) and solvent control (ethanol) (0 - 0.1%) (B) «-calendic acid 
(8E, lOE, 12Z CLN),y^-calendic acid (8E，lOE, 12E CLN) and catalpic acid (9E, HE, 
13Z CLN) (0 - 12 |uM) for 72 hours at 37°C. The cell viability was determined by 
MTT reduction assay as described in Chapter 2. Results were expressed as the 
average percentage inhibition of growth 土 S.E. of quadruplicate cultures, comparing 
to the untreated cells as a control. 
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Figure 3.2 Growth-inhibitory effects of different positional and geometric 
isomers of CLNs on the human neuroblastoma SH-SY5Y cells. SH-SY5Y cells 
(1 X 10^ cells/ml) were cultured overnight in 96-well microplate and incubated with 
different concentrations of (A) «-eleostearic acid (9Z, HE, 13E CLN), ^-eleostearic 
acid (9E，HE, 13E CLN), jacaric acid (8Z，lOE, 12Z CLN), punicic acid (9Z, HE, 
13Z CLN) (0 - 20 jaM) (B) a-calendic acid (8E, lOE, 12Z CLN), y^-calendic acid (8E, 
lOE, 12E CLN) and catalpic acid (9E, HE, 13Z CLN) (0 - 20 |iM) for 72 hours at 
37°C. The cell viability was determined by MTT reduction assay as described in 
Chapter 2. Results were expressed as the average percentage inhibition of growth 土 
S.E. of quadruplicate cultures, comparing to the untreated cells as a control. 
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Figure 3.3 Growth-inhibitory effects of different positional and geometric 
isomers of CLNs on the human neuroblastoma SK-N-DZ cells. SK-N-DZ cells 
(1 X 10^ cells/ml) were cultured overnight in 96-well microplate and incubated with 
different concentrations of oc-eleostearic acid (9Z, HE, 13E CLN) and jacaric acid 
(8Z, lOE, 12Z CLN) (0 - 20 for 72 hours at 37°C. The cell viability was 
determined by MTT reduction assay as described in Chapter 2. Results were 
expressed as the average percentage inhibition of growth 土 S.E. of quadruplicate 
cultures, comparing to the untreated cells as a control. 
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Figure 3.4 Effect of a- and y-linolenic acids on the growth of human 
neuroblastoma LA-N-1 cells. Human neuroblastoma LA-N-1 cells (1 x 
cells/well) were cultured overnight and incubated with different concentrations (0 -
40 (j,M) of linolenic acids in 96-well microplate for 72 hours. The growth-inhibitory 
effect was measured by MTT reduction assay as described in Chapter 2. Results were 
expressed as the average percentage inhibition of growth 士 S.E. of quadruplicate 
cultures, comparing to the untreated cells as a control. 
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Figure 3.5 Effect of conjugated linoleic acid (CLA) and stearic acid on the 
growth of human neuroblastoma LA-N-1 cells. Human neuroblastoma LA-N-1 
cells (1 X 104 cells/well) were cultured overnight and incubated with different 
concentrations of CLA (0 - 300 ^iM) or stearic acid (0 - 25 jiM) in 96-well 
microplate for 72 hours. The growth-inhibitory effect was measured by MTT 
reduction assay as described in Chapter 2. Results were expressed as the average 
percentage inhibition of growth 士 S.E. of quadruplicate cultures, comparing to the 
untreated cells as a control. 
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Table 3.1 The estimated IC50 values of different CLN isomers and other fatty 
acids on the human neuroblastoma cell lines at 72 hour incubation. 
Fatty acids 
Estimated IC50 value (|aM) at 72 hours for different 
cell lines as determined by MTT assay 
LA-N-1 SH-SY5Y 
Jacaric acid � 3 . 5 � 4 . 5 
a-eleostearic acid � 8 � 7 . 5 
P-eleostearic acid � 5 ~5 
a-calendic acid -4.5 � 5 
P-calendic acid � 6 -8.5 
Punicic acid -14 � 1 2 
Catalpic acid � 9 � 1 1 
«-linolenic acid >40 ND 
y-linolenic acid >40 ND 
9E,11ECLA -120 ND 
Stearic acid >25 ND 
Human neuroblastoma cells (1 x 10 cells/well) were cultured overnight and 
incubated with different concentrations of CLN isomers or various fatty acids in 
96-well microplate for 72 hours. The growth-inhibitory effect was measured by MTT 
reduction test as described in Chapter 2. The IC50 value is the estimated 
concentration of the isomer that results in 50% inhibition of cell proliferation under 
specified experimental conditions. In each set of experiment, the samples were in 
quadruplicates. 
ND: Not determined 
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Figure 3.6 Growth-inhibitory effect of jacaric acid (8Z, lOE, 12Z CLN) on the 
human neuroblastoma LA-N-1, SH-SY5Y and SK-N-DZ cells. The human 
neuroblastoma cells (1 x 10^ cells/ml) were cultured overnight in 96-well microplate 
and incubated with different concentrations of jacaric acid ( 0 - 1 2 |iM) for 72 hours 
at 37°C. The cell viability was determined by MTT reduction assay as described in 
Chapter 2. Results were expressed as the average percentage inhibition of growth 土 
S.E. of quadruplicate cultures, comparing to the untreated cells as a control. 
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Figure 3.7 Anti-proliferative effect of jacaric acid (8Z，lOE, 12Z CLN) on 
human neuroblastoma LA-N-1 cells as measured by tritiated thymidine 
incorporation assay. The human neuroblastoma cells (1 x 10^  cells/ml) were 
cultured overnight in 96-well microplate and incubated with different concentrations 
of jacaric acid ( 0 - 1 0 |iM) for 72 hours at 37°C. The cells were then pulsed with 0.5 
|xCi [^H]-TdR for 6 hours and frozen overnight. The plate was thawed and the cells 
were harvested onto a glass microfiber filter plate. The radioactivity (cpm) was 
measured by scintillation counter and results were expressed as the average 
percentage inhibition of [^H]-TdR incorporation 土 S.E. of quadruplicate cultures, 
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3.2.2 Direct cytotoxic effect of jacaric acid on neuroblastoma LA-N-1 cells in 
vitro 
The trypan blue exclusion assay was used to examine the direct cytotoxicity of 
jacaric acid on LA-N-1 cells. Dead cells would be stained dark blue while viable 
cells with intact cell membrane would exclude the dye. LA-N-1 cells (1 x 10^) were 
incubated with different concentrations of jacaric acid for 24, 48 or 72 hours at YTC. 
The number of viable cells and dead cells were counted under a light microscope 
using a hematocytometer. Over 70% of LA-N-1 cells remained viable after various 
treatments for different time periods (Figure 3.8). As shown in Figure 3.9, the 
number of viable cells was time- and dose-dependently descended after treatment 
with jacaric acid. Therefore, jacaric acid only exhibited slight direct cytotoxicity on 
LA-N-1 cells while the strong anti-proliferative effect of jacaric acid may be due to 
other mechanisms such as induction of apoptosis or differentiation. 
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Figure 3.8 Effect of jacaric acid (8Z, lOE, 12Z CLN) on the viability of human 
neuroblastoma LA-N-1 cells. LA-N-1 cells (1 x 10^  cells/ml) were incubated either 
with solvent control (0.04% ethanol) or different concentrations of jacaric acid (0 - 8 
I^ M) at 37�C for 1 ,2 and 3 days. The number of viable cells and non-viable cells 
were counted by trypan blue exclusion test using a hematocytometer. Results were 











1 1 l o - u u o u
 J I W A 一 O S
 O J
 W A P B I a J
 办 s q B I A
 o / o 
Chapter 3: A nti-proliferative Effect 
Solvent control 4 |xM jacaric acid 
12 
10 
6 |aM jacaric acid 8 |aM jacaric acid 
2 
Time of incubation (Days) 
Figure 3.9 Effect of jacaric acid (8Z，lOE, 12Z CLN) on the in vitro growth of 
human neuroblastoma LA-N-1 cells. LA-N-1 cells (1 x 10^  cells/ml) were 
incubated with different concentrations of jacaric acid (0 - 8 |iM) at 37°C for 1,2 and 
3 days. The number of viable cells was counted by trypan blue exclusion test using a 
hematocytometer. Results were expressed as average number of viable cells 土 S.D. of 
triplicate cultures. 
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3.2.3 Cytotoxicity of jacaric acid on primary murine cells and human normal 
cells 
A safe anti-cancer drug candidate should be able to kill cancer cells specifically 
while having minimal effects on normal cells. Hence, the cytotoxic effects of jacaric 
acid on different primary murine cells and human normal cells were tested. Bone 
marrow cells, splenocytes and thioglycollate-elicited peritoneal macrophages were 
obtained from BALB/c mice and were incubated with different concentrations of 
jacaric acid for 48 hours. The viability of the cells was determined using MTT 
reduction assay. As shown in Figure 3.10, jacaric acid exerted negligible cytotoxicity 
on the three different types of primary murine cells at concentrations up to 12 |iM. 
On the other hand, the cytotoxic effect of jacaric acid on a human embryonic kidney 
cell line HEK-293 and human peripheral blood mononuclear cells was also examined. 
The cell viability of the human cells remained 80% as seen from Figure 3.11. The 
above findings indicate that jacaric acid only exhibited little, if any, direct cytotoxic 
effect on normal cells. In other words, jacaric acid was found to be relatively 
non-toxic to normal cells. 
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Figure 3.10 Effect of jacaric acid (8Z, lOE, 12Z CLN) on the growth of murine 
bone marrow cells, peritoneal macrophages and splenocytes. All the murine 
normal cells were isolated from female BALB/c mice and using isolation methods as 
described in Chapter 2. The murine normal cells (1 x 10^ cells/ml) were incubated 
with different concentrations ( 0 - 1 2 f^M) of jacaric acid at 37°C for 48 hours. The 
cell viability was determined by MTT reduction assay as described in Chapter 2. The 
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Figure 3.11 Effect of jacaric acid (8Z, lOE, 12Z CLN) on the growth of human 
embryonic kidney HEK-293 cells and human peripheral blood mononuclear 
cells (PBMC). Human PBMC was obtained from peripheral blood from healthy 
donors. The isolation method was described in Chapter 2. (A) HEK-293 cells (6 x 
104 cells/ml) and (B) human PBMC (1 x 10^ cells/ml) were incubated with different 
concentrations (0 - 20 |iM) of jacaric acid at 37°C for 48 hours. The cell viability was 
determined by MTT reduction assay. Results were expressed as the average 
percentage cell viability 士 S.E. of quadruplicate cultures, comparing to the untreated 
cells as a control. 
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3.2.4 Kinetic and reversibility studies of the anti-proliferative effects of jacaric 
acid on LA-N-1 cells 
The kinetics of the growth-inhibitory effect of jacaric acid on LA-N-1 cells was 
studied. The cells were incubated with different concentrations of jacaric acid for 24, 
48 and 72 hours. The cell proliferation was determined using MTT reduction assay. 
Jacaric acid inhibited the growth of LA-N-1 cells in vitro in a time- and 
dose-dependent manner (Figure 3.12). The IC50 value decreased from 8 \iM (24 
hours) to 4.5 |iM (48 hours) and lastly to 3.5 fiM (72 hours). Optimal 
anti-proliferative effect was observed at 72-hour incubation with >90% inhibition on 
cell proliferation at a concentration of 5 ^M. 
To investigate the reversibility of the anti-proliferative effect of jacaric acid on 
LA-N-1 cells, the cells were treated with different concentrations of jacaric acid for 
different periods of time (10, 24 and 48 hours). The cells were washed with RPMI 
plain medium three times to remove jacaric acid and then re-incubated back in fresh 
complete medium up to 48 hours. The results showed that jacaric acid (4, 6, 8 and 10 
I^M) exerted only 11%, 29%，36% and 50% inhibition on cell growth after 10 hours 
of incubation, but increased to 30%, 73%, 84% and 89% correspondingly after 24 
hours of incubation (Fig. 3.13). The above indicates that the anti-proliferative effect 
of jacaric acid at 10 hour-incubation was partially reversible. It was found that for 
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longer incubation time and at higher concentrations of jacaric acid, the reversibility 
of the anti-proliferative effect of jacaric acid on LA-N-1 cells was greatly reduced. In 
order to allow jacaric acid to exert its growth-inhibitory effect on LA-N-1 cells, a 
treatment period such as 24 hours or longer is needed. 
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Figure 3.12 Kinetic study on the growth-inhibitory effect of jacaric acid (8Z, 
lOE, 12Z CLN) on the human neuroblastoma LA-N-1 cells. LA-N-1 cells (1 x 10^  
cells/ml) were cultured overnight in 96-well microplate and then incubated with 
different concentrations ( 0 - 1 0 ^iM) of jacaric acid at 37°C for 24, 48 and 72 hours. 
The cell viability was determined by MTT reduction assay as described in Chapter 2. 
Results were expressed as the average percentage inhibition of growth 土 S.E. of 
quadruplicate cultures, comparing to the untreated cells as a control. 
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Figure 3.13 Reversibility study on the growth-inhibitory effect of jacaric acid 
(8Z, lOE，12Z CLN) on the human neuroblastoma LA-N-1 cells. LA-N-1 cells 
(1 X 10^ cells/ml) were cultured overnight in 96-well microplate and then treated with 
different concentrations ( 0 - 1 0 fiM) of jacaric acid at 37°C. Jacaric acid was 
removed and replaced with complete medium at corresponding time points and all 
cultures were incubated up to 48 hours. The cell viability was determined by MTT 
reduction assay as described in Chapter 2. Results were expressed as the average 
percentage inhibition of growth ± S.E. of quadruplicate cultures, comparing to the 
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3.2.5 Synergistic anti-proliferative effect of jacaric acid with daidzein and 
retinoic acid on LA-N-1 cells in vitro 
Daidzein and retinoic acid were reported to exhibit an anti-proliferative effect 
on neuroblastoma cells as demonstrated by previous work in our group (Lo et al., 
2007) as well as other research groups (Chapman, 1980; Sidell, 1982). In the present 
study, whether jacaric acid can exhibit a synergistic anti-proliferative effect with 
these two natural products on LA-N-1 cells was examined. As shown in Figure 3.14， 
if LA-N-1 cells were either treated with jacaric acid ( 2 - 3 |j.M) or daidzein (30 - 60 
)j,M) only for 48 hours, the percentage growth inhibition was less than 30%. However, 
when the cells were co-incubated with jacaric acid and daidzein at the same time, the 
percentage growth inhibition was found to be significantly greater than the 
summation of the percentages of growth inhibition exerted by jacaric acid only and 
by daidzein only. Similar finding was obtained for cells treated with jacaric acid and 
retinoic acid (Figure 3.15). The results showed that jacaric acid exerted an 
anti-proliferative effect on LA-N-1 cells synergistically with daidzein or retinoic acid 
when they were present at lower concentrations. 
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Figure 3.14 Synergistic anti-proliferative effect of jacaric acid (JA) and daidzein 
(D). LA-N-1 cells (1 x 10^ cells/ml) were cultured overnight and incubated with 2 
or 3 i^ M of jacaric acid (black bars), 30 - 60 [iM of daidzein (grey bars), or 
combinations of jacaric acid and daidzein (white bars) at 37°C for 48 hours. The cell 
viability was determined by MTT reduction assay as described in Chapter 2. The 
results were expressed as the average percentage inhibition of growth 士 S.E. of 
quadruplicate cultures, comparing to the untreated cells as a control. 
*, ** Significantly different from the sum of the % inhibition by jacaric acid only 
and daidzein only. 
* p < 0 . 0 5 . 
• * p < 0.001. 
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Figure 3.15 Synergistic anti-proliferative effect of jacaric acid (JA) and retinoic 
acid (RA). LA-N-1 cells (1 x 10^ cells/ml) were cultured overnight and incubated 
with 1 or 2 |iM of jacaric acid (black bars), 2 - 6 fiM of retinoic acid (grey bars), or 
combinations of jacaric acid and retinoic acid (white bars) at 37°C for 48 hours. The 
cell viability was determined by MTT reduction assay as described in Chapter 2. The 
results were expressed as the average percentage inhibition of growth 土 S.E. of 
quadruplicate cultures, comparing to the untreated cells as a control. 
** Significantly different from the sum of the % inhibition by jacaric acid only and 
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3.2.6 Modulatory effect of jacaric acid on the number of cell division in 
LA-N-1 cells 
The anti-proliferative effect of jacaric acid shown on LA-N-1 cells can be 
followed using CFSE staining and flow cytometric analysis described previously 
(Lyons, 2000). Briefly, the carboxyfluorescein diacetate succinimidyl ester with two 
acetate groups and a succinimidyl ester functional group is cell-permeable and 
non-fluorescent. Once the molecules entered the cells, the acetate groups would be 
cleaved by cellular esterases and the molecules would become fluorogenic. They 
could no longer get out of the cell and would form adducts with cellular proteins. 
During cell division, the level of CFSE in cells would be halved and shared between 
daughter cells. Therefore, the number of cell division committed by the cells could 
be followed. 
In this study, LA-N-1 cells (5 x 10^) were stained with 20 )iM CFSE and 
seeded into 5 culture dishes with 1 x 10^ cells in each dish. The cells were then 
serum starved for 24 hours and cells in one of the dish were harvested. The 
fluorescent intensity was recorded by flow cytometry as the initial reading. The other 
four dishes were given 10% serum and either treated with solvent control or different 
concentrations of jacaric acid for 4 days. The cells were harvested and the fluorescent 
intensity of the cells was measured by flow cytometry. For cells that went through 
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cell division, the fluorescent intensity would be halved. Therefore, for cells 
which committed to higher number of cell division, the CFSE fluorescent intensity 
was lower, and vice versa. As shown in Figure 3.16，jacaric acid suppressed the 
number of cell division committed by LA-N-1 cells in a dose-dependent manner. 
FITC-A 
Figure 3.16 Modulatory effect of jacaric acid (8Z, lOE，12Z CLN) on the 
number of cell division committed by the human neuroblastoma LA-N-1 cells. 
LA-N-1 cells (5 x 10^) were stained with 20 }iM CFSE on day 0 and then serum 
starved for 24 hours until day 1. Then the cells were supplemented with 10% serum 
and treated with either solvent control (0.02% ethanol) or different concentrations of 
jacaric acid ( 2 - 4 ^M) for 4 days (i.e. until day 5). The cells were harvested and the 
fluorescent intensity of the cells was measured by the FACSCanto flow cytometer 
(BD Biosciences) with excitation at 488 nm and emission at 525 nm. The x-axis 
shows the CFSE fluorescent intensity which is inversely proportional to the number 
of cell division committed by LA-N-1 cells. Red line: cells stained with CFSE and 
serum starved for 24 hours on day 1; black line: solvent control; green line: cells 
treated with 2 \lM of jacaric acid; blue line: cells treated with 3 |iM of jacaric acid; 
purple line: cells treated with 4 \iM of jacaric acid on day 5. 
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3.2.7 Effect of jacaric acid on the cell cycle profile of LA-N-1 cells 
To investigate whether the anti-proliferative effect of jacaric acid on LA-N-1 
cells was due to its modulatory effect on cell cycle progression, the cell cycle 
distribution of LA-N-1 cells after treatment with jacaric acid for 24 and 48 hours 
was studied using PI staining and flow cytometric analysis. PI is a dye that 
intercalates into double-stranded DNA and forms a fluorogenic adduct. The cell cycle 
involves a number of steps including Go, Gi, S, G2 and M phases. During cell 
division, the DNA content of a cell is replicated and then shared between two 
daughter cells. Therefore, by flow cytometric analysis after PI staining, the DNA 
content indicates the cell cycle phases where the cell populations are located in. It 
was reported that genes related to cell cycle are often found to be mutated or the 
expression levels of checkpoint proteins are altered in cancer cells (Vermeulen et al., 
2003). Dysfunction of proteins or deregulation of cell cycle progression was resulted. 
In this study, L A - N - 1 cells were first synchronized to G Q / G I phase of the cell 
cycle by serum starvation. The cells were then given 10% serum and treated with 
solvent control or different concentrations of jacaric acid for 24 hours or 48 hours. 
The DNA content of treated cells was analyzed by PI staining and flow cytometry. 
Quite unexpectedly, there was no significant difference between the cell cycle 
distribution of cells treated with jacaric acid and that with solvent control under the 
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Figure 3.17 Jacaric acid (8Z, lOE, 12Z CLN) did not show significant effect on 
the cell cycle profile of human neuroblastoma LA-N-1 cells after 24 and 48 
hours of treatment. LA-N-1 cells (2 x 10 )^ were cultured in 100 mm dish overnight 
and then synchonised by serum starvation for 24 hours. After that, 10% serum was 
added back to the medium and the cells were treated either with (A) solvent control 
(0.02% ethanol); (B) 1 |xM jacaric acid or (C) 2 |xM jacaric acid for 24 or 48 hours at 
37°C. The cells were then harvested and fixed with ethanol for at least 30 minutes. 
Following fixation, the cells were washed with PBS once and then stained with 
propidium iodide (PI). The stained samples were analyzed by flow cytometry to 
obtain cell cycle profiles. The distribution of cells in cell cycle was calculated by 
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3.2.8 Effect of jacaric acid on the colony forming ability of LA-N-1 cells in soft 
agar 
It was found previously that the clonogenicity of cancer cells in agar correlated 
well with the tumorigenicity, invasiveness and metastatic ability of the cells 
(Hamburger and Salmon, 1977; Saiga et al” 1987). As jacaric acid exhibited potent 
anti-proliferative effect on LA-N-1 cells, its influence on the colony forming ability 
of LA-N-1 cells was investigated to see whether jacaric acid could suppress such 
malignant properties of the neuroblastoma cells. 
LA-N-1 cells were grown in soft agar, with or without incubation with jacaric 
acid in a 6-well plate for 3 weeks. The ability of the cells to form colonies was 
determined by counting the number of visible colonies under the light microscope. 
As shown in Figure 3.18, the colony forming ability of LA-N-1 cells in soft agar was 








Figure 3.18 Jacaric acid (8Z, lOE, 12Z CLN) suppressed the colony forming 
ability of human neuroblastoma LA-N-1 cells in soft agar in a dose-dependent 
manner. LA-N-1 cells (2.5 x lO* cells/well) were seeded in soft agar supplemented 
with complete culture medium, with solvent control (0.04% ethanol) or two different 
concentrations of jacaric acid (5 [iM and 8 in a 6-well culture plate. The cells 
were then incubated at 37°C in a humidified incubator with 5% CO2 supply for 21 
days. The number of colonies was counted under a light microscope with 100-fold 
magnification. 
** Significantly different from the solvent control, p < 0.001 
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3.2.9 Effect of jacaric acid on the invasiveness of LA-N-1 cells 
Metastasis was often observed in neuroblastoma patients at the time of 
diagnosis (Dubois et al., 1999). Patients with metastatic tumors in bone marrow and 
bones had poor prognosis and low survival rate (Ladenstein et al., 1995; Zhang et al., 
2007). Prevention and eradication of metastasis would certainly help in increasing 
the long-term survival rate (Zhong et al., 2009). The initial step of metastasis is 
invasion of the local tissues through losing cell-cell contact (Ara and DeClerck, 
2006). Therefore, the effect of jacaric acid on the migratory ability or invasiveness of 
LA-N-1 cells was examined using an in vitro Transwell® system. 
Briefly, the cells were pre-treated with solvent control or jacaric acid for 48 
命 
hours. The upper chamber of the Transwell was coated with a layer of Matrigel to 
give an extracellular matrix environment. The lower compartment was filled with 
NIH-3T3 conditioned medium which contained chemoattractants. The treated cells 
were then loaded onto the upper chamber above the Matrigel layer and then 
incubated for 24 hours at 37°C. Time was allowed for the cells to migrate through the 
extracellular matrix and a membrane with pore of size 8 i^m towards the 
chemoattractants. After incubation, the cells migrated to the lower surface of the 
membrane were fixed and stained. The cell number was counted under a light 








Figure 3.19 Jacaric acid (8Z, lOE，12Z CLN) suppressed the migratory ability of 
human neuroblastoma LA-N-1 cells. LA-N-1 cells (1 x 10^) were either treated 
with solvent control (0.02% ethanol) or different concentrations of jacaric acid (2 and 
4 |4.M) for 48 hours. After treatment, 1 x 10^ control or jacaric acid-treated cells in 
100 |Lil culture medium were seeded onto the upper chamber of a Transwell® placed 
in a 24-well microplate. The lower chamber was filled with 1 ml of NIH-3T3 cell 
conditioned medium as chemoattractant. The cells were then incubated for 24 hours 
at 37°C to allow migration. After that, the cells on the upper side of the Transwell® 
membrane were removed with a cotton swab. Cells on the lower side were fixed with 
methanol and stained with Hemacolor Staining Solutions. The cells on the lower 
surface of the membrane were counted in 5 random fields under a 320 fold 
magnification. Each bar represents the mean 士 S.D. of triplicate wells. 
** Significantly different from the solvent control, p < 0.001 
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3.2.10 Effect of jacaric acid on the in vivo tumorigenicity of the LA-N-1 cells 
As shown in Section 3.2.9, jacaric acid suppressed the clonogenicity of 
LA-N-1 cells in soft agar. Other than the in vitro experiments performed, the effect of 
jacaric acid on the in vivo tumorigenicity of LA-N-1 cells in nude mice was also 
examined. 
The LA-N-1 cells were first treated with jacaric acid for 16 hours. After 
incubation, the cells were washed with PBS twice and then resuspended in RPMI 
medium. The cell suspension was mixed with Matrigel at a volume ratio of 1:1. The 
mixture containing 5 x 10^ cells was injected subcutaneously (s.c.) onto the back of 
each nude mouse. The size of the tumor was measured using a vernier caliper and the 
weight of the mice was measured every two to three days. The tumor weight was 
determined at the end of the experiment after sacrificing the mice and the ratio of 
tumor weight to body weight was calculated. Results in Figure 3.20C indicated that 
pre-treatment of LA-N-1 cells with jacaric acid significantly lowered the in vivo 
tumorigenicity of the cells. 
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Figure 3.20 The effect of in vitro jacaric acid (8Z, lOE, 12Z CLN) pre-treatment 
on the tumorigenicity of human neuroblastoma LA-N-1 cells in vivo. (A) Volume 
of tumor. (B) Body weight of mice on Day 28 after tumor implantation. (C) Ratio of 
tumor weight to body weight on Day 28. LA-N-1 cells (5 x 10^) were either treated 
with solvent control (0.02% ethanol) or with jacaric acid (4 )iM) in vitro for 14 hours. 
Control or jacaric acid-treated cells (5 x 10^) in 200 ^L BD Matrigel® and RPMl 
mixture were inoculated subcutaneously onto the back of 8 weeks old inbred female 
BALB/c nude mice. The perpendicular dimensions of the tumor were measured 
every 2 or 3 days using a vernier caliper and the volume of the tumor was calculated 
by the formula [volume = length x width x height x 71/6]. The results were expressed 
as the average volume of tumor on six mice 士 S.D. The tumor weight was measured 
at the end of the experiment. 
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3.3 Discussion 
In this chapter, the potency of the anti-proliferative effect of seven CLN 
isomers on human neuroblastoma cell lines was compared. The seven isomers have 
different geometrical and positional configurations which may lead to the difference 
in the growth-inhibitory effect on the cells. Among the seven isomers, namely 
a-eleostearic acid {cis-9, trans-\\, trans-\2) CLN), p-eleostearic acid {trans-9, 
trans-\\, trans-\7> CLN), a-calendic acid {trans-%, trans-10, cis-Xl CLN), p-calendic 
acid {trans-^, trans-lQi, trans-M CLN), catalpic acid {trans-9, trans-W, cis-13 CLN), 
jacaric acid (cz5-8, transA^, cis-\2 CLN) and punicic acid {cis-9, trans-\\, c/5-13 
CLN), jacaric acid was found to be the most potent isomer for its anti-proliferative 
effect on the three neuroblastoma cell lines LA-N-1, SH-SH5Y and SK-N-DZ. The 
estimated IC50 values at 72-hour incubation as determined by the MTT reduction 
assay were as low as 3.5 |xM, 4.5 ^M and 5 jxM respectively for the three cell lines. 
Our results suggested that the strong anti-proliferative effect of CLNs on human 
neuroblastoma cells was not specific to one certain cell line only. The 
anti-proliferative effect of jacaric acid on LA-N-1 cells was confirmed using tritiated 
thymidine incorporation assay and the estimated IC50 value obtained (4.5 |aM) was 
similar to that determined by MTT assay. As demonstrated, the IC50 values of CLNs 
on inhibiting the growth of LA-N-1 cells are much lower than those of stearic acid, 
-124 -
Chapter 3: A nti-proliferative Effect 
a-linolenic acid, y-linolenic acid and CLA. The results indicate that the strong 
anti-proliferative effect of CLNs is due to the three conjugated double bonds. 
The seven CLN isomers can be found naturally in some seed oils (Takagi and 
Itabashi, 1981; Gaydou et al, 1987). Some of the isomers can also be synthesized 
chemically by alkaline isomerization of a-linolenic acid (Spitzer et al., 1994; 
Igarashi and Miyazawa, 2005), although a mixture of CLA and CLN isomers would 
be produced and required purification. 
Comparisons among the CLN isomers of their potency in inhibiting the growth 
of cancer cells were performed by different groups of researchers (Suzuki et al, 2001; 
Igawashi and Miyazawa, 2005; Yasui et al., 2006a). Suzuki et al. (2001) suggested 
that the 9, 11, 13-CLN isomers were more cytotoxic than the 8, 10, 12-CLN isomers 
on mouse transformed fibroblast cells and human monocytic leukemia cells. On the 
other hand, Igawashi and Miyazawa (2005) and Yasui et al. (2006a) showed that 
diW-trans CLN isomers exhibited stronger cytotoxic effect on human tumor cell lines 
when compared to other isomers. Suzuki et al. (2001) pointed out that the difference 
in the cytotoxic effect of each CLN isomer was due to their difference in oxidative 
stability since the proposed mechanism of the cytotoxic effect by CLN involves lipid 
peroxidation. They found that the 9，11，13-CLN isomers were less stable than the 8, 
10，12-CLN isomers. However, our findings contradicted with the previous reports 
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mentioned above. The most potent isomer found in this study, jacaric acid (8Z, lOE, 
12Z CLN), is neither an a.\\-trans isomer nor having the conjugated double bonds at 
the carbon number 9, 11 and 13 positions. In addition, previous work from our group 
also showed that jacaric acid exerted the strongest growth-inhibitory effect on human 
promyelocytic leukemia HL-60 cells among the five CLN isomers tested (Yip, 2007). 
Recently, Yang et al. (2009) have further tested the oxidative stabilities of 10 CLN 
isomers and they reported that the oxidative stability of 8, 10，12-CLN isomers was 
lower than that of 9，11，13-CLN isomers. Furthermore, the c,t,c-CLN isomers were 
the least stable one when compared with t,t,t-CLN and c,t,t-CLN isomers. These 
findings agreed with the result in the present study. Jacaric acid is a c,t,c-CLN isomer 
in which the cw-double bonds resulted in the oxidative instability. Yang et al. (2009) 
explained that cw-double bond has a higher free energy level than rra«5-double bond 
and is more susceptible to autoxidation. Moreover, for conjugated double bonds 
closer to the carboxyl terminal of the fatty acid chain, the isomer would be less stable 
because of the resonance delocalization. It is more likely for the CLN isomer to lose 
an electron or a proton to give a free radical intermediate. Again, this supports our 
result that jacaric acid having conjugated double bonds closer to the carboxyl end of 
the carbon chain showed more potent anti-proliferative effect than 9，11，13-CLN 
isomers on human neuroblastoma cells. The discrepancy between the findings of 
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Suzuki et al. (2001) and Yang et al. (2009) may due to the difference in experimental 
set-up in the measurement of oxidative stability which has yet to be elucidated. 
In our study, jacaric acid was chosen for further investigation due to its high 
potency and LA-N-1 cells were used as a major model due to its high sensitivity to 
jacaric acid. To develop a safe drug for cancer treatment, the cytotoxicity of the 
candidate drug on normal cells must be considered. Therefore, the in vitro cytotoxic 
effects of jacaric acid on primary murine cells and human normal cells were 
examined. Jacaric acid was found to show insignificant cytotoxic effect on the 
murine cells including bone marrow cells, splenocytes and thioglycollate-elicited 
peritoneal macrophages. Similarly, the cytotoxic effect of jacaric acid on human 
peripheral blood mononuclear cells and embryonic kidney HEK-293 cells was found 
to be minimal, indicating jacaric acid is a relatively safe candidate as it exerts its 
activity specifically on cancer cells. 
Kinetic study using MTT reduction assay revealed that jacaric acid exhibited 
anti-proliferative effect on LA-N-1 cells in a time- and dose-dependent manner. The 
estimated IC50 values dropped from 8 |iM (24 hours) to 4.5 )xM (48 hours) and finally 
to 3.5 |JM (72 hours). In other words, longer incubation time was needed for jacaric 
acid to demonstrate its growth-inhibitory effect at lower concentrations. Besides, the 
reversibility study showed that the anti-proliferative effect of jacaric acid was 
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partially reversible at short incubation time with the cells. A recent publication 
suggested that cancer cells can recover from apoptosis induction if the drug was 
removed within a short incubation period (Tang et al., 2009). The ability of the 
neuroblastoma cells to recover from treatment with jacaric acid was found to be 
inversely proportional to the length of incubation time in the present study. For 
instance, if LA-N-1 cells were exposed to jacaric acid for longer periods of time (24 
hour and 48 hour), the growth inhibition would be less reversible or even 
irreversible. 
To find out whether jacaric acid inhibited the growth of LA-N-1 cells by its 
cytotoxic or cytostatic effect, trypan blue exclusion assay was performed. It was 
found that jacaric acid only exerted little, if any, direct cytotoxic effect on the human 
neuroblastoma LA-N-1 cells. The doubling time of LA-N-1 was also lengthened by 
jacaric acid. It was supported by the findings in the CFSE staining assay as the 
number of cell division committed by LA-N-1 cells was reduced by jacaric acid 
treatment. 
Nevertheless, jacaric acid did not exhibit significant effect on the cell cycle 
distribution of LA-N-1 cells after 24 and 48 hours of treatment as seen in PI staining 
and flow cytometric analysis. Previous work in our group showed that jacaric acid 
only arrested human promyelocytic leukemia HL-60 cells at G Q / G I phase of the cell 
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cycle slightly (Yip, 2007). A few reports have been published about the effect of 
conjugated fatty acids on the cell cycle profile of cancer cells. For example, 
conjugated eicosapentaenoic acid (cEPA) with three out of five double bonds that are 
conjugated was found to arrest HL-60 cells at Gi/S phase (Yonezawa et al., 2005). 
Similarly, Cho et al. (2006) found that lOE, 12Z-CLA induced Gi cell cycle arrest in 
human colon cancer HT-29 cells. Hu et al. (2008) reported that conjugated trienoic 
fatty acids arrested rat glioblastoma cells at G Q / G I phase. The reason why jacaric acid 
did not show any significant effect on cell cycle progression of the human 
neuroblastoma LA-N-1 cells remains obscure. It may due to the low concentrations 
of jacaric acid being used or the time-points tested are inadequate. Further 
experiments would be required to confirm whether jacaric acid can affect the cell 
cycle distribution of the LA-N-1 cells. 
Daidzein and retinoic acid are well-documented to be able to inhibit the growth 
and induce differentiation in neuroblastoma cells (Lo, 2007; Chapman, 1980; Sidell, 
1982). We attempted to test whether these two compounds would work in synergy 
with jacaric acid to enhance its growth inhibitory effect on neuroblastoma cells. 
LA-N-1 cells were co-incubated with jacaric acid and daidzein or retinoic acid for 48 
hours. MTT reduction assay showed that jacaric acid and daidzein exhibited 
synergistic anti-proliferative effect on LA-N-1 cells. Lo et al. (2007) suggested 
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daidzein, a major type of soy isoflavones, inhibited the growth of neuroblastoma 
cells by preventing the cells to enter G2/M phase of the cell cycle and inducing 
neuronal cell differentiation. Nevertheless, the mechanism for the observed 
synergistic anti-proliferative effect of jacaric acid and daidzein awaits further 
investigation. Similarly, a synergistic growth-inhibitory effect was shown when 
LA-N-1 cells were co-incubated with jacaric acid and retinoic acid. Many reports 
suggested retinoic acid induced neuronal differentiation in neuroblastoma cells 
(Sidell et al, 1983; Pahlman et ai, 1984; Preis et al., 1988; Redfern et al., 1995). 
Allegretto et al. (1993) reported retinoic acids bound to retinoic acid receptors (RAR) 
and retinoid X receptors (RXR) and activated transcription of target genes such as 
cellular retinoic acid binding protein II (CRABP II) and RAR-p (Redfern et al., 
1995). Several publications suggested retinoic acids induced neuronal differentiation 
by activating signalling pathways including Jun/AP-1 (de Groot & Kruijer, 1991)， 
ERKl/2 (Singh et al., 2003), JNK (Yu et ai, 2003) and PI3K/Akt pathways 
(Lopez-Carballo et al., 2002). Again, the exact mechanism by which jacaric acid and 
retinoic acid exerted synergistic anti-proliferative effect on LA-N-1 cells is still 
unclear and requires further studies. 
Since jacaric acid exerted potent growth-inhibitory effect on the neuroblastoma 
LA-N-1 cells, it would also be interesting to find out whether jacaric acid had any 
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effect on the clonogenicity of LA-N-1 cells in soft agar. As suggested by Saiga et al. 
(1987)，the colony forming ability of cancer cells in agar reflects their malignant 
properties such as in vivo tumorigenicity, invasiveness and metastatic potential. In 
this study, LA-N-1 cells were grown in soft agar with or without jacaric acid. The 
results indicated that the colony forming ability of LA-N-1 cells was reduced 
significantly by jacaric acid in a dose-dependent manner. In addition, the 
invasiveness of jacaric acid-treated LA-N-1 cells was examined in the Transwell® 
system. It was found that jacaric acid lowered the migratory ability of LA-N-1 cells 
towards chemoattractants through the extracellular matrix in vitro. Collectively, 
jacaric acid suppressed the malignant properties of LA-N-1 cells in vitro. 
It would be intriguing to study whether jacaric acid had any effect on the in 
vivo tumorigenicity in xenogeneic BALB/c nude mice since we have shown that 
jacaric acid suppressed the colony forming ability and invasiveness in vitro. LA-N-1 
cells were pre-treated with jacaric acid for 16 hours before injected subcutaneously 
onto the back of the nude mice. It was found that in vitro treatment of LA-N-1 cells 
with jacaric acid impaired the growth of the tumor cells in vivo. Previous study by 
丁Suzuki et al. (2004a) also described tung oil which contains high levels of 
a-eleostearic acid (9Z, HE, 13E-CLN) strongly suppressed the growth of 
transplanted colon cancer DLD-1 cells on the back of athymic nude mice. Further 
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experiments can be done to study the effect of oral or intravenous administration of 
jacaric acid to the mice on the growth of transplanted neuroblastoma. 
In conclusion, the seven CLN isomers were shown to exhibit potent 
anti-proliferative effect on human neuroblastoma cells and they only exerted 
negligible direct cytotoxic effect on LA-N-1 cells as well as normal murine and 
human cells. Jacaric acid also lengthened the doubling time of LA-N-1 cells by 
reducing the number of cell division committed by the cells. The colony forming 
ability, the in vitro invasiveness and in vivo tumorigenicity of LA-N-1 cells were also 
suppressed by jacaric acid significantly. In the following chapters (Chapter 4 and 5), 
the possible mechanisms by which jacaric acid can inhibit the growth of human 
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4.1 Introduction 
Neuroblastoma is the most common extracranial solid tumor in children. It 
arises from the precursor cells in the neural crest of the sympathetic nervous system 
which fail to differentiate into fully functional cells (Francisco et al.，2007). The loss 
of balance among proliferation, differentiation, migration and apoptosis leads to 
transformation. As a result, developing cells are more susceptible to tumorigenesis 
(Johnsen et al., 2009). . 
Apoptosis is one of the twelve types of cell death described by Kroemer et al. 
(2009) in a recent review of cell death classification. According to Kerr et al. (1972), 
apoptosis is a term that describes a type of cell death with specific morphological 
changes including rounding-up of the cell, shrinkage of cell volume, chromatin 
condensation, nuclear fragmentation and blebbing of cell membrane. Some of the 
above phenomena may not necessarily occur during apoptosis. Meanwhile, some of 
them can be found in other types of cell death. Therefore, a number of assays 
showing the occurrence of several apoptosis-associated morphological changes after 
induction are essential to confirm apoptosis. 
Unlike necrosis, in which the cell membrane ruptures and releasing toxic 
substances to the surrounding tissues, apoptosis is regarded as a more regulated type 
of cell death (Russo et al； 2006). In normal development of multicellular organisms, 
apoptosis is responsible for eliminating unwanted cells (Antonsson, 2001). Failure of 
cells to undergo apoptosis in response to stimulus would lead to development of 
-134-
Chapter 4: Apoptosis- and differentiation-inducing effects 
cancer (Thompson et al., 1992). Thus, induction of tumor cell apoptosis is a novel 
approach in cancer therapy. 
There are two main pathways of apoptosis according to the source of activation 
signals, and they are known as the extrinsic and intrinsic apoptotic pathways. The 
extrinsic pathway, also called death receptor pathway, is triggered by binding of 
ligands like FasL, TNF-a, TNF-P and TRAIL to the death receptors on the cell 
surface (Schmitz et al., 2000; Belizario et al,, 2007). Intracellular adaptors such as 
FADD, a Fas-associated protein with a death domain or TRADD, a TNF receptor 
associated with a death domain would be recruited by the activated death receptors. 
The recruitment would bring about to a chain cleavage and activation of the initiator 
caspase-8, its specific substrate and the effector caspase-3. In the intrinsic pathway, 
also called the mitochondrial pathway, cytochrome c is released from the 
mitochondria upon intracellular stimulus after DNA damage or generation of reactive 
oxygen species (ROS) (Antonsson, 2001). Cytochrome c released into the cytosol 
would associate with apoptotic protease-activating factor (Apaf-1) readily which 
would in turn bind to procaspase-9 with its caspase recruitment domain (CARD) 
(Belizario et al., 2007). The complex formed is known as apoptosome which consists 
of oligomers of Apaf-1, cytochrome c and dATP. It provides a platform for several 
procaspase-9 molecules to self-process and then recruit and activate the effector 
caspase-3 (Russo et al., 2006). The activated caspase-3 would cleave specific 
substrates such as inhibitor of caspase-activated DNase (ICAD) and allow the 
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endonuclease CAD to cleave DNA into oligomeric fragments (Fulda and Debatin, 
2006). 
It was suggested that in apoptosis, the activated caspases would damage the 
mitochondria and result in loss of mitochondrial membrane potential and generation 
of ROS (Ricci et al, 2004). On the other hand, chemical agents that can enhance the 
ROS production in cells would disturb the cellular redox potentials and hence 
inducing or facilitating the mitochondrial membrane permeabilization (Fulda and 
Debatin, 2006)，leading to release of cytochrome c to cytosol. Therefore, ROS play 
an important role in apoptosis. 
CLNs have been shown to have apoptosis-inducing activities in tumor cells, 
including colon cancer (Tsuzuki et al., 2004a; Yasui et al., 2005) and leukemia 
(Kobori et al., 2006; Yip, 2007; Kobori et al., 2008). However, the 
apoptosis-inducing effect of CLNs on neuroblastoma cells has not yet been examined. 
In this chapter, the apoptosis-related events in human neuroblastoma cells treated 
with jacaric acid (8Z, lOE, 12Z CLN), the most potent CLN isomer, were studied. 
Biochemical analyses including DNA laddering and measurement of caspase 
activities were performed. The change in ultrastructure of cells, phosphatidylserine 
(PS) exposure to outer leaflet of plasma membrane, mitochondrial membrane 
depolarization and reactive oxygen species production were also examined. 
Pahlman et al. (1990) suggested that neuroblastoma cells might result from the 
blockade of neuroblasts at several stages of neuronal differentiation and the inability 
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of the cancer cells to mature along the neuronal lineage. In some neuroblastoma 
patients, spontaneous regression of tumor was observed (Evans et al； 1976). One of 
the possible mechanisms for this observation is that the neuroblastoma cells 
differentiate into cells which are more mature and become non-proliferating 
(Gushing and Wolbach, 1927). The ability of neuroblastoma cells to undergo 
differentiation in vitro upon induction by chemical and biological agents was 
reported by many research groups (Prasad and Hsie, 1971; Prasad and Sinha, 1976; 
Prasad et al.’ 1979; Pahlman et al, 1981; Sidell, 1982; Danon and Kaminsky, 1985). 
The most commonly used inducer is retinoic acid (Pahlman et al.\ 1990; Wu et al, 
2009). It was reported that neuronal differentiation induced by retinoic acid 
correlates with the decreased expression of proto-oncogene N-myc (Thiele et al., 
1985). N-myc was found to be often amplified in neuroblastoma patients. Its role 
would be discussed in detail in Chapter Five. 
Due to this special ability of neuroblastoma to undergo differentiation upon 
stimulation, we attempted to assess the differentiation-inducing effect of CLNs on 
human neuroblastoma cells. The most commonly quantified characteristic of 
neuronal differentiation is the length of neurite outgrowth (Abemayor and Sidell, 
1989). The morphological changes of the jacaric acid-treated cells were observed by 
microscopic examination. In addition, the changes in cell size and granularity of the 
neuroblastoma cells were evaluated by flow cytometric analysis. 
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4.2 Results 
4.2.1 Induction of DNA fragmentation and apoptotic ultrastructural changes 
in LA-N-1 cells by jacaric acid 
As mentioned in the introduction of this chapter, during apoptosis, the activated 
caspase-3 would cleave specific substrates such as ICAD and allow the endonuclease 
CAD to cut genomic DNA into characteristic oligonucleosomal fragments 
(Nicholson, 1999). Another morphological characteristic in apoptotic cells is 
chromatin condensation. It was found that a nuclear factor, called apoptotic 
chromatin condensation inducer in the nucleus (Acinus), is a substrate of caspase-3 
and is converted into the active form by cleavage (Sahara et al., 1999). Acinus was 
found to be essential for chromatin condensation during apoptosis in vitro. 
To assess the apoptosis-inducing effect of jacaric acid on human neuroblastoma 
LA-N-1 cells, the DNA was extracted from treated cells and subjected to agarose gel 
electrophoresis. As shown in Figure 4.1，jacaric acid induced DNA fragmentation in 
LA-N-1 cells in a dose- and time-dependent manner. The DNA fragments are 
separated by 180-220 bp due to the association with the histone core complex 
(Robertson et al.’ 2000). 
Hendzel et al. (1998) suggested chromatin condensation in apoptosis is 
resulted from the loss of structural integrity of the euchromatin, nuclear martrix and 
nuclear lamina. In the present study, Hoechst 33342 staining was employed to stain 
the DNA in jacaric acid-treated LA-N-1 cells. Using fluorescent microscopy, the 
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ultrastructure of cells could be observed. As seen from Figure 4.2, apoptotic 
morphological changes like chromatin condensation and nuclei fragmentation were 
induced in the nucleus of neuroblastoma cells treated with jacaric acid. The DNA 
was found to be condensed and formed a cap along the inner nuclear membrane 
(Figure 4.2C), indicating that apoptosis was induced in the human neuroblastoma 
cells. 
- 3 : 1 6 hour treatment 
Solvent control 
4 |iM jacaric acid 
6 ^M jacaric acid 
Lane 4 - 6: 64 hour treatment 
Lane 4: Solvent control 
Lane 5: 4 juM jacaric acid 
Lane 6: 6 A^M jacaric acid 
Lane 7: 100 bp DNA marker 
Figure 4.1 Induction of DNA fragmentation in jacaric acid-treated human 
neuroblastoma LA-N-1 cells. LA-N-1 cells (3 x 10 ) were either incubated with 
solvent control (0.03% ethanol) or different concentrations of jacaric acid ( 4 - 6 }iM) 
for 16 or 64 hours at 37°C. The cells were harvested and then lysed with IGEPAL 
lysis buffer. The lysate was centrifuged after 10 minutes of incubation and the 
supernatant containing DNA was obtained. The supernatant was treated with 5% 
SDS, RNase and Proteinase K to remove RNA and protein respectively in the 
mixture. The DNA was precipitated with 3 M sodium acetate and washed with 70% 
ethanol followed by absolute ethanol. The pellets obtained were dissolved in TioEo.i 
buffer. After incubated at 65°C for 5 minutes, a loading dye was mixed with each 
sample and subjected to 1% agarose gel electrophoresis. The gel was stained with 
ethidium bromide and visualized under UV illumination. 
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Figure 4.2 Induction of apoptotic ultrastructural changes in the human 
neuroblastoma LA-N-1 cells by jacaric acid (8Z, lOE, 12Z CLN). LA-N-1 cells 
(25000 cells/well) were cultured overnight and either incubated with solvent control 
(0.02% ethanol) or different concentrations of jacaric acid ( 0 - 4 |aM) for 48 hours. 
The cells were then fixed with ethanol and stained with Hoechst 33342 for 20 
minutes. The cells were observed under a fluorescent microscope (Nikon TE2000). 
Ultrastructural changes indicated by white arrows. (A) LA-N-1 cells treated with 
solvent control. (B) LA-N-1 cells treated with 2 |jM jacaric acid (C) 3 |j.M jacaric 
acid and (D) 4 jacaric acid. The magnification is 200X. 
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4.2.2 Induction of phosphatidylserine externalization by jacaric acid in human 
neuroblastoma cells as detected by Annexin V-GFP/ PI dual staining 
Phosphatidylserine (PS) is a membrane aminophospholipid located in the inner 
leaflet of the plasma membrane in viable cells (van Engeland et al, 1998). The 
membrane asymmetry of PS was proposed to be maintained by an energy-dependent 
movement 'flip' performed by the enzyme PS translocase (Balasubramanian and 
Schroit, 2003; Balasubramanian et al., 2007). During apoptosis, PS was reoriented 
to the outer layer of the plasma membrane in order to allow binding and removal of 
the apoptotic cell by phagocytes. Balasubramanian et al. (2007) suggested the 
externalization requires inactivation of the translocase with sustained increase in 
Ca level in the cytosol. 
In order to detect this phenomenon during apoptosis, Annexin V was used. It is 
a phospholipid binding protein which binds to PS moieties strongly in the presence 
of Ca (van Engeland et al, 1998). In the present study, we would like to 
differentiate whether the jacaric acid-treated neuroblastoma cells undergo apoptosis 
or necrosis, dual staining was utilized. PI can only enter cells with permeable cell 
membrane and binds to DNA while Annexin V used was conjugated with a green 
fluorescent protein (GFP). Early apoptotic cells with intact cell membrane would be 
Annexin V-positive and Pl-negative. On the other hands, cells undergoing necrosis 
or late apoptosis would be both Annexin V- and Pl-positive. As seen from Figure 4.3， 
LA-N-1 cells treated with 4 )iM or 6 jxM jacaric acid had an increased percentage of 
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early apoptotic cells, which were Annexin V-positive and Pl-negative. Interesting, 
pre-treatment of LA-N-1 cells with an antioxidant enzyme, superoxide dismutase 
(SOD), before jacaric acid treatment lowered the percentage of cells that were 
Annexin V-positive and Pl-negative (early apoptotic cells) when compared to the 
ones which were treated with jacaric acid only (Figure 4.3). Similarly, the 
apoptosis-inducing activity of jacaric acid was confirmed with another human 
neuroblastoma cell line, the SH-SY5Y cells. As shown in Figure 4.4, the percentage 
of SH-SY5Y cells that were Annexin V-positive and Pl-negative (early apoptotic 
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Figure 4.3 The effect of superoxide dismutase (SOD) on jacaric acid-induced 
apoptosis in human neuroblastoma LA-N-1 cells. LA-N-1 cells (1 x 10^) were 
either untreated or preincubated with 200 units/ml SOD for 4 hours and then treated 
with either (A) solvent control (0.03% ethanol) or (B) 4 |LIM jacaric acid and (C) 6 
|iM jacaric acid for 12 hours at 37°C. The cells were then harvested and stained with 
GFP-conjugated Annexin V and propidium iodide (PI). The number at the bottom 
right quadrant represents the percentage of cells stained with Annexin V but negative 
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Figure 4.4 Induction of phosphatidylserine externalization in jacaric 
acid-treated human neuroblastoma SH-SY5Y cells. The neuroblastoma SH-SY5Y 
cells (10^ cells/ml) were either incubated with (A) solvent control (0.03% ethanol), 
or jacaric acid at (B) 2 ^iM (C) 4 and (D) 6 \iM for 24 hours at 37�C hours and 
then stained with the GFP-conjugated Annexin V and propidium iodide (PI) dye. At 
the top right quadrant, cells with both Annexin V and PI positive signals are necrotic 
cells. At the bottom right quadrant, the number indicates the percentage of cells 
which were Annexin V positive and PI negative and represents the early apoptotic 
cells. 
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4.2.3 Effect of jacaric acid on the mitochondrial membrane potential in human 
neuroblastoma cells 
As described in the introduction, there are two main pathways of apoptosis: 
intrinsic (mitochondrial) pathway and extrinsic (death receptor) pathway. The 
mitochondrial pathway involves permeabilization of outer mitochondrial membrane 
which resulted in release of cytochrome c and other apoptogenic proteins from the 
intermembrane space (Tsujimoto and Shimizu, 2007). The release of cytochrome c 
leads to activation of executioner caspases and a series of apoptosis-associated 
morphological and biochemical changes in the cells (Green and Reed, 1998). 
Mitochondrial release of cytochrome c was suggested to be via opening of 
mitochondrial permeability transition pore (MPTP) and reduction of mitochondrial 
membrane potential (A4^m) by the pro-apoptotic proteins Bax/Bak (Shimizu et ai, 
2001). 
To examine whether the jacaric acid-induced apoptosis in LA-N-1 cells 
involves the mitochondrial pathway, the of the treated cells was measured 
using an inner mitochondrial membrane-permeant cationic lipophilic fluorochrome 
JC-1 followed by flow cytometric analysis. In normal cells with high JC-1 
forms J-aggregates which emits red fluorescence at 590 nm after excitation at 488 
nm. However, when the A平m is depolarized in apoptotic cells, JC-1 would exist in 
monomeric form and emits green fluorescence at 527 nm (Salvioli et al., 1997). In 
the present study, the neuroblastoma LA-N-1 and SH-SY5Y cells were treated with 
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solvent control or jacaric acid for 24 hours and then stained with JC-1. The cells were 
analyzed by flow cytometry and the results are shown in Figure 4.5 and 4.6. The 
x-axis represents the intensity of green fluorescence while the y-axis represents the 
intensity of red fluorescence. There was a significant shift of cell population to the 
R1 region after treatment with jacaric acid, meaning more cells with high 
green-to-red ratio of fluorescent intensity. This increase in the ratio indicates the 
reduction or loss of AH^m. Therefore, jacaric acid caused mitochondrial membrane 
depolarization in the human neuroblastoma cells. 
-147-
10^  10 ' 10� 101 102 FITC-A 10^  10^  
Chapter 4: Apoptosis- and differentiation-inducing effects 
o 
R1 





10° 101 102 
FITC-A 
W 10 ' 
Figure 4.5 Effect of jacaric acid (8Z, lOE，12Z CLN) on the mitochondrial 
membrane depolarization in human neuroblastoma LA-N-1 cells. The 
neuroblastoma LA-N-1 cells (10^ cells/ml) were either incubated with (A) solvent 
control (0.04% ethanol), or (B) 4 |j,M jacaric acid and (C) 8 |iM jacaric acid for 24 
hours at 37°C and then stained with the mitochondria-selective JC-1 dye. In the left 
quadrant, cells with normal polarized mitochondrial membranes emit red 
fluorescence. In the right quadrant the number indicates the percentage of cells 
which emits green fluorescence and represents cells with depolarized mitochondrial 
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Figure 4.6 Effect of jacaric acid (8Z，lOE，12Z CLN) on the mitochondrial 
membrane depolarization in human neuroblastoma SH-SY5Y cells. The 
neuroblastoma SH-SY5Y cells (10^ cells/ml) were either incubated with (A) solvent 
control (0.03% ethanol), or jacaric acid at (B) 2 ^M (C) 4 i^M and (D) 6 |iM for 24 
hours at 37°C and then stained with the mitochondria-selective JC-1 dye. In the left 
quadrant, cells with normal polarized mitochondrial membranes emit red 
fluorescence. In the right quadrant the number indicates the percentage of cells which 
emits green fluorescence and represents cells with depolarized mitochondrial 
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4.2.4 Effect of jacaric acid on the caspase-3 activity in LA-N-1 cells 
Caspases (cysteinyl aspartate-specific proteinase) belong to a group of cysteine 
proteases which are responsible for cleaving cellular polypeptides and give rise to 
many biochemical and morphological events in cell death (Nicholson, 1999). The 
family has a conserved cysteine side chain and is specific for cleaving proteins with 
aspartate. They use the cysteine side chain as a nucleophile to hydrolyze peptide 
bond (Timmer and Salveen, 2007). Twelve caspases have been found in humans 
(Chowdhury et al” 2008; Eckhart et al.’ 2008), while seven of which have a defined 
function related to apoptosis (Pop and Salvesen, 2009; Kumar, 2007). Caspase-2, -8， 
-9 and -10 are initiator caspases as they get activated through recruitment to 
signalling complexes while caspase-3, -6 and -7 are effector caspases as they are 
responsible for cleaving most of the cellular substrates associated with apoptosis. In 
this study, we focused on examining the activity of caspase-3 in jacaric acid-treated 
neuroblastoma cells. 
Caspase-3 is the main executioner of both the intrinsic and extrinsic apoptotic 
pathways. For the extrinsic pathway, upon binding of death ligands to death receptors, 
the receptors would recruit adaptor proteins with death domain and would bring 
about the activation of caspase-8. Activated caspase-8 would initiate apoptosis via 
cleavage of downstream effector caspases such as caspase-3 (Fulda and Debatin, 
2008). 
For the intrinsic pathway, cytochrome c released from mitochondria forms an 
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apoptosome with Apaf-1 and caspase-9. The apoptosome complex triggers activation 
of caspase-3 while other mitochondrial proteins including second 
mitochondria-derived activator of caspase/ direct inhibitor of apoptosis 
protein-binding protein with low PI (Smac/DIABLO) and Omi/HtrA2 counteract 
with the apoptosis-inhibiting activity of inhibitor of apoptosis protein (lAP). 
Activation of caspase-3 through either or both of intrinsic and extrinsic pathways 
would result in a number of characteristic apoptotic morphological and biochemical 
changes in the cells (Saelens et al., 2004). 
Since DNA fragmentation and chromatin condensation were observed in 
jacaric acid-treated neuroblastoma cells, it would be worthwhile to test whether the 
upstream caspase, caspase-3, is responsible for the occurrence of these events. 
LA-N-1 cells were incubated with solvent control or jacaric acid for 48 hours. After 
that, the cytosolic proteins were extracted from the cells. The caspase enzymatic 
activity in the caspase-containing protein extract was followed by a fluorogenic assay. 
Briefly, the protein extract was incubated with a substrate Ac-DEVD-AMC which 
would be cleaved by caspase-3 and become fluorogenic. In addition, in order to 
eliminate the possibility of non-specific degradation of the substrate, a caspase-3 
inhibitor Ac-DEVD-CHO was added to one set of the samples before reacting with 
the substrate. In this way, the caspase-specific signal could be determined (Galluzzi 
et al., 2009). The results in Figure 4.7 indicated that jacaric acid triggered the 
activation of caspase-3 in neuroblastoma LA-N-1 cells significantly. 
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Figure 4.7 Activation of caspase-3 in jacaric acid-treated human neuroblastoma 
LA-N-1 cells. LA-N-1 cells (5 x 10^) were either incubated with solvent control 
(0.03% ethanol) or different concentrations of jacaric acid ( 2 - 6 fiM) for 48 hours at 
37°C. The cells were harvested and then lysed with lysis buffer (50 / 10^ cells). 
The lysate was incubated on ice for 10 minutes and vortexed vigorously. The lysate 
was centrifuged at 18,000 x g for 3 minutes at 4°C. The supernatant was collected 
and the protein concentration was determined by Bradford protein assay. Fifty 
microgram protein in 50 |j.I lysis buffer was mixed with 2-fold caspase reaction 
buffer containing 10 mM DTT and 100 |ig/ml BSA. The specific caspase substrate 
(Ac-DEVD-AMC) was added to all the control and test samples with or without 
pre-treatment with specific caspase-3 inhibitor (Ac-DEVD-CHO) for 30 minutes at 
37°C. The reaction mixture was incubated for 1 hour at 37°C. The fluorescent 
intensity was measured at excitation of 360 nm and emission at 465 nm by 
fluorescence plate reader, Tecan Polarion, using AMC solution (0 - 5 mM) as 
standard. 
** Significantly different from the control, p < 0.001 
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4.2.5 Effect of jacaric acid on the reactive oxygen species (ROS) generation in 
human neuroblastoma cells 
Reactive oxygen species are oxygen-containing molecules with one or more 
unpaired electrons (Halliwell and Whiteman, 2004). The members of ROS include 
hydroxy 1 radical (H0'), superoxide anion {Oi'), singlet oxygen ('O2), hydrogen 
peroxide (H2O2) and peroxyl radical (ROO.). They are generated in cells during 
normal metabolism (Valko et ai, 2007). The ROS in the body are maintained at a 
level which pro-oxidant and antioxidant reactions are at equilibrium by enzymatic 
and non-enzymatic antioxidants. Excess ROS would result in oxidative stress and 
damage to cellular macromolecules. 
Apoptosis can be induced by a number of pro-oxidants (Bojes et ai, 1997) 
such as hydrogen peroxide (Satoh et ai, 1996; Gardner et ai, 1997). The sudden 
increase in ROS level in the cells would cause opening of the mitochondrial 
permeability transition pore (MPTP) and leads to mitochondrial release of 
cytochrome c (Cai and Jones, 1998). Fariss et al. (2005) suggested the release of 
cytochrome c was mediated by oxidation of cardiolipin which binds cytochrome c in 
the inner mitochondrial membrane. On the other hand, mitochondria are the main 
source of ROS in a cell (Mates and Sanchez-Jimenez, 2000). In the normal electron 
transport chain, a small number of electrons sometimes escape to oxygen and result 
in formation of a superoxide anion (Fariss et al,, 2005). In Section 4.2.3, 
mitochondrial membrane depolarization was observed in jacaric acid-treated 
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neuroblastoma cells. In order to determine whether ROS played a role in the 
jacaric-acid induced apoptosis in the neuroblastoma cells, a cell-permeant 
ROS-sensitive fluorochrome, H 2 D C F D A was used. The probe was first hydrolysed 
by cellular esterase to 2,7-dichlorodihydrofluorescein ( H 2 D C F ) , which was then 
oxidized by ROS such as H2O2, ROO* and HO* to give 2,7-dichlorofluorescein (DCF) 
(Gomes et al., 2005). DCF emits green fluorescence at 522 nm when excited at 488 
nm. 
Briefly, human neuroblastoma cells were treated with solvent control or jacaric 
acid for 1 hour or 24 hours with or without co-incubation with a-tocopherol. The 
cells were then stained with H 2 D C F D A and analysed using a flow cytometer. The 
results in Figure 4.8 showed that jacaric acid increased the cellular level of ROS 
( H 2 O 2 , ROO* and HO.) in the neuroblastoma cells and 25 foM a-tocopherol was able 
to suppress the increase induced by jacaric acid. To quantify the ROS level in the 
neuroblastoma cells, the assay was repeated in 96-well plate and the fluorescent 
intensity was determined using a fluorescent plate reader. From Figure 4.9, it can be 
seen that jacaric acid induced significant increase in ROS levels in both LA-N-1 and 
SH-SY5Y cells when compared to those treated with solvent control. Besides, 
a-tocopherol suppressed the increase in ROS significantly (Figure 4.9A). 
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Figure 4.8 Effect of jacaric acid (8Z, lOE，12Z CLN) on the reactive oxygen 
species (ROS) generation in human neuroblastoma cells. (A) LA-N-1 cells 
(1 X 10^) were cultured overnight and pre-stained with H 2 D C F D A (10 ^iM) for 30 
minutes at 37°C in dark. The cells were then treated with either solvent control 
(0.03% ethanol) or jacaric acid (3 )LIM) with or without 25 jxM a-tocopherol for an 
hour. The cells were harvested and the fluorescent intensity of the stained cells was 
measured by the FACSCanto flow cytometer (BD Biosciences) at excitation of 488 
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nm and emission at 525 nm. Red line: solvent control (34.21%); black line: cells 
treated with 3 \iM of jacaric acid (64.36%); green line: cells treated with 3 }xM of 
jacaric acid and 25 ^M a-tocopherol (35.33%). (B) SH-SY5Y cells (1 x 10^ cells) 
were cultured overnight and incubated either with solvent control (0.03% ethanol) or 
jacaric acid (6 fxM) in 50 mm culture dish for 24 hours. After incubation, the cells 
were trypsinized and stained with 100 |xM 2',7'-dichlorodihydrofluorescein diacetate 
( H 2 D C F D A ) and incubated in dark at 37°C for an hour. The fluorescent intensity of 
the stained cells was measured by the FACSCanto flow cytometer (BD Biosciences) 
at excitation of 488 nm and emission at 525 nm. The number corresponds to the 
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Figure 4.9 The effect of jacaric acid (8Z, lOE, 12Z CLN) on the ROS release in 
human neuroblastoma cells. (A) LA-N-1 cells (I x cells/well) were cultured 
overnight and incubated with different concentrations of jacaric acid (0 - 4 }j.M) with 
or without 20 \iM a-tocopherol for 1 hour. (B) SH-SY5Y cells (1 x ⑴彳 cells/well) 
were cultured overnight and incubated with different concentrations ( 0 - 1 0 |iM) of 
jacaric acid in 96-well microplate for 24 hours. The cells were then stained with 
H 2 D C F D A (10 |J,M) for 30 minutes at 37°C in dark. The fluorescent intensity was 
measured by the Polarion automated microplate fluorescence reader (Tecan) at 
excitation of 485 nm and emission at 535 nm. 
•Significantly different from the solvent control, (a) p < 0.01; (b) p < 0.001 
n Significantly different from the no a-tocopherol group, p < 0.005 
Significantly different from the solvent control, p < 0.01 
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4.2.6 Morphological changes induced by jacaric acid in SH-SY5Y cells 
It was found that there is a positive correlation between neuronal differentiation 
and favourable outcome in neuroblastoma patients (Pahlman et al., 1990). As 
discussed in Chapter 3, the differentiation-inducing effect of jacaric acid on human 
neuroblastoma cells may contribute to the growth-inhibitory effect on the cells. Since 
LA-N-1 cells have a strong tendency to form clumps during growth (Prasad, 1991), it 
was considered to be unsuitable for study of the differentiation-inducing effect of 
jacaric acid. A thrice-subcloned neuroblastoma cell line, SH-SY5Y, from the 
neuroblast-like clonal subline SK-N-SH (Biedler, et al. 1978) was used as a cell 
model in the study of neuronal differentiation of neuroblastoma cells in vitro. The 
cell line was shown to undergo differentiation upon incubation with phorbol ester 
(Pahlman et al, 1981; Spinelli et al.’ 1982) or retinoic acid (Pahlman et al., 1984). 
In the present study, the morphology of the jacaric acid-treated SH-SY5Y cells 
was observed under a light microscope after fixing and staining. It is well recognized 
that neurite extension is a characteristic of neuronal differentiation (Abemayor and 
Sidell, 1989). As shown in Figure 4.10，the neurites of jacaric-acid treated cells were 
longer than those treated with solvent control for 96 hours. Retinoic acid-treated cells 
were used as a positive control. In addition, the length of neurite outgrowth was 
measured for quantitative comparison. Figure 4.11 shows that the mean neurite 
length increased from 14.46 \xn\ (solvent control) to 23.86 \im (0.5 i^M jacaric acid) 






Figure 4.10 Induction of neurite outgrowth by jacaric acid (8Z，lOE, 12Z CLN) 
in SH-SY5Y cells. SH-SY5Y cells (25,000 cells/well) were cultured overnight and 
incubated with either (A) solvent control (0.01% ethanol) or two different 
concentrations of jacaric acid (B) 0.5 (C) 1 \iM or (D) retinoic acid (1 |iM) in a 
24-well culture plate for 96 hours. The cells were then fixed with methanol and 
stained with Hemacolor staining solutions. The morphology was observed by light 
microscope. The scale bars represent 50 |xm and the magnification is 1OOX. 
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Figure 4.11 Effect of jacaric acid (8Z, lOE, 12Z CLN) on the neurite length in 
SH-SY5Y cells. SH-SY5Y cells (25,000 cells/well) were cultured overnight and 
incubated with either (A) solvent control (0.01% ethanol) or (B) 0.5 jiM jacaric acid 
and (C) 1 |JM jacaric acid in a 24-well culture plate for 72 hours. The cells were 
fixed, stained and the length of neurites was measured. At least 200 neurites were 
measured in the control and treatment groups. 
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Figure 4.12 Effect of jacaric acid (8Z，lOE，12Z CLN) on the cell size and 
granularity of SH-SY5Y cells. The cell size and granularity of SH-SY5Y, as 
reflected by forward scatter and side scatter respectively, were analyzed by flow 
cytometry. SH-SY5Y cells (1 x 10^ cells) were cultured overnight and incubated with 
either (A) solvent control (0.01% ethanol), (B) 0.5 |iM jacaric acid, (C) 1 pM jacaric 
acid or (D) 1 |iM retinoic acid in a 50 mm dish for 96 hours. After treatment, the cell 
size and granularity were analyzed by FACSCanto flow cytometer. 
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4.3 Discussion 
As seen in Chapter Three, jacaric acid inhibited the growth of human 
neuroblastoma cells both in vitro and in vivo. This cytostatic effect of jacaric acid 
may be due to inhibition on cells entering the cell cycle, increase in the number of 
cells committing cell death and/or induction of cell differentiation into normal-like 
cells. How jacaric acid exerted its effect on cell cycle of neuroblastoma cells was 
discussed in the previous chapter. In this chapter, we would focus on discussing the 
latter two. 
To date, at least 12 ways of cell death were found and characterized (Kroemer 
et al, 2009). According to the Nomenclature of Cell Death (Galluzzi et ai, 2009), a 
cell should be considered as dead when one or more of the following requirements 
are fulfilled, (a) The cell membrane is no longer intact; (b) The cell, including the 
nucleus, has completely disintegrated; and (c) Its fragments are engulfed by a cell in 
the neighbourhood in vivo. Two of twelve types of cell death, apoptosis and necrosis, 
were studied intensively (Boujrad et al., 2007; de Bruin and Medema, 2008). In 
Chapter Three, necrosis was excluded to be the main type of cell death caused by 
jacaric acid since the direct cytotoxic effect on neuroblastoma cells by jacaric acid 
was minimal as determined by the trypan blue exclusion assay (Section 3.2.2). The 
apoptosis-inducing effect of jacaric acid can be investigated by a number of 
complementary yet methodologically unrelated techniques like fluorescence 
microscopy, cytofluorometry and agarose gel electrophoresis (Galluzzi et ai, 2009). 
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Internucleosomal DNA fragmentation is a widely accepted biochemical 
hallmark of apoptosis. It is resulted from the excision of genomic DNA nucleosome 
chains by an endogenous endonuclease caspase-activated DNase (Wyllie, 1980) 
regardless of the DNA sequences (Moore et al., 1993). By subjecting the DNA 
extracted from jacaric acid-treated cells to agarose gel electrophoresis, characteristic 
DNA ladders were observed as visualized under UV illumination after staining the 
gel with ethidium bromide. The DNA fragments are separated by 180 bp and its 
multiples due to the binding of hi stone HI to chromatin which is spaced every 
180-220 bp. The proteins associated to the chromatin prevent the apoptotic 
endonuclease from accessing and cleaving DNA (Robertson et al., 2000). This assay 
is a cornerstone method to differentiate apoptotic and necrotic cell death (Galluzzi et 
al, 2009). 
Another nuclear event in apoptosis is chromatin condensation which results 
from degradation of euchromatin, lamins and reorganization of intranuclear protein 
matrix and leading to loss of nuclear integrity (Hendzel et al., 1998). This allows 
heterochromatin to aggregate to bring about the phenomenon of chromatin 
condensation. The aggregation of heterochromatin is then digested by endonucleases 
to give rise to DNA fragmentation (Robertson et al., 2000). To assess the ability of 
jacaric acid in inducing chromatin condensation, jacaric acid-treated LA-N-1 cells 
were fixed with ethanol and then stained with Hoechst 33342. The cells were 
examined under a fluorescence microscope and typical apoptotic chromatin 
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condensation was observed. Robertson et al. (2000) reviewed that chromatin 
condensation is controlled in both caspase-dependent and -independent manners. 
Sahara et al. (1999) identified a molecule Acinus to be necessary for apoptotic 
chromatin condensation to occur. In addition, Acinus requires activation by 
caspase-3. On the other hand, apoptosis-inducing factor (AIF), a protein released 
from the mitochondria, is translocated to nucleus where it induces chromatin 
condensation in the absence of caspase-activation (Lorenzo and Susin, 2007). 
Nevertheless, the pattern of chromatin condensation is very different between those 
induced by AIF and Acinus (Robertson et al., 2000). Further experiments on the 
expression and localization of Acinus and AIF are needed to determine which 
protein factor(s) is/are involved in the jacaric-acid induced chromatin condensation. 
Externalization of PS to the outer layer of plasma membrane is an early event 
in apoptosis. Under normal physiological conditions, the asymmetrical distribution 
of PS on the lipid bilayer is maintained by an energy-dependent lipid transporter 
aminophospholipid translocase which is responsible for flipping or shuttling PS 
from outer to inner leaflet of the membrane (Zwaal et al., 2005). During apoptosis, 
caspase-mediated release of Ca^ "^  from mitochondria and endoplasmic reticulum (ER) 
would result in the inactivation of PS translocase as well as activation of scramblase 
(Balasubramanian et al., 2007). The scramblase catalyzes the bidirectional 
phospholipid transport and promotes the collapse of the membrane asymmetry with 
PS on the surface of an apoptotic cell. PS on the cell surface would be recognized by 
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macrophages with a PS receptor and this initiates the engulfment and removal of the 
apoptotic cells (Zwaal et al., 2005). In the present study, PS externalization was 
detected with a GFP-conjugated molecule Annexin V which binds strongly to PS in 
the presence of Ca2+ (van Engeland et al, 1998). Since necrotic cells with 
permeabilized membrane also allow binding of Annexin V to PS, in order to 
differentiate normal cells, early apoptotic cells and late apoptotic cells (or necrotic 
cells), dual staining of the treated neuroblastoma cells was performed. PI can only 
enter nuclei of cells with permeabilized plasma and nuclear membrane and bind to 
DNA. Therefore, cells that are both Annexin V- and Pl-positive are late apoptotic 
cells (or necrotic cells). From the results, there was 10% - 20% of the cell population 
being Annexin V-positive and Pl-negative after jacaric acid treatment, indicating that 
jacaric acid triggered PS external ization and thus apoptosis in the neuroblastoma 
cells. Moreover, since the proposed mechanism of the apoptosis-inducing effect of 
jacaric acid is via lipid peroxidation (Tsuzuki et al., 2004a), it would be intriguing to 
study whether addition of an antioxidant enzyme, SOD, could lower the 
apoptosis-inducing effect of jacaric acid. Superoxide dismutase (SOD; EC 1.15.1.1) 
is known to catalyze the conversion of highly reactive superoxide radicals into less 
reactive hydrogen peroxide (Mates and Sanchez-Jimenez, 2000). We demonstrated 
that the percentage of apoptotic cells was significantly reduced by pre-incubation of 
the neuroblastoma cells with SOD before jacaric acid treatment. The result indicated 
that ROS, at least superoxide, was involved in the apoptosis induced by jacaric acid. 
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Mitochondria play an important role in the intrinsic apoptotic pathway. 
Shibayama-Imazu Qt al. (2008) proposed that superoxide production might damage 
the mitochondrial membranes, cause opening of permeability transition pores (PTP) 
and reduction of mitochondrial membrane potential (A4^m). Opening of PTP would 
facilitate the release of pro-apoptotic proteins such as cytochrome c which would 
activate a cascade of enzymes and give rise to a number of apoptosis-associated 
morphological and biochemical changes. Mitochondrial membrane permeability 
(MMP) can be detected by monitoring the dissipation of (Galluzzi et al., 2009). 
An inner mitochondrial membrane-permeant cationic lipophilic fluorochrome JC-1 
was used to stain the treated neuroblastoma cells followed by flow cytometric 
analysis. From the results, there was a significant rise in the percentage of cell 
population with depolarized mitochondrial membrane potential after jacaric acid 
treatment, revealing that jacaric acid caused increase in MMP in the neuroblastoma 
cells. 
Caspase-3 was found to play a central role in mediating nuclear apoptosis and 
is required for many characteristic nuclear and other morphological alterations 
related to apoptosis (Hirata et al., 1998; Porter and Janicke, 1999). Cell lines without 
caspase-3 were killed by different apoptotic inducers without DNA fragmentation 
and other typical apoptotic-associated morphological changes (Oberhammer et al,, 
1993). Introduction of caspase-3 back to the cell line restored DNA fragmentation 
and cellular blebbing during apoptosis (Janicke et al., 1998). As jacaric acid was 
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demonstrated to produce DNA ladders and induce chromatin condensation in human 
neuroblastoma cells in Section 4.2.1, we would like to further investigate the effect 
of jacaric acid on the caspase-3 activity of LA-N-1 cells. Caspases-containing 
protein was extracted from neuroblastoma cells treated with solvent control or 
jacaric acid for 48 hours and then incubated with a caspase-3 fluorogenic substrate 
Ac-DEVD-AMC. Previous studies reported that a protein poly(ADP-ribose) 
polymerase (PARP) which is responsible for recognizing DNA damage was cleaved 
at the site DEVDNI^G during apoptosis (Lazebnik et al.’ 1994). In addition, Porter and 
Janicke (1999) reviewed the substrate preference of caspase-3 on DEVDG, cleaving 
between the aspartic acid (D) and the glycine (G). Upon cleavage by activated 
caspase-3, AMC would be released and emit fluorescence at 465 nm when excited at 
360 nm. The results showed that jacaric acid induced caspase-3 activity in human 
neuroblastoma LA-N-1 cells significantly, indicating the participation of caspase-3 
in jacaric-acid induced apoptosis. Since the substrate can also be cleaved by other 
proteases non-specifically, the specific caspase-3 inhibitor Ac-DEVD-CHO was 
used. It was found to suppress the caspase-3 activity significantly, verifying the 
activation of caspase-3 in jacaric acid-induced apoptosis. 
In general, a relatively reducing cellular environment favours proliferation 
while a slightly oxidizing cellular environment stimulates differentiation in cells. 
However, a very oxidizing environment would result in apoptosis or even necrosis 
(Valko et al., 2007). CLNs were suggested and reported to induce apoptosis via lipid 
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peroxidation (Igarashi and Miyazawa, 2000; Tsuzuki et ai, 2004a). Lipid 
peroxidation is a chain reaction which generates lipid hydroperoxides. The 
hydroperoxides produced would promote further lipid peroxidation and ROS would 
be formed (Igarashi and Miyazawa, 2000.) Aoshima et al, (1997) found that ROS 
were generated during lipid hydroperoxide-induced apoptosis in rat 
pheochromocytoma PC 12 cells. Tsuzuki et al. (2004a) also demonstrated that 
a-eleostearic acid increased the amounts of phospholipid hydroxide and 
thiobarbituric acid reactive substances (TBARS) in colon cancer DLD-1 cells. 
Moreover, the increase could be suppressed by an antioxidant, a-tocopherol. 
a-tocopherol is a lipophilic antioxidant which can scavenge ROS like superoxide, 
hydroxyl and peroxyl radicals. Addition of a-tocopherol together with 
13-L-hydroperoxylinoleic acid (LOOH) could depress the LOOH-induced ROS 
production and restore viability of PC-12 cells (Aoshima et al., 1997). Therefore, it 
would be interesting to see whether similar condition would apply to our system. 
Using H 2 D C F D A staining, the amount of ROS in the two neuroblastoma cell lines 
was estimated by flow cytometer as well as fluorescent plate reader. Jacaric acid 
treatment resulted in a dose-dependent enhancement of ROS generation in both 
LA-N-1 and SH-SY5Y cells, and the increase in LA-N-1 cells was significantly 
suppressed by co-incubation with a-tocopherol. Overproduction of ROS would lead 
to mitochondrial permeability transition (Galluzzi et al., 2009) and hence release of 
cytochrome c and other pro-apoptotic proteins to the cytosol. The effect of jacaric 
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acid on lipid peroxidation would be further discussion in the next chapter. 
A special characteristic of neuroblastoma is the spontaneous regression of 
tumor in a subgroup of patients with stage 4s neuroblastoma, although some display 
tumor metastasis. The observation may be associated with delayed neuroblast cell 
differentiation and/or late activation of apoptosis (Pritchard and Hickman, 1994; 
Tonini and Pistoia, 2006). Differentiation therapy has been used in a clinical trial for 
high-risk neuroblastoma patients in combination with other chemotherapeutic drugs 
or following autologous bone marrow infusion (Matthay et al., 1999; Matthay et aL, 
2009). The combination resulted in a higher event-free survival compared to those 
patients who did not receive differentiation therapy using 13-c/5-retinoic acid. In 
addition, different research groups reported the ability of neuroblastoma cells to 
undergo neuronal differentiation upon induction by dbcAMP (Prasad and Hsie, 
1971)，DMSO (Kimhi et al, 1976)，sodium butyrate (Prasad and Sinha, 1976)， 
Vitamin E (Prasad et al, 1979)，phorbol ester (Pahlman et al, 1981) and retinoic 
acid (Sidell, 1982). Some of the differentiation-inducing effect was reversible after 
removal of the agent while some induced terminal differentiation in the 
neuroblastoma cells which was irreversible (Prasad, 1991). Since neuroblastoma 
arises from the failure of neuroblast to mature along the neuronal lineage (Pahlman 
et al., 1990)，agents that can induce neuronal differentiation in neuroblastoma into 
normal-like cells would be of great therapeutic value. Hence, an attempt to assess 
the capability of jacaric acid in inducing differentiation of human neuroblastoma 
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cells was made. Valko et al. (2007) proposed a slightly oxidizing cellular 
environment stimulates differentiation in cells while a strongly oxidizing 
environment would result in apoptosis or even necrosis, therefore, a low dose of 
jacaric acid was added to the cell cultures. After incubation of neuroblastoma 
SH-SY5Y cells for 96 hours, the cells were fixed and stained. Significant induction 
of neurite outgrowth was observed in jacaric acid-treated cells, although the neurite 
length was not as long as that of retinoic acid-treated cells. The cell density was not 
affected considerably at low dosages used. Quantification of the neurite length 
showed a dose-dependent increase in the neurite outgrowth. Flow cytometric 
analysis also revealed that jacaric acid induced a slight increase in the cell size and 
granularity of the neuroblastoma cells. 
From the above results, we clearly demonstrated the apoptosis-inducing ability 
of jacaric acid in human neuroblastoma cells. The apoptosis induced involves PS 
externalization, ROS production, mitochondrial membrane depolarization, caspase-3 
activation, chromatin condensation and DNA fragmentation. The underlying 
mechanisms would be discussed in the next chapter. Besides, jacaric acid induced 
morphological differentiation in SH-SY5Y cells. Further experiments are required to 
determine whether the cells became functionally more mature. The expression of 
microtubule-associated proteins such as MAP-2 and neurofilament can be studied by 
confocal microscopy while the activity of neurotransmitter-producing enzymes like 
tyrosine hydroxylase can be measured. 
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5.1 Introduction 
More than ten years ago, Zamzami et al. (1995) found that the sequence of 
early apoptotic events started from loss of ROS generation from uncoupled 
mitochondrial electron transport chain (ETC) and followed by damage of inner 
mitochondrial membrane. After that, cell shrinkage would be observed, together with 
increase in membrane permeability and change in lipid packaging (PS 
externalization). The role of ROS in mediating apoptosis was shown by (i) induction 
of apoptosis by treatment with ROS (Sandstrom et al., 1994; Aoshima et al” 1997), 
(ii) inhibition of endogenous antioxidant systems or promotion of ROS formation by 
chemicals could also induce apoptosis (Hockenbery et al., 1993; Ratan et al., 1994) 
and (iii) addition of exogenous antioxidants could sometimes inhibit apoptosis 
(Tsuzuki et al., 2004a). In Chapter Four, we have demonstrated the induction of ROS 
generation in human neuroblastoma cells by jacaric acid. In this chapter, we would 
like to further characterize the underlying mechanisms for the growth-inhibitory and 
apoptosis-inducing effects of jacaric acid. Tsuzuki et al. (2004a) and Yasui et al. 
(2006a) reported the growth suppression of tumor in vivo and cancer cells in vitro by 
CLN isomers, including a-eleostearic acid, p-eleostearic acid, a-calendic acid and 
p-calendic acid, via lipid peroxidation. Moreover, work from Aoshima et al. (1997) 
showed that lipid hydroperoxide triggered apoptosis in rat pheochromocytoma 
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PC12h cells with enhanced ROS production. To investigate whether lipid 
peroxidation was involved in jacaric acid-induced growth suppression, human 
neuroblastoma LA-N-1 cells were co-incubated with different concentrations of 
jacaric acid and an antioxidant a-tocopherol. 
In Section 4.2.4，caspase-3 was found to be activated in jacaric acid-treated 
neuroblastoma LA-N-1 cells. Caspase-3 is the common executioner caspase for both 
the extrinsic and intrinsic apoptotic pathways (Fulda and Debatin, 2006). It was 
suggested to be responsible for cleaving various cellular substrates to bring about 
apoptosis-associated nuclear events including chromatin condensation and 
polynucleosomal DNA fragmentation (Porter and Janicke, 1999). To further confirm 
the involvement of caspases especially caspase-3 in jacaric acid-induced apoptosis 
and anti-proliferation, the neuroblastoma LA-N-1 cells were pre-treated with caspase 
inhibitors before incubating with different concentrations of jacaric acid. After 48 
hour treatment, the cell viability was determined by MTT reduction assay. 
The differences of embryonic malignancies like neuroblastoma and adult 
tumors are the length of latency period and the number of genetic aberrations 
(Johnsen et al., 2009). The latency period is usually very much shorter in embryonic 
tumors with less genetic alterations. Since embryonic tumors arise from immature 
tissue where the dividing cells have higher migratory ability and sometimes resistant 
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to apoptosis, these cells need fewer changes in DNA to become tumorigenic 
(Scotting, et al. 2005). One of the oncogenes which is often found to be amplified 
but not mutated in neuroblastoma is N-myc (Schwab et al., 2003). N-myc protein 
belongs to a group of transcription factors containing basic helix-loop-helix leucine 
zipper (bHLHZ) motifs at the C-terminal. The bHLHZ domain of N-myc was found 
to mediate DNA binding via heterodimerization with another bHLHZ protein Max 
(Hurlin et al., 1999). The heterodimer would activate transcription of genes 
containing E-box DNA recognition sequences by the transactivation domain at the 
N-terminal (Grandori et al., 2000). In addition to N-myc, other members of the Max 
interacting proteins, including Mad, Mnt and Mga, also form heterodimer with Max 
to antagonize the functions of N-myc in promoting cell growth (Luscher and Larsson, 
1999). N-myc amplification is often found in advanced-stage neuroblastoma and is 
associated with poor outcome in the patients (Schwab et al., 2003). In neural 
progenitor cells, N-myc is transiently expressed to define the direction of neuronal 
differentiation (Nakagawara, 2005). Nevertheless, N-myc expression level was found 
to decrease in terminally differentiated cells (Mugrauer et al., 1988) and 
differentiated neuroblastoma cells induced by retinoic acid in vitro (Thiele et al., 
1985; Matsumoto et al., 1989). In Chapter Four, jacaric acid was shown to induce 
morphological differentiation in human neuroblastoma cells. In this chapter, we 
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would investigate the effect of jacaric acid on the gene expression of members of 
Max/Myc/Mad transcription factor family in human neuroblastoma cells at the 
transcriptional level. In addition, the expression of N-myc protein would also be 
determined in jacaric acid-treated neuroblastoma LA-N-1 cells. 
Neuroblastoma cells were found to be resistant to apoptosis due to deregulation 
of intrinsic apoptotic pathway and aberration of the extrinsic pathway (Johnsen et al., 
2009). In regulation of apoptosis, the intrinsic pathway is negatively controlled by 
anti-apoptotic or pro-survival Bcl-2 family members including Bcl-2, B C I - X L , Bcl-w, 
Mcl-l, Al and Bcl-B. They contain 4 Bcl-2 homology domains (BHl - BH4) and a 
transmembrane domain. They protect cells against a variety of apoptotic inducers and 
are essential for cell survival by counteracting the pro-apoptotic members of the 
same family (Wong and Puthalakath, 2008), such as Bad, Bid, Bik, Bim, Bmf, Hrk, 
Noxa and PUMA. The pro-apoptotic proteins are also called BH3-only proteins and 
they are essential for initiating mitochondrial apoptotic pathway. Another group of 
pro-apoptotic proteins with multiple BH domains is regarded as the adaptor 
molecules as they are translocated to the outer mitochondrial membrane and 
permeabilize the membrane upon activation and oligomerization. The activation and 
oligomerization of the adaptor molecules Bax and Bak was proposed to be induced 
by Bid (Eskes et al., 2000) and Bim (Marani et al.’ 2001). Bid was reported to play a 
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role in the cross-talk between the death receptor pathway and mitochondrial pathway 
of apoptosis. Cleavage of Bid by activated caspase-8 followed by translocation of 
truncated Bid (tBid) would result in mitochondrial release of cytochrome c via Bax 
and Bak (Fulda and Debatin, 2006; Cory and Adams, 2002). The structures of Bcl-2 
family members are shown in Fig. 5.1. 
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Figure 5.1 Different structures of pro-survival and pro-apoptotic BcI-2 family 
members 
(Modified from Wong and Puthalakath, 2008) 
It was found that in neuroblastoma cells, the balance between the expression 
levels of proteins related to apoptosis shifted to higher level of anti-apoptotic ones 
and lower levels of pro-apoptotic ones (Abel et al., 2005). This makes the cell more 
resistant to apoptosis inducers in chemotherapy, especially in relapse tumors. High 
expression levels of anti-apoptotic proteins such as Bcl-2 (Castle et al” 1993), 
BC1-XL (Dole et al.’ 1995) and survivin (Islam et al, 2000; Azuhata et al., 2001) 
were reported to be correlated with poor prognosis and resistance to 
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chemotherapy-induced apoptosis. On the other hand, lower expression levels of 
pro-apoptotic proteins like BIm induced by brain-derived neurotropic factor 
protected neuroblastoma cells from pac 1 itaxeI-triggered cell death (Li et al., 2007). A 
novel agent is required to strengthen the apoptosis-triggering ability of the current 
treatments by targeting the defects in apoptosis programs in neuroblastoma cells 
specifically. Since apoptosis-associated phenomena including mitochondrial 
membrane depolarization, increased ROS generation, activation of caspase-3 and 
DNA fragmentation were observed in jacaric acid-treated neuroblastoma LA-N-1 
cells, it would be of interest to examine whether the expression levels of 
apoptosis-associated Bcl-2 family members were affected by jacaric acid. As a 
preliminary study, the mRNA expression levels of one anti-apoptotic protein Bcl-2 
and one pro-apoptotic protein Bak were studied by real-time PGR. 
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5.2 Results 
5.2.1 Effect of antioxidant a-tocopherol on the anti-proliferative effect of 
jacaric acid on LA-N-1 cells 
More than two decades ago, Begin et al. (1988) already proposed the 
correlation of the ability of a polyunsaturated fatty acid (PUFA) in killing malignant 
cells and the extent of lipid peroxidation caused by the fatty acid in cells. Cornelius 
et al. (1991) reported the cytotoxicity by cw-parinaric acid (9Z，HE, 13E, 15Z-18:4) 
on human monocytic leukemia 11-937 cells could be suppressed by an antioxidant, 
butylated hydroxytoluene (BHT), indicating the involvement of an oxidative 
mechanism in the conjugated fatty acid-induced cytotoxicity. Das (1999) also 
provided evidence that the tumoricidal effect of PUFAs was associated with an 
increase in free radical production and subsequent lipid peroxidation in treated 
cancer cells. In order to examine whether lipid peroxidation was involved in the 
anti-proliferative activity of jacaric acid in human neuroblastoma cells, LA-N-1 cells 
were co-incubated with jacaric acid and an antioxidant a-tocopherol for 48 hours. 
The results showed that the growth-inhibitory effect of jacaric acid on neuroblastoma 
LA-N-1 cells was suppressed significantly by a-tocopherol in a dose-dependent 
manner (Figure 5.2). On the other hand, a-tocopherol alone did not exhibit obvious 
effect on the viability of LA-N-1 cells. 
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Figure 5.2 Effect of antioxidant a-tocopherol on the anti-proliferative effect of 
jacaric acid on LA-N-1 cells. LA-N-1 cells (1 x lO'^  cells/well) were seeded in 
96-well plate and cultured overnight. The cells were then treated with different 
concentrations of jacaric acid (0 - 6 |iM) and a-tocopherol (0 - 25 \iM) 
simultaneously for 48 hours. The cell viability was measured by MTT reduction 
assay as described in Chapter 2. The data were expressed as % cell viability 
compared to the control (no jacaric acid and a-tocopherol added) which was regarded 
as 100% viability. 
*Significantly different between the groups with a-tocopherol and the group with no 
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5.2.2 Effect of caspase inhibitors on the anti-proliferative effect of jacaric acid 
on LA-N-1 cells 
Tsuzuki et al. (2004a) and Tsuzuki et al. (2007) reported the increase in both 
expression levels and activities of caspase-3, -8 and -9 in human colorectal 
adenocarcinoma DLD-1 cells treated with CLN a-eleostearic acid or conjugated EPA 
(5Z, 7E, 9E, 14Z, 17Z-20:5). Previous work from our lab also demonstrated 
enhanced caspase-3 and -9 activities in jacaric acid-treated human promyelocytic 
leukemia HL-60 cells (Yip, 2007). Co-incubation of the HL-60 cells with 
pan-caspase inhibitor III and jacaric acid significantly lowered the percentage of cells 
undergoing DNA fragmentation, indicating the involvement of caspases in jacaric 
acid-induced apoptosis. The pan-caspase inhibitor (Boc-D-FMK) is a broad-spectrum 
cell-permeable and irreversible caspase inhibitor, but a poor inhibitor of caspases-2, 
-5, -6 and -10 (Chauvier et al,, 2006). It was added to LA-N-1 cells 16 hours before 
jacaric acid treatment. Another specific caspase-3 inhibitor Ac-DMQD-CHO was 
also used in the experiment. As shown in Figure 5.3, pre-treatment of LA-N-1 cells 
with caspase inhibitors markedly restored the viability of cells treated with relatively 
low concentration (3 |iM) of jacaric acid. Interestingly, the effect of caspase 
inhibitors on the viability of cells treated with higher concentrations (4 - 5 |iM) of 
jacaric acid was not significant. 
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• Jacaric acid only 
• Caspase inhibitor III (Boc-D-fink) + jacaric acid 
O Caspase-3 inhibitor IV (Ac-DMQD-CHO) + 
jacaric acid 
I 
3 4 . 5 
Concentration of jacaric acid (jiM) 
Figure 5.3 Effect of caspase inhibitors on the anti-proliferative effect of jacaric 
acid in human neuroblastoma LA-N-1 cells. LA-N-1 cells (1 x 10'^  cells/well) were 
seeded in 96-well plate and cultured overnight. The cells were pre-treated with 25 
[iM caspase inhibitors for 16 hours before incubated with different concentrations of 
jacaric acid ( 3 - 5 |iM) simultaneously for 48 hours. The cell viability was measured 
by MTT reduction assay as described in Chapter 2. The data were expressed as % 
cell viability as compared to the control (no jacaric acid and caspase inhibitor added) 
which was regarded as 100% viability. The values from the groups pre-incubated 
with caspase inhibitors differ significantly from the group treated with jacaric acid 
only. 
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5.2.3 Jacaric acid modulated the mRNA expression of N-myc and other related 
transcription factors in LA-N-1 cells 
Grandori et al. (2000) reviewed the profound effect of Myc/Max/Mad network 
members in cell proliferation, differentiation and death. Briefly, Max-interacting 
proteins such as Mad, Mga, Mnt and Myc form heterodimers with Max and results in 
transcriptional activation or repression of specific target genes. These 
Max-interacting proteins are short-lived and their biosynthesis is tightly regulated. In 
general, Mad and Mnt repress transcription when heterodimerize with Max (Hurlin et 
al., 1999) while Myc activates transcription of target genes involved in cell cycle 
progression and differentiation (Luscher and Larsson, 1999). N-myc is a member of 
the proto-oncogene family comprised of c-myc, N-Myc and L-myc. It has been 
expressed only in a restricted set of cancer cells with neural characteristics, including 
neuroblastoma and retinoblastoma (Zimmerman et al., 1986). It was reported that 
Myc was necessary to maintain the tumorigenicity (Felsher and Bishop, 1999) while 
inactivating Myc would result in cell cycle arrest, differentiation, apoptosis and 
tumor regression in transgenic models (Arvanitis and Felsher, 2006). As 
demonstrated in previous chapters, jacaric acid reduced the number of cell division 
committed by the treated neuroblastoma cells, suppressed the in vivo tumorigenicity 
and induced morphological differentiation in human neuroblastoma cells. Here, we 
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would like to study whether Myc and the members of Max/Myc/Mad network were 
involved in the growth-inhibitory effect of jacaric acid on LA-N-1 cells. LA-N-1 is a 
human neuroblastoma cell line with N-myc amplified to about 20 - 30 fold (Lee et al, 
1991). The effect of jacaric acid on the mRNA expression of the transcription factors 
in LA-N-1 cells was examined by real-time PGR. Figure 5.4 shows that jacaric acid 
caused reduction in mRNA expression of N-myc in a dose-dependent manner. The 
expression of Max was also markedly suppressed by jacaric acid in LA-N-1 cells. On 
the other hand, the expression levels of N-myc antagonists Mad, Mnt and Mga were 
increased in jacaric acid-treated LA-N-1 cells (Figure 5.5). 
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Figure 5.4 Jacaric acid suppressed the mRNA expression of N-myc and Max in 
human neuroblastoma LA-N-1 cells. LA-N-1 cells (5 x 10 )^ were either treated 
with solvent control (0.03% ethanol) or three different concentrations of jacaric acid 
(2 |iM, 4 |j,M and 6 |iM) for 48 hours. After treatment, the cells were harvested and 
total mRNA was extracted using TRIZOL method. cDNA was then synthesized from 
the mRNA by reverse transcription and the expression levels were determined by 
quantitative PGR using TaqMan® Universal PGR reaction mix according to the 
manufacturer's instructions. The data were analyzed by method described by 
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Figure 5.5 Jacaric acid increased the mRNA expression of N-myc antagonists, 
Mad, Mnt and Mga in human neuroblastoma LA-N-1 cells. LA-N-1 cells (5 x 10^) 
were either treated with solvent control (0.03% ethanol) or different concentrations 
of jacaric acid (2 - 6 foM) for 48 hours. After treatment, the cells were harvested and 
total mRNA was extracted using TRIZOL method. cDNA was then synthesized from 
the mRNA by reverse transcription and the expression levels were determined by 
quantitative PGR using Power SYBR Green® and TaqMan® Universal PGR reaction 
mix according to the manufacturer's instructions. The data were analyzed by 
method described by Livak and Schmittgen (2001). 
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Chapter 5: Underlying Mechanisms 
5.2.4 Jacaric acid modulated the protein expression of N-myc 
Over-expression of N-myc in the developing neuroectoderm of transgenic mice 
resulted in development of neuroblastoma (Weiss et al., 1997). Knockdown of N-myc 
by transfecting antisense oligonucleotide into neuroblastoma cells reduced the 
tumorigenicity in nude mice (Burkhart et al., 2003). On the other hand, decrease in 
N-myc expression level was demonstrated during induction of differentiation in 
neuroblastoma cells by retinoic acid (Thiele et al., 1985). These findings suggested a 
crucial role of N-myc deregulation in neuroblastoma development. It was proposed 
that N-myc amplification gave rise to increased expression of a wild-type N-myc 
which contributes to tumorigenesis and progression of tumors to greater malignancy 
(Schwab et al., 1984). In the present study, the expression level of N-myc protein 
was determined in jacaric acid-treated neuroblastoma LA-N-1 cells by Western blot. 
As shown in Figure 5.6, jacaric acid also decreased the N-myc expression at the 
protein level in a dose-dependent manner. 
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Jacaric acid concentration 
Control 2 |aM 4 n M 6 |aM 
N-myc 
63 kDa 
0.240 0.301 0.005 
P-actin 
42 kDa 
Figure 5.6 The effect of jacaric acid on the expression of N-myc protein in 
human neuroblastoma LA-N-1 cells. The neuroblastoma LA-N-1 cells (2 x 10^) 
were cultured overnight and then treated with different concentrations of jacaric acid 
(0 - 6 |xM) for 48 h. The total cell lysate was extracted from the cells and analyzed by 
Western blot. The protein (20 |ig per sample) was electrophoresed on a 
polyacryamide gel and then transferred to a PVDF membrane for probing with 
specific primary antibody for N-myc (Santa Cruz). It was followed by probing with 
secondary antibody conjugated with horseradish peroxidase and ECL detection assay 
was performed to generate signals by exposing the membrane to an X-ray film. The 
relative intensity of the protein band was normalized against the corresponding 
p-actin band and compared with the control. 
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5.2.5 Jacaric acid modulated the mRNA expression of apoptosis-associated 
genes 
Yasui et al (2006a) demonstrated that both a- (9Z, HE, 13E-CLN) and 
p-eleostearic acid (9E，HE, 13E-CL) significantly down-regulated Bel-2 mRNA in 
human colon cancer Caco-2 cells whereas Bax mRNA was up-regulated by 
P-eleostearic acid. Bcl-2 is an anti-apoptotic protein which guards the integrity of 
mitochondria and prevents release of cytochrome c to the cytosol unless neutralized 
by a BH3-only protein (Cory and Adams, 2002). It is followed by translocation of 
Bax and Bak to the outer mitochondrial membrane. The activation and 
homo-oligomerization of Bax and Bak would permeabilize the outer mitochondrial 
membrane. It gives rise to efflux of apoptogenic proteins like cytochrome c, Omi and 
DIABLO and hence downstream apoptosis-associated events. In Section 4.2.3, 
mitochondrial membrane depolarization was observed in jacaric acid-treated 
neuroblastoma cells, indicating the increase in MMP induced by jacaric acid. It 
would be possible that the balance between anti-apoptotic and pro-apoptotic proteins 
was disrupted thus triggering the mitochondrial apoptotic pathway. Therefore, the 
relative levels mRNA expression of two of the Bcl-2 family members, Bcl-2 and Bak, 
in LA-N-1 cells treated with solvent control or jacaric acid were determined by 
real-time PGR using Taqman® gene expression assays. It was found that jacaric acid 
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Figure 5.7 Jacaric acid suppressed the mRNA expression of anti-apoptotic 
protein Bcl-2 in human neuroblastoma LA-N-1 cells after 48 hours of treatment. 
LA-N-1 cells (5 x 10^) were either treated with solvent control (0.03% ethanol) or 
three different concentrations of jacaric acid (2 |xM, 4 |iM and 6 foM) for 48 hours. 
After treatment, the cells were harvested and total mRNA was extracted using 
TRIZOL method. cDNA was then synthesized from the mRNA by reverse 
transcription and the expression levels were determined by quantitative PCR using 
Taqman® Universal PCR reaction mix according to the manufacturer's instructions. 
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Figure 5.8 Jacaric acid increased the mRNA expression of pro-apoptotic protein 
Bak in human neuroblastoma LA-N-1 cells after 48 hours of treatment. LA-N-1 
cells (5 X 10^) were either treated with solvent control (0.03% ethanol) or three 
different concentrations of jacaric acid (2 |iM, 4 |j.M and 6 ^iM) for 48 hours. After 
treatment, the cells were harvested and total mRNA was extracted using TRIZOL 
method. cDNA was then synthesized from the mRNA by reverse transcription and 
the expression levels were determined by quantitative PCR using Taqman® Universal 
PCR reaction mix according to the manufacturer's instructions. The data were 
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5.3 Discussion 
In this chapter, we attempted to evaluate the involvement of lipid peroxidation, 
caspases, transcription factors and Bcl-2 family members in the growth-inhibitory 
effect by jacaric acid on human neuroblastoma cells. As seen in Chapter 3，jacaric 
acid only inhibited the growth of neuroblastoma cells but not normal murine and 
human cells. The differential effect of jacaric acid on cancer cells and normal cells 
may be due to the vulnerability of cancer cells to damage by ROS-generating agents 
(Hileman et ai, 2004). It was suggested that the cancer cells often generate high 
levels of ROS (Szatrowski and Nathan, 1991) and are under persistent oxidative 
stress (Toyokuni et al., 1995; Kondo et al, 1999). There are two possible reasons for 
the large amounts of ROS produced in cancer cells. Firstly, Sun (1990), Sato et al. 
(1992) and Jaruga et al. (1994) reported down-regulation of antioxidant enzymes in 
tumor cells compared to their normal counterparts. This decrease in antioxidant 
enzymatic activities might be associated with stimulation of cell proliferation in 
tumors via activation of proto-oncogenes and transcription factors (Toyokuni et al., 
1995; Kondo et al., 1999). Another reason for the excess ROS production may be 
related to the alteration in oxidative metabolism in the tumor cells. Cancer cells were 
found to be highly glycolytic by Warburg (Smith, 2000) and it was suggested to be 
due to irreversible damage on the respiratory chain (Warburg, 1956). The less 
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efficient mitochondrial ETC resulted in increased glycolysis in order to fulfil the ATP 
need of the cells. In addition, this altered ETC would give rise to enhanced ROS 
generation because electrons would escape and be captured by molecular oxygen to 
form superoxide radical. This leads to persistent oxidative stress in the cancer cells. 
Similarly, Tsuzuki et al. (2004a) proposed the specificity of a-eleostearic acid (9Z, 
l lE , 13E-CLN) on inducing apoptosis in tumor cells was due to the weaker 
antioxidant enzyme expression in tumor cells as compared to normal tissues (Tisdale 
and Mahmoud, 1983) which results in lower capability of the cancer cells to recover 
from a-eleostearic acid-induced lipid peroxidation. This difference in metabolism 
between cancer and normal cells would be a promising therapeutic target in treating 
cancer. Mechanisms involving ROS production are targeted by some anticancer 
drugs currently used in clinical treatment such as doxorubicin, arsenic trioxide and 
bleomycin in killing tumor cells (Hileman et al., 2004). Jacaric acid was shown to 
induce ROS generation in human neuroblastoma cells and it would be a potential 
candidate for improving the current treatment for neuroblastoma which results in 
many side effects on the growth and development of the patients. 
There is a debate on whether conjugated fatty acids acted as antioxidants or 
pro-oxidants in prevention of atherosclerosis and anticarcinogenic effect. 
Kritchevsky et al. (2000) suggested the possibility of antioxidant activity of CLA 
-192-
Chapter 5: Underlying Mechanisms 
involved in anti-atherosclerosis. Besides, Ha et al. (1990) and Ip et al. (1991) 
proposed that the anticarcinogenic effect of CLA might be due to its antioxidant 
properties. However, van de Berg et al. (1995) and Chen et al. (1997) reported that 
CLA did not function as an effective antioxidant or antioxidant precursor. On the 
contrary, it may function as a pro-oxidant instead. The definition of antioxidant is a 
substance that is able to delay the onset or reduce the oxidation rate of autoxidizable 
materials (Nawar, 1996). In general, an effective antioxidant should be able to donate 
an electron or a hydrogen readily to form a relatively stable intermediate. In addition, 
the intermediate should not induce formation of new free radicals or be oxidized 
rapidly by a chain reaction (Chen et al., 1997). Nevertheless, conjugated fatty acid 
CLA was found to form an unstable free radical intermediate after donating an 
electron or a hydrogen atom and the intermediate would be oxidized quickly into 
furan fatty acids (Yurawecz et al., 1995). Therefore, the health beneficial activities of 
CLA might not be contributed by its antioxidant property. 
An interesting finding by Tsuzuki et al. (2004c) is that oxidation of one of the 
CLN isomers, a-eleostearic acid, did not increase the levels of lipid hydroperoxide 
and TEARS in a cell-free system. On the other hand, significant increase of 
membrane phospholipid peroxidation and TBARS was observed in colon cancer 
DLD-1 cells treated with a-eleostearic acid. This may give us a hint that CLNs are 
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required to incorporate into cell membrane to induce lipid peroxidation. In order to 
understand the underlying mechanism of the anti-proliferative effect of jacaric acid 
on human neuroblastoma cells, LA-N-1 cells were co-incubated with different 
concentrations of jacaric acid and a-tocopherol for 48 hours, a-tocopherol was found 
to reverse the growth-inhibitory effort of jacaric acid on LA-N-1 cells significantly 
without much effect on the neuroblastoma cells when incubated alone. The results 
strongly support the previous findings by Tsuzuki et al. (2004a) and Yasui et al. 
(2006a) that CLN suppressed tumor growth and induced apoptosis via lipid 
peroxidation, a-tocopherol exerts its antioxidant activity by competing with the 
reaction: ROO* + RH -> ROOH + R*. a-tocopherol (TH2) would react with peroxyl 
radicals to form a-tocopherol radical: TH2 + ROO' — ROOH + TH' a-tocopherol is 
an efficient antioxidant since the intermediate radical (TH') is relatively stable due to 
delocalization of the unpaired electron (Nawar, 1996). It is speculated that 
a-tocopherol effectively scavenge the lipid hydroperoxide induced by jacaric acid 
incorporation and hence suppressed the jacaric acid-induced growth inhibition in the 
neuroblastoma cells. Further experiments should be performed to measure the levels 
of phospholipid hydroperoxide and TBARS in jacaric acid-treated neuroblastoma 
cells to confirm to the role of lipid peroxidation in jacaric acid-induced growth 
inhibition. In addition, it would be intriguing to investigate the expression levels of 
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antioxidant enzymes such as SOD in human neuroblastoma cells in response to 
jacaric acid treatment. 
Pre-treatment of human neuroblastoma LA-N-1 cells with caspase inhibitors 
was shown to lower the growth-inhibitory effect of jacaric acid at lower 
concentrations (e.g. 3 fxM). It revealed that caspases, at least caspase-3, played a role 
in the jacaric acid-induced growth inhibition or apoptosis. The phenomena including 
DNA fragmentation and nuclear condensation observed might be due to the 
caspase-3 activity. To establish this correlation, further experiments using dual 
staining of Hoechst 33342 or DAPI with caspase-specific fluorogenic substrate and 
observed by fluorescence/ confocal microscopy should be carried out. However, at 
higher concentrations of jacaric acid, pre-treatment of the neuroblastoma cells with 
caspase inhibitors did not exhibit significant effect on the viability of cells when 
compared to those treated with jacaric acid only. Chipuk and Green (2005) suggested 
that apoptotic inducers sometimes initiate caspase-independent cell death (CICD) 
with the presence of caspase inhibitors. The major morphological difference between 
apoptosis and CICD is the absence of nuclear fragmentation. Cells undergoing CICD 
showed normal without controlled organelle breakdown and formation of 
apoptotic bodies. It is possible for the broad spectrum caspase inhibitor III containing 
fmk which can be metabolized into toxic intermediates that lead to the growth 
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inhibition. Nevertheless, Go 1 stein and Kroemer (2005) reviewed that inhibition of 
caspase activity was shown to result in a switch from apoptosis to necrosis or 
autophagy (death with accumulation of autophagosomes and subsequently vacuoles) 
depending on the cell type, conditions and stimuli. To understand the mechanism of 
growth inhibition by higher concentrations of jacaric acid on neuroblastoma cells in 
the presence of caspase inhibitors, the morphology of the dying cells should be 
examined so as to determine the type of cell death involved. Although it remains 
unclear why caspase inhibition has differential effect on the growth inhibition 
induced by lower and higher concentrations of jacaric acid, an interesting finding by 
Cauwels et al. (2003) may give us some idea. Caspase inhibition by zVAD-fmk did 
not protect the cells from apoptotic cell death induced by TNF but rather sensitized 
the cells to the toxicity via enhancing ROS production and mitochondrial damage. 
This is arisen from the absence of caspase activation and hence lack of cleavage 
inactivation of caspase targets such as phospholipase A2 ( P L A 2 ) and 
receptor-interacting protein (RIP) which are implicated in the ROS generation to 
toxic levels (Chipuk and Green, 2005). Hence, we may speculate that LA-N-1 cells 
pre-treated with caspase inhibitors were more sensitive to ROS induced by higher 
concentrations of jacaric acid than those without pre-treatment and would undergo 
cell death even in presence of caspase inhibitors. 
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N-myc is a gene which encodes a transcription factor normally located on the 
distal short arm of chromosome 2 (Brodeur, 2003). N-myc amplification was reported 
in 22% of neuroblastomas and about 31% of patients of advanced stage (Brodeur et 
aL, 1997). Amplification of N-myc was found to be associated with rapid progression 
of neuroblastoma (Seeger et al.’ 1985) and advanced disease stage (Brodeur et ai, 
1984). Myc heterodimerizes with Max to activate transcription of target genes in 
stimulating cell growth, proliferation and inhibiting terminal cell differentiation 
while Mad and Mnt repress Myc-induced transcription. Ayer and Eisenman (1993) 
found that there was a switch from Myc:Max to MadiMax heterocomplexes in 
phorbol ester-induced monocytic differentiation of human myeloid leukemia U937 
cells. Work done by Cetinkaya et al. (2007) also demonstrated the combination of 
IFN-y and retinoic acid down-regulated N-myc by enhancing protein turnover, 
up-regulated Mad expression and decreased N-Myc/Max dimerization in human 
neuroblastoma cells. IFN-y worked in synergy with retinoic acid in inducing 
differentiation and inhibiting growth of neuroblastoma cells (Wuarin et al, 1991). 
The combination also suppressed tumor growth in nude mice (Cornaglia-Ferraris et 
al., 1992). In the present study, jacaric acid was shown to lower the mRNA 
expression levels of N-myc and Max while up-regulated the N-myc antagonists Mad, 
Mga and Mnt. It gives us some hints on the change in the transactivation activity of 
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the Myc/Max/Mad network. It is speculated that higher expression of N-myc 
antagonists would displace N-myc/Max complexes from the promoter of target genes 
and hence leads to suppression of transcription. Further experiments are required to 
determine the DNA binding and transcription activity of N-myc/Max heterodimer in 
jacaric acid-treated cells. Western blot revealed that jacaric acid also lowered the 
protein expression of N-myc in human neuroblastoma cells. It may be associated 
with the reduced tumorigenicity and induced morphological differentiation by jacaric 
acid as shown in previous chapters. Cetinkaya et al. (2007) reported that combined 
retinoic acid and IFN-y treatment modulated the turnover rate of N-myc protein. 
N-myc protein was found to be unstable and with a short half-life of 30 minutes 
(Ramsay et al., 1986). The degradation of N-myc proteins was shown to be mediated 
by the ubiquitin system in an ATP-dependent manner (Ciechanover et al., 1991). It 
would be worthwhile to examine whether jacaric acid treatment would have any 
effect on the degradation and the stability of N-myc proteins in human 
neuroblastoma cells. Experiments like co-immunoprecipitation followed by Western 
blot can also be performed to examine whether there is a shift from N-myc:Max to 
other transcriptional heterocomplexes. LA-N-1 used in this study is a neuroblastoma 
cell line with N-myc amplification. Screening of the effect of jacaric acid treatment 
on N-myc expression in other cell lines with N-myc amplification could be done to 
-198-
Chapter 5: Underlying Mechanisms 
determine whether the effect was tumor cell line-specific or generally applicable to 
other N-myc amplified cell lines. 
As mentioned by Fulda (2009), it is the ratio of pro-survival and pro-apoptotic 
proteins instead of the expression level of one single Bcl-2 family member that 
determines whether stressed cells are to live or commit apoptosis. Figure 5.9 shows 





Figure 5.9 The model of Bcl-2 family members interaction on mitochondrial 
integrity (Adopted from Cory and Adams, 2002) 
In living cells, the mitochondria are protected by Bcl-2 and its anti-apoptotic 
homologues. lAPs in the cytosol would inhibit the activation of caspase-3 by 
blocking caspase-9 activation (Fulda, 2009). Upon binding by BH-3 only proteins 
such as Bad and Bim, Bcl-2 will free the adaptor proteins Bak and Bax, followed by 
the homo-oligomerization of Bax/Bak and permeabilization of the outer 
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mitochondrial membrane. As a result, cytochrome c and other apoptogenic proteins 
like Omi and DIABLO are then released from the intermembrane space and lead to 
subsequent caspases activation. 
In this study, we demonstrated that jacaric acid reduced Bcl-2 mRNA 
expression level in neuroblastoma LA-N-1 cells and increased the mRNA expression 
of Bak at the same time. The result was similar to that obtained by Yasui et al. (2006a) 
in which a- and p-eleostearic acid suppressed the Bcl-2 expression in human colon 
cancer cells. A preliminary study on the protein expression of Bcl-2 was performed 
and a decrease in Bcl-2 expression was observed in jacaric acid-treated 
neuroblastoma cells (data not shown). Previous study by Yip (2007) in our group also 
showed that jacaric acid increased the protein expression levels of Bak and Bad 
while lowered those of Bcl-2 and BC1-XL in human promyelocytic leukemia HL-60 
cells. Niizuma et al. (2006) reported that neuroblastoma cells with high Bcl-2 
expression showed resistance to retinoic acid (RA)-induced apoptosis while those 
with low Bcl-2 expression were sensitive to RA, indicating the important role of 
Bcl-2 in RA-triggered cell death. By adding a Bcl-2 inhibitor HA 12-1, 
neuroblastoma cells with high Bcl-2 expression became more sensitive to RA. This 
may explain why retinoic acid acted in synergy with jacaric acid in human 
neuroblastoma LA-N-1 cells, as shown previously in Section 3.2.5. Since RA has a 
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potent effect in inducing differentiation in neuroblastoma cells, a combination of RA 
with jacaric acid might be used to augment the apoptosis-inducing effect of the 
treatment. Studies on the differential expression levels of other Bcl-2 family 
members induced by jacaric acid would be needed to have a broader view of 
interplay between opposing Bcl-2 family members in the neuroblastoma. Truncated 
Bid would be of particular interest since its cleavage product by caspase-8 or 
granzyme B would has different affinities to Bak and Bax (Cartron et ai, 2003). 
When taken together, our results demonstrated that the growth inhibition by 
jacaric acid on neuroblastoma cells can be restored by an antioxidant a-tocopherol, 
revealing the possible involvement of lipid peroxidation in jacaric acid-induced 
growth inhibition. Caspase inhibitors also lowered the growth-inhibitory effect of 
jacaric acid, confirming the role of activated caspases in neuroblastoma cells treated 
with jacaric acid. The differential effects of jacaric acid on transcription factor 
N-myc and its counterparts have shed some light on the mechanism by which jacaric 
acid can exert its anti-proliferative effect on the neuroblastoma cells. Finally, the 
effect of jacaric acid on the mRNA and protein expression of Bcl-2 family members, 
together with evidence of dissipation, showed that the human neuroblastoma 
LA-N-1 cells probably underwent the intrinsic apoptotic pathway upon treatment 





Chapter 6: Conclusions and future perspectives 
Conjugated linolenic acid (CLN), a group of fatty acids with 18 carbons and 
three conjugated double bonds, was first identified in 1956 by McLean and Clark. 
Since then, more geometric and positional isomers of CLN were isolated and 
characterized. Conjugated fatty acids have attracted much attention from scientists 
for their health-beneficial effects in anti-atherosclerosis (Kritchevsky et al., 2000) 
anti-carcinogenesis (Ha et al., 1990)，antioxidant (Ip et al., 1991) and anti-obesity 
(Koba et al., 2002). One of the most intriguing activities of conjugated fatty acids is 
their anti-tumor potential. CLA which contains two conjugated double bonds was 
reported to exhibit anti-proliferative effect in a number of cancer cells including 
breast cancer, prostate cancer, gastrointestinal and colon cancer (Bhattacharya et al.’ 
2006). The advantage of CLN over CLA is the much higher content (60 - 80%, w/w) 
found in natural products such as minor seed oils (Tsuzuki et al., 2006). CLN also 
showed much stronger growth-inhibitory effect on cancer cells such as human colon 
cancer, hepatoma, lung adenocarcinoma and leukemia (Igarashi and Miyazawa, 2000; 
Tsuzuki et al., 2004a) as compared to CLA. 
Anti-tumor effect of CLN has been extensively studied on human colon 
cancer (Kohno et al., 2002; Yasui et al., 2005; Yasui et al., 2006a; 2006b; Tsuzuki 
and Kawakami, 2008). However, the anti-proliferative effect of CLN on human 
neuroblastoma cells and its underlying mechanisms remain unclear. The current 
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Study aims at investigating the modulatory effects of CLN on human neuroblastoma 
cells and elucidation of the possible underlying mechanisms. 
All the seven CLN isomers tested exhibited a dose-dependent 
growth-inhibitory effect on human neuroblastoma LA-N-1 cells. Among the seven 
isomers, jacaric acid (8Z, lOE, 12Z CLN) was found to be the most potent in its 
anti-proliferative effect and similar effect was observed in other two human 
neuroblastoma cell lines SH-SY5Y and SK-N-DZ. The potency of CLNs in 
inhibiting the growth of LA-N-1 cells was much stronger than other fatty acids with 
less or no conjugated double bonds. Our results agree with those in the literature. 
Jacaric acid inhibited the growth of LA-N-1 cells in a dose- and time-dependent 
manner. The growth-inhibitory effect was also partially reversible. Jacaric acid was 
relatively non-toxic to murine and human normal cells tested and the strong 
anti-proliferative effect on LA-N-1 cells was not likely to be due to direct 
cytotoxicity on the cells. Interestingly, jacaric acid exerted synergistic 
growth-inhibitory effect on LA-N-1 cells when combined with daidzein or retinoic 
acid. In addition, jacaric acid suppressed the colony-forming ability and invasiveness 
of LA-N-1 cells significantly. Moreover, pre-treatment with jacaric acid lowered the 
in vivo tumorigenicity of neuroblastoma LA-N-1 cells in nude mice. Further 
experiments should be performed to study the effect of oral or intravenous 
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administration of jacaric acid to the mice on the growth of transplanted 
neuroblastoma. It would be of interest to investigate the underlying mechanisms and 
to optimize the conditions by which the combination of jacaric acid and daidzein or 
retinoic acid could work in synergy in inhibiting the growth of neuroblastoma cells. 
A proposed mechanism for the anti-proliferative effect of CLN is the 
conversion of CLN to CLA which yields the potent growth-inhibitory effect on 
cancer (Tsuzuki et al.’ 2003; 2004; 2006). To examine this hypothesis, the 
conditioned medium from neuroblastoma cells treated with jacaric acid can be used 
to incubate with another set of neuroblastoma cells. In this way, whether CLN or the 
metabolite(s) of CLN serves as the active agent in exerting the growth-inhibitory 
effect on the neuroblastoma cells can be determined (Cornelius et ai, 1991). 
Other than the differential expression of antioxidant enzymes in cancer cells 
and normal cells, the different effects of jacaric acid on the viability of 
neuroblastoma cells and normal murine and human cells may also be due to the 
different rates in the uptake of this fatty acid. Das et al. (1987) reported significant 
differences between normal and tumor cells in fatty acid uptake and distribution. 
Measurement of CLN uptake would help to further delineate the underlying 
mechanism of the specificity of growth-inhibitory effect of CLN on neuroblastoma 
cells. 
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The growth-inhibitory effect on neuroblastoma cells exerted by jacaric acid 
might be related to its effect on the cell cycle progression of LA-N-1 cells. Therefore, 
the cell cycle profile of the jacaric acid-treated cells was analysed. Unexpectedly, the 
jacaric acid did not exhibit significant effect on the cell cycle distribution of LA-N-1 
cells under the experimental condition tested. On the other hand, jacaric acid was 
shown to suppress the number of cell division committed by LA-N-1 cells. Cell cycle 
analysis of neuroblastoma cells treated with different concentrations of jacaric acid 
for different time periods should be carried out to confirm whether jacaric acid can 
affect the cell cycle distribution of the LA-N-1 cells. 
Deregulation of apoptosis was reported in neuroblastoma which results in 
treatment resistance especially common in high-risk patients (Fulda, 2009). Induction 
of apoptosis in neuroblastoma would be a promising novel approach in 
neuroblastoma treatment. A number of apoptosis-associated events were monitored 
in jacaric acid-treated neuroblastoma cells. Being one of the biochemical hallmarks 
of apoptosis, DNA fragmentation was induced by jacaric acid in LA-N-1 cells in a 
time- and dose-dependent manner. Another nuclear event occurring during apoptosis, 
chromatin condensation, was observed in neuroblastoma LA-N-1 cells stained with 
Hoechst 33342 and then examined under a fluorescent microscope. Externalization 
of phosphatidylserine is a phenomenon commonly detected in early apoptotic cells. 
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Jacaric acid was shown to induce the disruption in membrane asymmetry in 
neuroblastoma cells, as detected by Annexin V/ PI dual staining. Interestingly, 
pre-incubation of the cells with superoxide dismutase before jacaric acid treatment 
lowered the percentage of early apoptotic cells. Mitochondrial membrane 
permeability transition is an early apoptotic event which would be followed by 
release of cytochrome c and other apoptogenic factors from the intermembrane 
spaces. Dissipation of was triggered in jacaric acid-treated human 
neuroblastoma cells as demonstrated by JC-1 staining. ROS production was also 
increased by jacaric acid treatment, which could be suppressed by co-incubation with 
a-tocopherol. These data suggested that apoptosis of neuroblastoma cells induced by 
jacaric acid might be via the intrinsic pathway. It would also be worthwhile to study 
the ratio of cytosolic and mitochondrial levels of apoptogenic factors to determine 
whether mitochondrial release of these factors is involved in the apoptotic cells. 
Furthermore, activation of caspase-3 was found in LA-N-1 cells incubated with 
jacaric acid for 48 hours. To confirm the involvement of caspase-3 in jacaric 
acid-induced apoptosis, the integrity and activity of caspase-3 substrates including 
PARP and Acinus should be examined in the future. 
A recent publication reported the reversibility of apoptosis in cancer cells 
(Tang et al, 2009). Since the anti-proliferative effect of jacaric acid was found to be 
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partially reversible, morphological observation of the cells with jacaric acid removed 
after different time periods could be done to see whether this would induce evasion 
from apoptosis and drug resistance in the cells. It would simulate the situation in 
high-risk neuroblastoma patients with relapse tumor after completion of the intensive 
multimodal therapy. 
Morphological differentiation was observed in human neuroblastoma 
SH-SY5Y cells treated with low concentrations of jacaric acid for 4 days. The 
morphological observation was supported by data obtained from flow cytometry. A 
slight increase in cell size and granularity was induced by jacaric acid in SH-SY5Y 
cells. Further experiments are required to determine whether the cells have matured 
both phenotypically and functionally. The expression of microtubule-associated 
proteins such as MAP-2 and neurofilament can be studied by confocal microscopy 
while the activity of neurotransmitter-producing enzymes like tyrosine hydroxylase 
can be measured. There are also a number of oncogenes such as c-jun, c-fos, c-myc 
and H-ras which the expression of which is associated with differentiation of 
neuroblastoma cells (de Groot and Kruijer, 1991; Cohrs et al,’ 1991) and are worthy 
of further investigation. 
Several research groups have proposed lipid peroxidation as the mechanism 
for the anti-tumor effect of CLNs on colon cancer cells (Tsuzuki et al., 2004a; Yasui 
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et al., 2006a). In this study, the growth-inhibitory activity of jacaric acid was reduced 
by co-incubation with an antioxidant a-tocopherol, suggesting the possible 
involvement of lipid peroxidation in the growth inhibition in the human 
neuroblastoma cells. Further confirmation is required by measuring the phospholipid 
hydroperoxide and TBARS in the jacaric acid-treated cells in vitro or tumor in vivo 
to directly evaluate the role of lipid peroxidation in jacaric acid-induced growth 
inhibition in neuroblastoma. 
In the present study, caspase inhibitors were shown to lower the 
growth-inhibitory effect of jacaric acid in human neuroblastoma cells, supporting the 
participation of caspases, as least caspase-3, in the jacaric acid-induced growth 
inhibition or apoptosis. The regulation of apoptosis upstream of caspase-3 in jacaric 
acid-induced apoptosis remains unclear. It would be important to find out how 
caspase-3 is activated and the molecular targets of jacaric acid in order to develop 
CLN into a safe and suitable candidate for neuroblastoma treatment. For instance, the 
factors involved in the extrinsic apoptotic pathway have not been studied in jacaric 
acid-treated neuroblastoma cells. From the evidence of mitochondrial membrane 
depolarization and increase in ROS generation in the neuroblastoma cells, the 
apoptosis induced by jacaric acid is likely to be via the intrinsic pathway, but it is still 
possible for the extrinsic pathway to be involved and cross-talk with the 
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mitochondrial via Bid. Therefore, the cleavage of Bid is of particular interest for 
further elucidation of the underlying mechanism of jacaric acid-induced apoptosis. 
The gene expression of Max/N-myc/Mad network family members was 
studied and the results showed that N-myc and Max were down-regulated in 
neuroblastoma cells treated with jacaric acid while the mRNA expression levels of 
N-myc antagonists were increased. In addition, the protein expression of N-myc was 
also found to be suppressed by jacaric acid. Further study on the time-dependent 
change of the N-myc protein is helpful in understanding the association of N-myc 
and neuronal differentiation. The DNA binding and transcription activity of 
N-myc/Max heterodimer in jacaric acid-treated cells could be examined. Moreover, 
the mechanism by which jacaric acid reduced the N-myc protein expression remains 
unclear since jacaric acid may act on the synthesis, stability or degradation of the 
protein. 
A preliminary study was performed to examine the mRNA expression level of 
two Bcl-2 family members, including Bcl-2 which encodes an anti-apoptotic protein 
and Bak which encodes a pro-apoptotic protein. The results showed that Bcl-2 was 
down-regulated while Bak was up-regulated in jacaric acid-treated neuroblastoma 
LA-N-1 cells. Studies on the differential expression levels of other Bcl-2 family 
members induced by jacaric acid would be needed to have a broader view of 
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interplay between opposing Bcl-2 family members in triggering the apoptosis of the 
neuroblastoma cells in response to CLN. 
In conclusion, the CLN isomer jacaric acid was shown to inhibit the growth 
of human neuroblastoma cells in vitro, probably by inhibiting the cells from 
committing cell division, triggering lipid peroxidation, inducing apoptosis and 
differentiation in the neuroblastoma cells. Nevertheless, there is still a long way for 
jacaric acid to be developed into a drug suitable for treatment of human 
neuroblastomas. More in vivo studies should be carried out to test the safety and 
efficacy of jacaric acid in animal models. The detailed mechanisms underlying the 
anti-tumor effect of jacaric acid on neuroblastoma cells have to be further explored 
before using jacaric acid in clinical trials for neuroblastoma patients. It is hoped that 
jacaric acid can be applied alone or in combinations with other chemotherapeutic 
drugs or natural products to treat children with high-risk neuroblastoma and improve 
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